data_2fry_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2fry _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.702 0.287 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 125.95 30.65 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -127.4 166.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.227 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.696 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -131.58 155.48 41.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.408 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 3.9 tt0 -134.04 154.02 51.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.961 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.539 ' OG1' ' HD2' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -111.44 162.05 15.48 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.284 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.71 -34.66 1.32 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.98 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.417 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 22.6 m-85 -123.99 122.87 26.2 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.84 60.91 2.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.177 1.918 . . . . 0.0 111.161 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.628 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 9.4 m-85 -87.75 154.27 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.838 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -95.6 152.52 18.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -89.28 171.87 9.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.54 -55.31 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.17 158.4 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.807 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -31.0 68.31 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.736 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 12.0 mp0 -87.13 26.12 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.997 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.724 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.6 mt-10 -110.33 -176.76 3.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.266 0.555 . . . . 0.0 111.635 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.577 ' CD2' ' CE2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -138.58 137.64 37.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.391 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.457 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -113.55 100.08 8.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 111.441 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CE2' ' CD2' ' A' ' 19' ' ' LEU . 20.5 m-30 -133.69 162.8 30.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 3.5 tp10 -81.33 95.88 7.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 0.8 OUTLIER -76.58 143.52 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.156 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.74 -39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.295 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -147.13 0.27 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.583 0.23 . . . . 0.0 111.167 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -108.38 146.22 33.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.589 0.709 . . . . 0.0 112.193 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.596 ' O ' ' N ' ' A' ' 5' ' ' VAL . 26.8 mmt -134.24 164.97 26.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.443 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.5 mt-10 -113.71 122.78 48.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.59 ' CG2' HG11 ' A' ' 5' ' ' VAL . 2.8 t -92.45 127.47 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.451 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.543 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -91.28 -39.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.21 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -87.99 118.19 27.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.088 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HB3' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.5 155.52 36.27 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.07 8.57 4.53 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.065 2.51 . . . . 0.0 113.416 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -88.43 -30.68 19.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.006 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -121.3 -36.23 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 110.649 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.413 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . 2.8 m-20 -96.83 165.2 16.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.586 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 36' ' ' ASP . 1.1 Cg_endo -44.43 177.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.086 2.524 . . . . 0.0 112.838 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -4.27 15.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.202 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.02 146.06 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.701 0.286 . . . . 0.0 110.9 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.572 ' CD1' HG11 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -124.07 169.96 11.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.426 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.543 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -144.92 137.57 26.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.429 . . . . 0.0 112.14 -178.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 7.0 p -134.91 157.7 46.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.95 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.782 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 4.5 pttm -92.27 135.2 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 111.896 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 46' ' ' ARG . 1.9 t30 -108.78 174.58 5.81 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.167 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.9 4.46 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.532 0.682 . . . . 0.0 109.417 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.552 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.79 -8.58 59.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.8 -15.22 38.2 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.481 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -118.22 138.25 52.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.907 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.782 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -120.08 125.7 74.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -117.51 -159.89 11.54 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.234 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.724 ' H ' ' HA ' ' A' ' 18' ' ' GLU . 1.2 mp -96.13 110.46 22.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.572 HG11 ' CD1' ' A' ' 40' ' ' TRP . 1.4 p -92.47 133.16 30.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.097 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HD2' HG21 ' A' ' 52' ' ' VAL . 77.5 Cg_endo -74.28 106.87 2.31 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.072 2.515 . . . . 0.0 111.797 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -51.63 -23.4 4.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.984 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -67.82 -10.84 56.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.852 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.628 ' CD2' ' HB3' ' A' ' 11' ' ' PHE . 18.6 m-85 -116.67 12.99 15.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.433 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.508 ' HA ' HD13 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -149.6 176.7 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HB ' HD12 ' A' ' 8' ' ' LEU . 9.5 p -139.16 120.15 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.04 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.5 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.0 t -65.2 145.69 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.139 0.495 . . . . 0.0 111.485 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.696 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.97 100.06 3.94 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.767 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.898 179.782 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.779 0.323 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 121.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -121.87 167.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.005 -178.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.642 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -133.14 157.6 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.19 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.8 tt0 -116.52 140.52 49.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.407 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 24' ' ' GLY . 1.9 p -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.148 0.499 . . . . 0.0 111.309 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -114.71 -37.74 4.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.061 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -133.12 162.28 58.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.738 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -46.1 175.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.143 2.562 . . . . 0.0 112.872 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 21' ' ' PHE . 51.7 p90 -93.42 129.23 39.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.638 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -130.04 117.78 20.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.47 126.9 46.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.3 m -132.47 -47.88 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.74 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.437 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -55.38 172.5 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.335 . . . . 0.0 110.994 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.72 -33.88 69.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HB2' ' CD2' ' A' ' 51' ' ' LEU . 2.4 mm-40 -92.73 32.77 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.613 0.244 . . . . 0.0 111.419 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.597 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.7 mt-10 -121.68 166.84 13.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.484 HD13 ' N ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -153.08 149.35 28.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.907 0.385 . . . . 0.0 110.715 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -100.65 111.56 23.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 111.389 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.556 ' CD2' ' HB2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -133.53 163.2 29.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.019 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 2.0 tp10 -69.4 99.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -73.45 128.28 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.318 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.543 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -88.92 -145.64 11.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.621 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.436 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 2.3 tt0 -95.82 -17.9 20.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.255 0.55 . . . . 0.0 110.689 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -142.6 144.08 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.851 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.43 164.25 29.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.261 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 1.5 pm0 -120.9 112.41 18.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.393 . . . . 0.0 110.291 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.477 ' CG2' HG13 ' A' ' 5' ' ' VAL . 14.3 t -91.37 137.25 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.745 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.573 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.8 -39.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.338 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -89.99 107.95 19.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.09 139.38 49.22 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -85.5 12.59 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -21.15 55.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.655 0.264 . . . . 0.0 111.079 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -115.12 -42.32 3.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.875 0.369 . . . . 0.0 110.46 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.86 100.98 36.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.98 61.61 7.47 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.575 2.184 . . . . 0.0 112.633 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HB2' ' CE3' ' A' ' 39' ' ' TRP . 0.9 OUTLIER -114.55 -75.46 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.38 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 m-90 -151.77 146.19 25.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.144 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.655 ' CD1' HG12 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -119.83 169.03 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.573 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -133.08 138.3 46.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 112.055 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -132.28 157.73 43.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.867 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.78 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.15 143.22 26.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.277 0.561 . . . . 0.0 111.444 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.556 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 4.5 t-20 -120.93 174.52 6.57 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.462 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.11 -10.75 24.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.568 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.422 ' HB2' ' CG ' ' A' ' 48' ' ' GLN . 2.8 mmp_? -83.35 -1.81 54.23 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.46 5.69 68.37 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.085 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.465 ' HG3' HD21 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -118.28 115.35 24.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.096 0.474 . . . . 0.0 111.939 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.78 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -104.07 132.53 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 41' ' ' LYS . . . -141.14 -178.27 17.24 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.858 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.597 ' H ' ' HA ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -73.47 111.52 8.68 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.279 0.561 . . . . 0.0 111.331 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.655 HG12 ' CD1' ' A' ' 40' ' ' TRP . 1.7 p -101.11 147.07 33.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.869 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 52' ' ' VAL . 53.9 Cg_endo -60.43 87.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.288 2.659 . . . . 0.0 111.519 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -53.38 -26.58 19.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.83 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -82.32 -0.18 44.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.497 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 2.5 m-85 -110.14 13.14 23.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.501 ' HA ' ' CG ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -149.39 177.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.093 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.59 ' CG1' HD22 ' A' ' 8' ' ' LEU . 7.5 p -131.23 121.33 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.482 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 33.9 t -65.38 146.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.801 0.81 . . . . 0.0 113.058 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.642 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -105.4 164.06 12.15 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.331 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--N 1.308 -1.198 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.891 -179.819 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.522 -0.124 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 119.54 23.6 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.57 166.48 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.205 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.716 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -135.19 158.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.173 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -134.22 139.89 46.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.95 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.644 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -111.2 165.52 11.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.184 0.516 . . . . 0.0 111.094 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.543 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.13 -31.53 3.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.639 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.411 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 34.4 m-85 -125.28 161.53 49.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 91.2 Cg_exo -44.11 151.72 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.661 2.24 . . . . 0.0 112.602 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 21' ' ' PHE . 9.2 t80 -95.42 130.25 42.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.954 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -129.06 144.37 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -170.94 161.87 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.808 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -173.06 89.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.074 0.464 . . . . 0.0 111.228 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.94 172.6 16.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.976 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -32.83 74.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.618 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.12 -50.87 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.759 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 51' ' ' LEU . 10.4 mt-10 -63.99 153.52 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.645 ' CD2' ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -149.2 159.43 44.26 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.09 153.09 19.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.645 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 46.8 m-85 -133.69 164.19 27.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.689 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.85 -156.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.43 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -51.64 126.92 18.97 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.722 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.429 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -125.16 86.26 0.36 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.086 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -95.4 -22.7 17.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 0.0 109.388 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 p -138.84 128.33 24.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.693 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.49 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -138.73 164.71 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.208 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 4.6 mt-10 -125.71 115.22 19.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 0.0 111.243 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' HG13 ' A' ' 5' ' ' VAL . 24.9 t -94.82 127.07 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 110.645 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.635 HD13 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.31 -77.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.636 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.117 0.484 . . . . 0.0 112.022 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.74 159.32 33.66 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.508 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HG3' ' CE3' ' A' ' 40' ' ' TRP . 6.4 Cg_exo -74.6 6.33 3.27 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.82 2.347 . . . . 0.0 113.09 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.38 -34.19 72.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.601 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -97.28 -44.77 6.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -123.27 100.83 38.66 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.372 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.92 57.18 5.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.476 2.117 . . . . 0.0 112.583 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' OE2' ' CZ2' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -121.75 -77.09 0.58 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.039 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.504 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -151.41 158.52 43.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.126 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.649 ' HE1' ' H ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -116.18 -179.23 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HD3' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -151.22 138.64 19.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.834 -179.053 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 2.9 p -131.18 154.49 48.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.661 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.769 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.22 136.85 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.475 0.655 . . . . 0.0 110.864 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.599 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 4.1 t-20 -109.29 174.57 5.81 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.734 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.3 -3.69 21.92 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.295 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.54 -2.66 56.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.343 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.04 83.88 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.887 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -118.52 138.34 52.59 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.91 0.386 . . . . 0.0 111.66 -179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.769 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -132.99 126.06 52.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' LYS . . . -133.5 -164.33 10.73 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.515 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -84.96 129.88 34.73 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.306 0.574 . . . . 0.0 111.529 -179.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.516 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 6.0 p -134.0 140.78 37.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.442 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -91.03 60.54 1.23 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.537 2.824 . . . . 0.0 111.885 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.745 ' HG3' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -45.24 -11.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -45.09 -20.71 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.099 -0.376 . . . . 0.0 111.495 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 56' ' ' TYR . 24.9 p90 -101.93 31.49 3.87 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.745 HG23 ' HG3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -148.63 176.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.691 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.434 ' N ' HG21 ' A' ' 57' ' ' VAL . 9.8 p -108.07 112.78 41.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -71.75 146.46 11.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.432 0.634 . . . . 0.0 112.07 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.716 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -100.87 161.54 13.53 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.332 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.766 0.317 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.91 120.56 24.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.53 166.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.69 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -128.87 161.83 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.42 0.629 . . . . 0.0 111.283 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.509 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 2.8 tt0 -139.14 146.81 41.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.178 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.583 ' OG1' ' HA ' ' A' ' 25' ' ' GLU . 5.7 p -105.7 163.05 12.99 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.922 0.392 . . . . 0.0 110.567 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.09 -35.81 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.368 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.497 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 10.0 m-85 -119.55 135.86 24.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.393 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.94 59.04 2.18 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.292 1.995 . . . . 0.0 110.387 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.581 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 13.1 m-85 -73.28 155.53 39.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.652 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -94.11 151.88 19.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.808 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 4.0 m -145.67 99.77 3.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.65 103.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 111.554 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.46 172.45 18.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.548 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -32.78 74.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.058 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -113.44 12.23 18.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.513 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 4.8 mt-10 -102.11 -173.79 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.675 0.274 . . . . 0.0 111.049 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.501 HD13 ' HA3' ' A' ' 50' ' ' GLY . 0.6 OUTLIER -147.02 160.53 42.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.352 0.596 . . . . 0.0 112.201 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.15 102.02 4.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.5 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.431 ' CE1' ' CE ' ' A' ' 27' ' ' MET . 4.3 p90 -129.74 164.05 24.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.701 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -52.26 133.04 34.46 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.221 0.534 . . . . 0.0 111.708 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.429 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -147.42 54.73 0.52 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.341 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.583 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 1.3 tt0 -59.72 -21.15 60.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 110.054 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -124.64 117.4 24.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.846 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.431 ' CE ' ' CE1' ' A' ' 21' ' ' PHE . 24.4 mtp -139.14 163.41 32.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.237 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 0.7 OUTLIER -126.38 112.35 15.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.635 0.255 . . . . 0.0 110.855 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.64 ' CG2' HG11 ' A' ' 5' ' ' VAL . 5.8 t -85.67 113.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.277 0.56 . . . . 0.0 111.252 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.578 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.61 -38.91 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.607 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -98.35 118.08 34.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.273 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 25.5 mmtp -91.94 142.29 26.3 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 5.1 Cg_exo -79.62 7.97 4.23 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.756 2.304 . . . . 0.0 112.766 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -51.68 67.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.24 -34.55 10.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.83 165.11 56.13 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.681 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.17 -75.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.706 2.271 . . . . 0.0 112.772 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -175.41 17.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -123.37 145.8 48.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.505 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -126.09 171.11 11.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.578 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -144.0 137.24 27.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.196 -179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 8.3 p -132.46 151.88 51.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.775 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 7.4 mttp -91.59 140.22 29.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.392 0.615 . . . . 0.0 110.75 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -115.49 174.75 5.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.182 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.66 -1.84 17.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.254 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.513 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 5.8 ttm180 -83.56 -7.45 59.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.57 -12.76 55.14 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.774 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HB3' HD23 ' A' ' 19' ' ' LEU . 2.6 mp0 -117.87 137.68 52.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.775 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.04 126.13 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.174 0.511 . . . . 0.0 110.123 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.501 ' HA3' HD13 ' A' ' 19' ' ' LEU . . . -110.35 -142.26 9.24 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.285 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.573 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -117.54 110.33 17.82 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.505 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.6 p -92.01 131.94 33.9 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.003 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 63.2 Cg_endo -74.53 107.19 2.4 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.3 2.667 . . . . 0.0 111.77 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HA ' ' HZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -49.86 -25.38 3.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.129 0.49 . . . . 0.0 111.914 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.56 -11.83 58.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.581 ' CD1' ' CD2' ' A' ' 11' ' ' PHE . 15.5 m-30 -116.44 13.51 15.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.736 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.494 HG13 ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -149.4 175.75 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.617 0.722 . . . . 0.0 112.491 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.42 ' CG1' ' CD1' ' A' ' 8' ' ' LEU . 10.7 p -139.68 117.78 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.895 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 2.2 t -65.21 145.82 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.133 0.492 . . . . 0.0 111.272 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.69 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -139.05 99.79 3.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.522 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.0 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.921 -179.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.521 -0.16 0 CA-C-O 120.801 0.334 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 129.12 34.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.68 167.75 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.987 0.423 . . . . 0.0 111.183 -178.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.69 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.9 160.57 42.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.481 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 4.2 tt0 -124.44 140.48 52.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.62 154.38 24.97 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.549 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.76 -40.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.951 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.18 161.68 22.91 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.51 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.59 -176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.887 2.391 . . . . 0.0 112.972 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.459 ' CE2' ' N ' ' A' ' 21' ' ' PHE . 25.1 p90 -118.16 132.48 56.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.053 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -129.66 117.89 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.665 0.269 . . . . 0.0 111.517 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.625 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -92.09 140.04 30.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.702 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 15' ' ' THR . 33.4 m -144.86 -31.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 14' ' ' VAL . 20.9 m -84.15 162.88 20.09 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 111.854 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -37.79 87.83 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.091 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -98.63 32.68 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.133 0.492 . . . . 0.0 110.253 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.63 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -101.79 176.29 5.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.829 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.53 ' HB2' ' HA3' ' A' ' 50' ' ' GLY . 2.7 mp -144.24 164.54 30.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.555 0.693 . . . . 0.0 112.11 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -134.85 100.41 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.755 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.459 ' N ' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -134.81 156.88 48.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.821 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HA ' ' CE1' ' A' ' 11' ' ' PHE . 5.9 mp0 -64.94 98.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CE ' ' CE ' ' A' ' 27' ' ' MET . 0.2 OUTLIER -73.74 133.94 43.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.282 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.48 -148.73 24.61 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.737 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 6' ' ' GLN . 2.2 tt0 -94.92 -17.14 22.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 0.0 111.228 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.09 132.62 43.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.309 0.576 . . . . 0.0 112.164 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -138.87 164.2 30.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.877 178.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 pt-20 -122.75 118.66 28.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.772 0.32 . . . . 0.0 110.556 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.508 HG22 ' CE2' ' A' ' 40' ' ' TRP . 23.3 t -93.87 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.251 0.548 . . . . 0.0 111.762 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.548 HD13 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.19 -44.21 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.756 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -110.09 120.42 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.397 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.474 ' HE3' HG11 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -99.72 139.27 20.71 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.321 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 38.2 Cg_endo -91.32 17.59 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.022 2.481 . . . . 0.0 112.544 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.97 -37.68 38.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.09 -44.09 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -123.75 101.03 36.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.801 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.75 79.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -119.3 -83.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.442 ' CD2' HD22 ' A' ' 51' ' ' LEU . 1.3 m0 -151.63 160.89 43.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.285 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.642 ' CD1' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -126.03 107.41 10.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.579 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -123.35 138.54 54.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.647 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -127.51 156.77 41.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.426 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.793 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 5.6 ptpp? -91.93 142.9 27.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.606 0.717 . . . . 0.0 111.655 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -122.52 175.43 6.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.953 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -0.38 4.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.082 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.77 -7.52 59.45 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.66 0.266 . . . . 0.0 110.593 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.4 -11.66 54.65 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.024 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.445 ' O ' HD22 ' A' ' 19' ' ' LEU . 5.9 mp0 -118.1 137.79 52.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.516 0.327 . . . . 0.0 110.396 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.793 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -116.32 130.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -115.43 -159.72 12.28 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.245 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.63 ' H ' ' HA ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -98.5 132.49 43.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.618 0.723 . . . . 0.0 110.73 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.642 ' CG1' ' CD1' ' A' ' 40' ' ' TRP . 2.1 p -118.66 150.01 47.44 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.172 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 52' ' ' VAL . 54.0 Cg_endo -60.79 82.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 123.355 2.704 . . . . 0.0 111.639 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.47 ' CB ' ' CE3' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -50.02 -26.78 4.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.82 -13.31 59.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.93 0.395 . . . . 0.0 111.157 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.562 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -101.94 30.93 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.372 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.631 ' CG2' ' CZ2' ' A' ' 40' ' ' TRP . 2.4 m -150.32 177.57 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 7.6 p -136.43 113.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.191 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.509 HG22 ' CH2' ' A' ' 40' ' ' TRP . 16.4 t -65.75 147.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.69 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -106.24 164.02 12.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.025 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.309 -1.162 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.112 -179.675 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 112.11 18.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -128.72 167.39 24.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.224 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.637 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -130.05 151.96 36.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 110.718 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 3.7 tt0 -115.55 144.47 43.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.25 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.41 ' CB ' ' HD2' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -115.9 153.25 31.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.581 HD21 ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -131.31 -44.08 1.03 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.044 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -100.71 157.05 34.43 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.853 0.358 . . . . 0.0 111.648 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.53 162.28 15.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.772 2.315 . . . . 0.0 112.054 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.477 ' CE2' ' CG2' ' A' ' 52' ' ' VAL . 3.2 m-85 -111.59 135.15 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.034 0.445 . . . . 0.0 111.616 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -129.03 118.86 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.301 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.8 m -103.53 142.7 33.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.384 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.88 -45.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.41 172.45 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.94 -37.5 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.033 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -63.16 -48.92 76.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.574 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.44 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -54.54 -171.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.825 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.701 ' HG ' ' HB3' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -178.79 158.25 0.98 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.122 178.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -100.79 116.66 33.21 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.479 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -133.5 162.63 31.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.02 178.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.446 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 11.8 pt-20 -65.13 107.57 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 110.112 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -73.85 120.53 19.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.636 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.448 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -103.37 -152.69 23.49 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.68 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -94.87 -1.16 53.24 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.503 0.192 . . . . 0.0 111.273 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -169.57 146.6 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.881 0.848 . . . . 0.0 113.017 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.504 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.65 164.59 29.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.795 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.619 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 4.2 pm0 -114.67 113.21 24.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.498 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 38.6 t -90.31 132.64 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 111.438 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.628 HD12 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.23 -81.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.465 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.37 128.35 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -105.09 117.26 58.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 17.3 Cg_exo -66.9 62.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.55 -52.47 5.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.011 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -85.5 -44.58 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -108.77 101.04 42.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.721 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -65.91 111.19 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.711 2.274 . . . . 0.0 112.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 24.6 tt0 -152.84 -98.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -151.68 161.36 42.8 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.54 ' HD1' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -118.94 159.38 23.91 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.628 ' HD3' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -137.35 138.6 40.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.38 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -133.68 159.94 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.946 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.72 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -91.92 143.27 26.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 0.0 112.275 -178.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.415 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -117.21 174.74 5.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.009 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.05 18.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.51 -7.25 59.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.719 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 3.23 87.67 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.434 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.701 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -118.02 115.65 25.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 122.181 0.192 . . . . 0.0 111.338 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.72 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -100.11 125.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.56 ' HA3' HD11 ' A' ' 19' ' ' LEU . . . -127.93 -178.9 15.56 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.555 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -73.76 135.39 43.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.848 -0.676 . . . . 0.0 111.147 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.54 HG12 ' HD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -132.83 140.86 39.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.254 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.492 ' HD2' HG21 ' A' ' 52' ' ' VAL . 42.0 Cg_endo -79.92 114.53 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.939 2.426 . . . . 0.0 111.404 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -57.95 -14.06 5.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.766 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -74.05 -8.04 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.407 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.581 ' O ' HD21 ' A' ' 8' ' ' LEU . 3.6 m-85 -117.81 15.59 14.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.455 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -149.97 176.28 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 111.775 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.483 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 7.9 p -135.75 116.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 177.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 22.2 t -65.13 146.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.637 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -108.23 163.7 12.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.198 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.309 -1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.82 0.343 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.08 121.58 26.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -124.95 167.68 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.888 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.669 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -133.55 157.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.454 0.645 . . . . 0.0 111.383 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.464 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 11.4 tt0 -122.21 138.53 54.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.39 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.28 156.63 22.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.257 0.551 . . . . 0.0 111.684 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.5 -41.24 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.752 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -94.45 161.64 28.51 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -166.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.744 2.296 . . . . 0.0 112.597 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 51.4 p90 -103.09 129.24 49.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.23 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -129.61 118.3 21.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.84 118.69 9.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.891 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.15 55.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.218 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m -149.7 172.47 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -75.13 -33.85 61.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.402 ' HG3' ' CD2' ' A' ' 51' ' ' LEU . 10.4 pt-20 -98.75 28.97 3.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.856 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.85 -168.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.204 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -178.85 148.94 0.43 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.222 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.17 116.31 32.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.134 0.492 . . . . 0.0 112.075 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CD2' ' HB2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -133.51 162.76 31.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.349 179.021 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -76.73 97.6 4.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.407 0.622 . . . . 0.0 110.294 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.05 142.96 45.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.202 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.18 -144.02 8.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.72 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.95 -16.32 22.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.016 0.436 . . . . 0.0 111.263 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.43 132.84 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.095 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.506 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.3 tpt -138.57 164.64 28.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.56 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.675 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -125.14 114.21 18.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.328 . . . . 0.0 110.853 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 25.6 t -95.25 137.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.57 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.609 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -86.53 -78.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.943 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 120.68 15.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.787 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -101.79 150.2 37.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 2.9 Cg_exo -76.24 55.63 4.67 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.849 2.366 . . . . 0.0 112.268 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -88.59 -35.82 16.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.986 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -113.33 -36.62 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.8 100.95 36.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.083 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -74.5 59.14 4.72 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.851 2.367 . . . . 0.0 112.154 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.76 -88.07 0.4 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.338 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -151.26 152.84 33.79 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.617 0.246 . . . . 0.0 110.786 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.641 ' CD1' HG11 ' A' ' 52' ' ' VAL . 1.1 p90 -114.74 172.21 7.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -143.68 138.86 29.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.675 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -131.71 157.73 43.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.362 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.766 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.17 143.05 26.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.248 0.546 . . . . 0.0 111.391 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.504 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 3.9 t30 -120.87 174.69 6.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.453 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -11.86 23.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.425 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.439 ' HB2' ' CG ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -83.48 0.87 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.326 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 7.57 58.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.191 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG3' HD22 ' A' ' 19' ' ' LEU . 3.2 pt20 -118.26 114.78 23.52 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.732 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.766 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -105.81 131.76 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.554 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -140.23 -170.14 11.92 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.559 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.54 ' H ' ' HA ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -79.83 107.0 12.27 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.493 0.663 . . . . 0.0 111.466 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 40' ' ' TRP . 1.9 p -92.4 146.75 33.09 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.982 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD2' ' CG2' ' A' ' 52' ' ' VAL . 57.2 Cg_endo -60.55 88.13 0.08 OUTLIER 'Trans proline' 0 CA--C 1.519 -0.233 0 C-N-CA 123.395 2.73 . . . . 0.0 111.283 178.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -52.69 -24.73 9.16 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.43 -6.66 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.553 ' O ' HD23 ' A' ' 8' ' ' LEU . 17.0 m-30 -108.67 20.6 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.526 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -150.07 176.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 111.78 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 5.0 p -132.85 113.56 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 21.9 t -65.67 147.26 12.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.669 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -105.66 163.91 12.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.099 -1.409 . . . . 0.0 109.174 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--N 1.309 -1.191 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.95 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.708 0.29 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 124.73 29.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.48 167.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.691 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.636 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.12 147.96 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.714 0.769 . . . . 0.0 111.433 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -106.24 140.39 39.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.969 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -114.06 155.2 26.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.49 0.662 . . . . 0.0 112.456 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.51 -40.66 1.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.544 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.41 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 1.7 m-85 -117.68 146.61 39.14 Favored Pre-proline 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 26.4 Cg_exo -62.62 163.25 21.88 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -117.77 153.06 34.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.548 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.056 0.455 . . . . 0.0 111.61 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -81.52 163.24 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -173.34 -42.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.1 m -94.29 172.61 8.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -65.2 -37.53 87.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.801 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -84.72 -4.07 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.922 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.9 170.69 16.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.801 ' HB2' ' HA3' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -159.0 156.25 29.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 112.001 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.95 101.85 4.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.582 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -132.3 165.45 24.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.04 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.28 102.24 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.582 0.706 . . . . 0.0 110.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -73.45 143.64 46.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.641 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 -160.34 11.39 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.656 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -95.33 10.9 34.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.949 0.375 . . . . 0.0 110.431 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' THR . . . . . 0.404 ' CG2' ' NE2' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -155.59 133.41 11.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.388 0.614 . . . . 0.0 112.144 -179.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.5 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.5 ptm -139.04 164.71 29.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.983 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 13.3 pt-20 -124.77 112.27 16.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.181 0.515 . . . . 0.0 110.696 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.463 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 31.9 t -91.85 134.7 29.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.595 ' CG1' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.79 -41.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.242 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -90.9 107.83 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.669 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.7 mmmm -93.81 114.78 63.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.961 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.02 92.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.125 . . . . 0.0 111.951 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.42 -52.5 6.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -114.53 -29.21 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.244 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -101.29 101.09 15.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.941 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.0 58.67 6.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.569 2.18 . . . . 0.0 112.304 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.53 -94.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.047 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -151.66 152.03 32.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CZ2' ' HA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.27 171.27 7.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.281 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.595 ' HD2' ' CG1' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -133.14 136.92 46.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 112.187 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.648 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 p -126.05 152.12 46.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.155 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -91.94 130.68 37.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.067 0.46 . . . . 0.0 110.343 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.57 174.61 5.8 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.353 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.29 3.14 16.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.206 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.82 -6.19 59.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.374 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.8 -27.85 14.69 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.812 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.484 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 5.1 mm-40 -117.75 138.81 51.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' A' ' 42' ' ' CYS . 0.7 OUTLIER -104.9 146.88 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.081 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.801 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -133.12 -159.36 9.1 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.56 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.569 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -105.14 120.24 41.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 0.0 111.089 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.486 ' H ' HG13 ' A' ' 52' ' ' VAL . 1.2 p -101.64 141.35 22.41 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HG3' ' CD2' ' A' ' 56' ' ' TYR . 91.4 Cg_endo -70.82 105.1 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.326 2.684 . . . . 0.0 111.23 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -55.96 -21.84 23.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -76.12 -9.59 58.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.298 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.562 ' O ' HD23 ' A' ' 8' ' ' LEU . 10.8 m-30 -110.39 18.79 19.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -150.23 176.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 112.363 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 7.1 p -136.33 118.5 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.992 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 60' ' ' LEU . 18.9 t -65.47 147.25 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.636 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -109.29 164.01 12.86 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.08 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.308 -1.212 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.858 -179.701 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.11 122.88 27.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.88 166.96 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.198 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.749 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -134.96 158.1 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.477 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.405 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 1.9 tt0 -130.98 143.84 51.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.729 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . 0.638 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -116.81 167.88 10.71 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.233 0.539 . . . . 0.0 110.999 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -130.93 -21.68 2.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.532 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -135.78 161.68 61.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -46.68 173.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.546 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 52' ' ' VAL . 2.9 t80 -102.29 138.92 38.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.07 118.49 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.618 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -109.29 171.72 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.57 -41.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.28 172.54 12.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.782 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -83.59 -30.12 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.07 33.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.502 ' O ' HD11 ' A' ' 19' ' ' LEU . 2.6 mt-10 -117.85 -170.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.319 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.718 ' CD2' ' CZ ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -148.31 141.09 24.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -113.24 102.15 10.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.529 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.718 ' CZ ' ' CD2' ' A' ' 19' ' ' LEU . 8.9 m-30 -116.7 163.4 16.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.249 0.547 . . . . 0.0 112.083 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -156.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.228 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.567 ' HD3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -51.83 133.67 31.64 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.22 0.534 . . . . 0.0 111.517 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.38 92.59 0.69 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.737 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.567 ' N ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tt0 -94.63 -20.63 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.59 0.71 . . . . 0.0 109.961 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.13 130.88 1.51 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.105 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 5' ' ' VAL . 2.7 mtt -138.85 164.54 29.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.614 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.1 mt-10 -125.7 115.26 19.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.863 0.363 . . . . 0.0 111.076 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' HG13 ' A' ' 5' ' ' VAL . 13.1 t -92.71 131.74 38.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.511 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.621 HD12 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -90.79 -67.99 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.712 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 127.78 33.07 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.0 158.94 32.28 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 111.912 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HG3' ' CZ3' ' A' ' 40' ' ' TRP . 60.1 Cg_endo -93.44 11.6 1.95 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.381 2.721 . . . . 0.0 113.09 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.81 -29.55 67.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.853 0.359 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.33 -38.87 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.738 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.06 100.94 35.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.33 53.09 4.36 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.61 2.207 . . . . 0.0 112.413 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 -83.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.578 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.417 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -151.32 152.37 33.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.575 0.226 . . . . 0.0 110.77 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.642 ' CZ2' ' HB2' ' A' ' 54' ' ' LYS . 4.5 p90 -119.63 172.12 7.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.024 0.44 . . . . 0.0 110.477 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.621 ' HD3' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -146.56 137.74 24.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.377 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 5.6 p -129.42 153.69 47.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.701 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.738 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -92.97 143.14 26.53 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.848 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . 0.541 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 32.0 t30 -121.88 174.48 6.85 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.354 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.89 -0.2 2.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.264 0.554 . . . . 0.0 109.915 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.586 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.92 -7.95 59.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.717 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.78 -5.52 52.36 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.234 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.512 ' HG2' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -119.1 138.75 52.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.052 0.453 . . . . 0.0 112.15 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.738 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.57 126.29 72.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.231 178.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.555 ' HA3' HD11 ' A' ' 19' ' ' LEU . . . -119.06 -168.16 13.98 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.94 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -87.87 129.08 35.33 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 4.9 p -134.12 131.38 20.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 53' ' ' PRO . 15.7 Cg_endo -84.55 92.2 0.76 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.365 2.71 . . . . 0.0 110.288 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.642 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -67.3 -9.51 41.61 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -46.75 -20.86 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . 0.444 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 14.3 p90 -102.69 12.72 35.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.638 ' HB ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -134.27 176.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -178.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.58 112.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.34 146.49 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.551 0.691 . . . . 0.0 112.322 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.749 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -98.69 160.89 13.96 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 179.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.984 -179.68 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.664 0.268 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 115.47 20.4 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -128.43 167.22 24.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.684 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.38 160.51 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 110.974 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.477 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 3.9 tt0 -126.05 144.52 50.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.503 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.63 139.81 48.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.266 0.555 . . . . 0.0 111.317 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.85 ' CD2' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -107.96 -48.33 3.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.082 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . 0.445 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 52.5 m-85 -93.62 161.57 30.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.276 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 11.7 Cg_endo -54.56 -165.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.817 2.345 . . . . 0.0 112.119 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 45.5 p90 -108.28 128.68 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.239 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t -130.13 117.89 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.586 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 m -147.71 124.27 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.644 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.74 -4.14 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.114 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.6 m -91.84 168.68 11.26 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.244 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -37.58 83.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.96 16.93 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.767 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLU . . . . . 0.445 ' HB3' ' CB ' ' A' ' 13' ' ' SER . 12.6 mt-10 -104.62 -176.62 3.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.739 ' HB2' ' HA3' ' A' ' 50' ' ' GLY . 0.4 OUTLIER -159.07 137.62 10.84 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.89 100.49 9.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.72 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PHE . . . . . 0.469 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -133.99 162.85 30.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.93 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -71.12 97.29 1.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.072 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -74.71 135.43 41.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.71 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.14 -160.62 22.54 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.47 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 2.6 tt0 -94.9 24.07 5.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.576 0.227 . . . . 0.0 111.211 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 p -169.79 123.12 0.74 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 111.843 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.45 164.73 29.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.421 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 0.3 OUTLIER -121.41 120.51 35.18 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' VAL . . . . . 0.421 ' CG2' HG11 ' A' ' 5' ' ' VAL . 37.3 t -98.57 129.94 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.24 0.543 . . . . 0.0 111.674 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . 0.592 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.59 -84.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.77 147.49 53.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.36 159.27 32.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.201 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.0 -1.33 6.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.814 2.343 . . . . 0.0 113.166 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.14 -46.24 88.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -107.49 -30.18 8.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.4 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 2.3 t70 -72.55 148.36 90.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.59 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 36' ' ' ASP . 2.0 Cg_endo -40.41 -76.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.147 2.565 . . . . 0.0 112.713 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 3.1 tt0 -161.18 14.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 5.9 m0 -138.96 146.08 40.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.322 . . . . 0.0 111.002 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.645 ' CD1' HG11 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -111.95 178.66 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.062 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.627 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -141.73 137.03 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.143 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' CYS . . . . . 0.546 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.4 p -132.56 156.22 47.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.077 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.784 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.81 136.71 32.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.553 0.692 . . . . 0.0 111.446 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -113.07 174.97 5.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.805 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.17 0.78 12.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -83.78 -6.66 59.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.08 -18.39 40.85 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.535 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLN . . . . . 0.465 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 9.5 mm100 -118.26 138.22 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.744 0.307 . . . . 0.0 110.74 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' VAL . . . . . 0.784 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -115.77 127.13 73.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 0.0 110.49 178.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.739 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -112.66 -144.34 9.17 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.477 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LEU . . . . . 0.627 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 1.0 OUTLIER -113.69 116.12 28.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.044 0.45 . . . . 0.0 110.503 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -92.43 140.44 24.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.481 ' CD ' HG21 ' A' ' 52' ' ' VAL . 59.0 Cg_endo -62.89 92.96 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.486 2.791 . . . . 0.0 111.598 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -53.19 -22.85 7.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.866 0.365 . . . . 0.0 111.815 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -78.91 -11.93 60.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -110.2 15.72 22.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.989 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.85 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -142.11 166.35 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.608 . . . . 0.0 112.564 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 12.8 p -123.1 113.96 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.294 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.8 t -65.4 146.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.804 0.811 . . . . 0.0 113.112 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.684 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -103.68 163.63 12.2 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.067 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.999 -179.745 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.16 121.13 43.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.702 0.287 . . . . 0.0 111.063 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 125.95 30.65 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.528 ' HB ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -127.4 166.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.227 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.696 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -131.58 155.48 41.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.408 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 3.9 tt0 -134.04 154.02 51.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.961 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.539 ' OG1' ' HD2' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -111.44 162.05 15.48 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.284 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.53 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.71 -34.66 1.32 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.98 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.417 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 22.6 m-85 -123.99 122.87 26.2 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.84 60.91 2.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.177 1.918 . . . . 0.0 111.161 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.628 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 9.4 m-85 -87.75 154.27 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.838 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -95.6 152.52 18.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -89.28 171.87 9.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 20.1 m -132.54 -55.31 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -46.17 158.4 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.807 -178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -31.0 68.31 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.736 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.413 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 12.0 mp0 -87.13 26.12 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.997 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.724 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.6 mt-10 -110.33 -176.76 3.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.266 0.555 . . . . 0.0 111.635 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.577 ' CD2' ' CE2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -138.58 137.64 37.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.391 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -113.55 100.08 8.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 111.441 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.577 ' CE2' ' CD2' ' A' ' 19' ' ' LEU . 20.5 m-30 -133.69 162.8 30.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 3.5 tp10 -81.33 95.88 7.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.539 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 0.8 OUTLIER -76.58 143.52 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.156 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.74 -39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.295 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -147.13 0.27 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.583 0.23 . . . . 0.0 111.167 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.46 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -108.38 146.22 33.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.589 0.709 . . . . 0.0 112.193 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.596 ' O ' ' N ' ' A' ' 5' ' ' VAL . 26.8 mmt -134.24 164.97 26.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.443 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.5 mt-10 -113.71 122.78 48.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.59 ' CG2' HG11 ' A' ' 5' ' ' VAL . 2.8 t -92.45 127.47 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.451 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.543 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -91.28 -39.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.21 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -87.99 118.19 27.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.088 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.42 ' HB3' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.5 155.52 36.27 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -83.07 8.57 4.53 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.065 2.51 . . . . 0.0 113.416 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . 0.42 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -88.43 -30.68 19.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.006 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -121.3 -36.23 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 110.649 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.413 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . 2.8 m-20 -96.83 165.2 16.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.586 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.413 ' HD2' ' CB ' ' A' ' 36' ' ' ASP . 1.1 Cg_endo -44.43 177.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.086 2.524 . . . . 0.0 112.838 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -4.27 15.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.202 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.02 146.06 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.701 0.286 . . . . 0.0 110.9 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.572 ' CD1' HG11 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -124.07 169.96 11.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.426 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.543 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -144.92 137.57 26.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.429 . . . . 0.0 112.14 -178.748 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 7.0 p -134.91 157.7 46.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.95 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.782 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 4.5 pttm -92.27 135.2 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 111.896 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.461 ' C ' ' H ' ' A' ' 46' ' ' ARG . 1.9 t30 -108.78 174.58 5.81 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.167 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.9 4.46 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.532 0.682 . . . . 0.0 109.417 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.552 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.79 -8.58 59.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.8 -15.22 38.2 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.481 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -118.22 138.25 52.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.907 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.782 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -120.08 125.7 74.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.45 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -117.51 -159.89 11.54 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.234 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.724 ' H ' ' HA ' ' A' ' 18' ' ' GLU . 1.2 mp -96.13 110.46 22.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.572 HG11 ' CD1' ' A' ' 40' ' ' TRP . 1.4 p -92.47 133.16 30.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.097 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.447 ' HD2' HG21 ' A' ' 52' ' ' VAL . 77.5 Cg_endo -74.28 106.87 2.31 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.072 2.515 . . . . 0.0 111.797 179.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.475 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -51.63 -23.4 4.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.984 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -67.82 -10.84 56.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.852 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.628 ' CD2' ' HB3' ' A' ' 11' ' ' PHE . 18.6 m-85 -116.67 12.99 15.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.433 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.508 ' HA ' HD13 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -149.6 176.7 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.433 ' HB ' HD12 ' A' ' 8' ' ' LEU . 9.5 p -139.16 120.15 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.04 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.5 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.0 t -65.2 145.69 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.139 0.495 . . . . 0.0 111.485 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.696 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.97 100.06 3.94 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.767 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.898 179.782 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.06 137.77 5.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.779 0.323 . . . . 0.0 111.166 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 121.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -121.87 167.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.005 -178.548 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.642 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -133.14 157.6 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.19 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.5 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 1.8 tt0 -116.52 140.52 49.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.407 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.543 ' OG1' ' O ' ' A' ' 24' ' ' GLY . 1.9 p -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.148 0.499 . . . . 0.0 111.309 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.605 ' CD2' ' N ' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -114.71 -37.74 4.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.061 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -133.12 162.28 58.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.738 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -46.1 175.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.143 2.562 . . . . 0.0 112.872 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 21' ' ' PHE . 51.7 p90 -93.42 129.23 39.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.638 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -130.04 117.78 20.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.47 126.9 46.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 24.3 m -132.47 -47.88 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.74 -179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.437 ' N ' ' HG3' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -55.38 172.5 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.335 . . . . 0.0 110.994 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.72 -33.88 69.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.463 ' HB2' ' CD2' ' A' ' 51' ' ' LEU . 2.4 mm-40 -92.73 32.77 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.613 0.244 . . . . 0.0 111.419 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.597 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.7 mt-10 -121.68 166.84 13.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.484 HD13 ' N ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -153.08 149.35 28.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.907 0.385 . . . . 0.0 110.715 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -100.65 111.56 23.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 111.389 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.556 ' CD2' ' HB2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -133.53 163.2 29.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.019 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.501 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 2.0 tp10 -69.4 99.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.434 ' HB2' ' HB3' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -73.45 128.28 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.318 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.543 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -88.92 -145.64 11.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.621 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.436 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 2.3 tt0 -95.82 -17.9 20.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.255 0.55 . . . . 0.0 110.689 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.5 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -142.6 144.08 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.851 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.526 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.43 164.25 29.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.261 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.502 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 1.5 pm0 -120.9 112.41 18.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.393 . . . . 0.0 110.291 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.477 ' CG2' HG13 ' A' ' 5' ' ' VAL . 14.3 t -91.37 137.25 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.745 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.573 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.8 -39.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.338 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -89.99 107.95 19.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.09 139.38 49.22 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -85.5 12.59 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -21.15 55.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.655 0.264 . . . . 0.0 111.079 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -115.12 -42.32 3.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.875 0.369 . . . . 0.0 110.46 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.86 100.98 36.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.98 61.61 7.47 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.575 2.184 . . . . 0.0 112.633 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' HB2' ' CE3' ' A' ' 39' ' ' TRP . 0.9 OUTLIER -114.55 -75.46 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.38 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 m-90 -151.77 146.19 25.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.144 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.655 ' CD1' HG12 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -119.83 169.03 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.573 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -133.08 138.3 46.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 112.055 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.8 OUTLIER -132.28 157.73 43.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.867 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.78 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.15 143.22 26.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.277 0.561 . . . . 0.0 111.444 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.556 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 4.5 t-20 -120.93 174.52 6.57 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.462 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.11 -10.75 24.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.568 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.422 ' HB2' ' CG ' ' A' ' 48' ' ' GLN . 2.8 mmp_? -83.35 -1.81 54.23 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.46 5.69 68.37 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.085 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.465 ' HG3' HD21 ' A' ' 19' ' ' LEU . 0.9 OUTLIER -118.28 115.35 24.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.096 0.474 . . . . 0.0 111.939 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.78 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -104.07 132.53 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.878 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.486 ' O ' ' HA ' ' A' ' 41' ' ' LYS . . . -141.14 -178.27 17.24 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.858 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.597 ' H ' ' HA ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -73.47 111.52 8.68 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.279 0.561 . . . . 0.0 111.331 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.655 HG12 ' CD1' ' A' ' 40' ' ' TRP . 1.7 p -101.11 147.07 33.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.869 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 52' ' ' VAL . 53.9 Cg_endo -60.43 87.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.288 2.659 . . . . 0.0 111.519 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -53.38 -26.58 19.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.83 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -82.32 -0.18 44.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.497 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 2.5 m-85 -110.14 13.14 23.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.501 ' HA ' ' CG ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -149.39 177.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.093 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.59 ' CG1' HD22 ' A' ' 8' ' ' LEU . 7.5 p -131.23 121.33 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.482 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 33.9 t -65.38 146.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.801 0.81 . . . . 0.0 113.058 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.642 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -105.4 164.06 12.15 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.331 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--N 1.308 -1.198 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.891 -179.819 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.35 124.25 49.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 119.54 23.6 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.57 166.48 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.205 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.716 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -135.19 158.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.173 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -134.22 139.89 46.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.95 -177.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.644 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -111.2 165.52 11.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.184 0.516 . . . . 0.0 111.094 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.543 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.13 -31.53 3.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.639 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.411 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 34.4 m-85 -125.28 161.53 49.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.411 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 91.2 Cg_exo -44.11 151.72 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.661 2.24 . . . . 0.0 112.602 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 21' ' ' PHE . 9.2 t80 -95.42 130.25 42.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.954 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -129.06 144.37 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -170.94 161.87 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.808 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.3 p -173.06 89.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.074 0.464 . . . . 0.0 111.228 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -160.94 172.6 16.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.976 -179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.77 -32.83 74.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.618 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -99.12 -50.87 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.759 179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.476 ' HG2' ' HB2' ' A' ' 51' ' ' LEU . 10.4 mt-10 -63.99 153.52 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.645 ' CD2' ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -149.2 159.43 44.26 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -101.09 153.09 19.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.645 ' CE1' ' CD2' ' A' ' 19' ' ' LEU . 46.8 m-85 -133.69 164.19 27.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.689 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.85 -156.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.43 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -51.64 126.92 18.97 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.722 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -125.16 86.26 0.36 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.086 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -95.4 -22.7 17.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 0.0 109.388 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 3.1 p -138.84 128.33 24.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.693 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.49 ' O ' HG12 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -138.73 164.71 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.208 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 4.6 mt-10 -125.71 115.22 19.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 0.0 111.243 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' HG13 ' A' ' 5' ' ' VAL . 24.9 t -94.82 127.07 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 110.645 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.635 HD13 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.31 -77.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.636 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.117 0.484 . . . . 0.0 112.022 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.74 159.32 33.66 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.508 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.481 ' HG3' ' CE3' ' A' ' 40' ' ' TRP . 6.4 Cg_exo -74.6 6.33 3.27 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.82 2.347 . . . . 0.0 113.09 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.38 -34.19 72.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.601 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -97.28 -44.77 6.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -123.27 100.83 38.66 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.372 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.92 57.18 5.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.476 2.117 . . . . 0.0 112.583 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' OE2' ' CZ2' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -121.75 -77.09 0.58 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.039 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.504 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -151.41 158.52 43.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.126 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.649 ' HE1' ' H ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -116.18 -179.23 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.635 ' HD3' HD13 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -151.22 138.64 19.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.834 -179.053 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 2.9 p -131.18 154.49 48.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.661 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.769 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.22 136.85 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.475 0.655 . . . . 0.0 110.864 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.599 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 4.1 t-20 -109.29 174.57 5.81 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.734 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.3 -3.69 21.92 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.295 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.54 -2.66 56.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.343 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.04 83.88 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.887 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -118.52 138.34 52.59 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.91 0.386 . . . . 0.0 111.66 -179.399 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.769 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -132.99 126.06 52.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.534 ' O ' ' HA ' ' A' ' 41' ' ' LYS . . . -133.5 -164.33 10.73 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.515 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.596 ' HA ' ' O ' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -84.96 129.88 34.73 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.306 0.574 . . . . 0.0 111.529 -179.104 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.516 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 6.0 p -134.0 140.78 37.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.442 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.452 ' O ' ' N ' ' A' ' 55' ' ' ASN . 0.5 OUTLIER -91.03 60.54 1.23 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.537 2.824 . . . . 0.0 111.885 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.745 ' HG3' HG23 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -45.24 -11.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -45.09 -20.71 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.099 -0.376 . . . . 0.0 111.495 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.518 ' CD2' ' O ' ' A' ' 56' ' ' TYR . 24.9 p90 -101.93 31.49 3.87 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.745 HG23 ' HG3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -148.63 176.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.691 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.434 ' N ' HG21 ' A' ' 57' ' ' VAL . 9.8 p -108.07 112.78 41.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -71.75 146.46 11.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.432 0.634 . . . . 0.0 112.07 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.716 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -100.87 161.54 13.53 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.332 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.65 142.31 27.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.044 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.91 120.56 24.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.717 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.52 ' HB ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.53 166.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.69 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -128.87 161.83 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.42 0.629 . . . . 0.0 111.283 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.509 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 2.8 tt0 -139.14 146.81 41.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.178 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.583 ' OG1' ' HA ' ' A' ' 25' ' ' GLU . 5.7 p -105.7 163.05 12.99 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.922 0.392 . . . . 0.0 110.567 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.51 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.09 -35.81 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.368 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.497 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 10.0 m-85 -119.55 135.86 24.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.393 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.94 59.04 2.18 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.292 1.995 . . . . 0.0 110.387 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.581 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 13.1 m-85 -73.28 155.53 39.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.652 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -94.11 151.88 19.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.808 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.488 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 4.0 m -145.67 99.77 3.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.65 103.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 111.554 -179.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -158.46 172.45 18.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.548 179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.45 -32.78 74.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.058 -179.835 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -113.44 12.23 18.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.513 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 4.8 mt-10 -102.11 -173.79 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.675 0.274 . . . . 0.0 111.049 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.501 HD13 ' HA3' ' A' ' 50' ' ' GLY . 0.6 OUTLIER -147.02 160.53 42.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.352 0.596 . . . . 0.0 112.201 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.15 102.02 4.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.5 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.431 ' CE1' ' CE ' ' A' ' 27' ' ' MET . 4.3 p90 -129.74 164.05 24.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.701 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.545 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -52.26 133.04 34.46 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.221 0.534 . . . . 0.0 111.708 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.429 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -147.42 54.73 0.52 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.341 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.583 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 1.3 tt0 -59.72 -21.15 60.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 110.054 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -124.64 117.4 24.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.846 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.431 ' CE ' ' CE1' ' A' ' 21' ' ' PHE . 24.4 mtp -139.14 163.41 32.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.237 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 0.7 OUTLIER -126.38 112.35 15.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.635 0.255 . . . . 0.0 110.855 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.64 ' CG2' HG11 ' A' ' 5' ' ' VAL . 5.8 t -85.67 113.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.277 0.56 . . . . 0.0 111.252 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.578 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.61 -38.91 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.607 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -98.35 118.08 34.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.273 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.408 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 25.5 mmtp -91.94 142.29 26.3 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.408 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 5.1 Cg_exo -79.62 7.97 4.23 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.756 2.304 . . . . 0.0 112.766 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -51.68 67.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.24 -34.55 10.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.83 165.11 56.13 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.681 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.17 -75.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.706 2.271 . . . . 0.0 112.772 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -175.41 17.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -123.37 145.8 48.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.505 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -126.09 171.11 11.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.578 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -144.0 137.24 27.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.196 -179.247 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.531 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 8.3 p -132.46 151.88 51.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.775 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 7.4 mttp -91.59 140.22 29.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.392 0.615 . . . . 0.0 110.75 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -115.49 174.75 5.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.182 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.66 -1.84 17.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.254 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.513 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 5.8 ttm180 -83.56 -7.45 59.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.57 -12.76 55.14 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.774 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.45 ' HB3' HD23 ' A' ' 19' ' ' LEU . 2.6 mp0 -117.87 137.68 52.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.775 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.04 126.13 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.174 0.511 . . . . 0.0 110.123 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.501 ' HA3' HD13 ' A' ' 19' ' ' LEU . . . -110.35 -142.26 9.24 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.285 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.573 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -117.54 110.33 17.82 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.505 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.6 p -92.01 131.94 33.9 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.003 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 63.2 Cg_endo -74.53 107.19 2.4 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.3 2.667 . . . . 0.0 111.77 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HA ' ' HZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -49.86 -25.38 3.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.129 0.49 . . . . 0.0 111.914 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.56 -11.83 58.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.581 ' CD1' ' CD2' ' A' ' 11' ' ' PHE . 15.5 m-30 -116.44 13.51 15.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.736 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.494 HG13 ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -149.4 175.75 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.617 0.722 . . . . 0.0 112.491 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.42 ' CG1' ' CD1' ' A' ' 8' ' ' LEU . 10.7 p -139.68 117.78 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.895 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.47 ' HA ' ' HA ' ' A' ' 5' ' ' VAL . 2.2 t -65.21 145.82 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.133 0.492 . . . . 0.0 111.272 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.69 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -139.05 99.79 3.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.522 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 22.0 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.921 -179.939 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.645 -0.182 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.67 129.93 49.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 111.091 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 129.12 34.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.68 167.75 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.987 0.423 . . . . 0.0 111.183 -178.37 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.69 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.9 160.57 42.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.481 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 4.2 tt0 -124.44 140.48 52.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -111.62 154.38 24.97 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.549 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.76 -40.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.951 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -101.18 161.68 22.91 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.51 -179.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.59 -176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.887 2.391 . . . . 0.0 112.972 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.459 ' CE2' ' N ' ' A' ' 21' ' ' PHE . 25.1 p90 -118.16 132.48 56.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.053 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -129.66 117.89 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.665 0.269 . . . . 0.0 111.517 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.625 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -92.09 140.04 30.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.702 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.438 HG22 ' N ' ' A' ' 15' ' ' THR . 33.4 m -144.86 -31.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.438 ' N ' HG22 ' A' ' 14' ' ' VAL . 20.9 m -84.15 162.88 20.09 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 111.854 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.69 -37.79 87.83 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.091 -179.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -98.63 32.68 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.133 0.492 . . . . 0.0 110.253 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.63 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.5 OUTLIER -101.79 176.29 5.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.829 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.53 ' HB2' ' HA3' ' A' ' 50' ' ' GLY . 2.7 mp -144.24 164.54 30.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.555 0.693 . . . . 0.0 112.11 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -134.85 100.41 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.755 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.459 ' N ' ' CE2' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -134.81 156.88 48.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.821 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.44 ' HA ' ' CE1' ' A' ' 11' ' ' PHE . 5.9 mp0 -64.94 98.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.406 ' CE ' ' CE ' ' A' ' 27' ' ' MET . 0.2 OUTLIER -73.74 133.94 43.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.282 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.48 -148.73 24.61 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.737 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 6' ' ' GLN . 2.2 tt0 -94.92 -17.14 22.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 0.0 111.228 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.09 132.62 43.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.309 0.576 . . . . 0.0 112.164 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.514 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -138.87 164.2 30.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.877 178.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.584 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 pt-20 -122.75 118.66 28.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.772 0.32 . . . . 0.0 110.556 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.508 HG22 ' CE2' ' A' ' 40' ' ' TRP . 23.3 t -93.87 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.251 0.548 . . . . 0.0 111.762 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.548 HD13 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.19 -44.21 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.756 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -110.09 120.42 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.397 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.474 ' HE3' HG11 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -99.72 139.27 20.71 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.321 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 38.2 Cg_endo -91.32 17.59 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.022 2.481 . . . . 0.0 112.544 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.97 -37.68 38.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.09 -44.09 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -123.75 101.03 36.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.801 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.75 79.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -119.3 -83.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.442 ' CD2' HD22 ' A' ' 51' ' ' LEU . 1.3 m0 -151.63 160.89 43.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.285 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.642 ' CD1' ' CG1' ' A' ' 52' ' ' VAL . 0.0 OUTLIER -126.03 107.41 10.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.579 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -123.35 138.54 54.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.647 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.584 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -127.51 156.77 41.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.426 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.793 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 5.6 ptpp? -91.93 142.9 27.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.606 0.717 . . . . 0.0 111.655 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -122.52 175.43 6.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.953 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -0.38 4.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.082 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.77 -7.52 59.45 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.66 0.266 . . . . 0.0 110.593 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.4 -11.66 54.65 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.024 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.445 ' O ' HD22 ' A' ' 19' ' ' LEU . 5.9 mp0 -118.1 137.79 52.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.516 0.327 . . . . 0.0 110.396 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.793 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -116.32 130.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.53 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -115.43 -159.72 12.28 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.245 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.63 ' H ' ' HA ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -98.5 132.49 43.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.618 0.723 . . . . 0.0 110.73 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.642 ' CG1' ' CD1' ' A' ' 40' ' ' TRP . 2.1 p -118.66 150.01 47.44 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.172 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.567 ' HD2' ' CG2' ' A' ' 52' ' ' VAL . 54.0 Cg_endo -60.79 82.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 123.355 2.704 . . . . 0.0 111.639 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.47 ' CB ' ' CE3' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -50.02 -26.78 4.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.82 -13.31 59.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.93 0.395 . . . . 0.0 111.157 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.562 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -101.94 30.93 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.372 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.631 ' CG2' ' CZ2' ' A' ' 40' ' ' TRP . 2.4 m -150.32 177.57 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.481 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 7.6 p -136.43 113.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.191 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.509 HG22 ' CH2' ' A' ' 40' ' ' TRP . 16.4 t -65.75 147.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.69 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -106.24 164.02 12.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.025 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.309 -1.162 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.112 -179.675 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.7 142.79 57.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 112.11 18.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -128.72 167.39 24.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.224 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.637 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -130.05 151.96 36.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 110.718 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.538 ' HA ' ' HA ' ' A' ' 26' ' ' THR . 3.7 tt0 -115.55 144.47 43.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.25 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.41 ' CB ' ' HD2' ' A' ' 23' ' ' LYS . 0.8 OUTLIER -115.9 153.25 31.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.581 HD21 ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -131.31 -44.08 1.03 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.044 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -100.71 157.05 34.43 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.853 0.358 . . . . 0.0 111.648 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.53 162.28 15.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.772 2.315 . . . . 0.0 112.054 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.477 ' CE2' ' CG2' ' A' ' 52' ' ' VAL . 3.2 m-85 -111.59 135.15 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.034 0.445 . . . . 0.0 111.616 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -129.03 118.86 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.301 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.8 m -103.53 142.7 33.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.384 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 27.7 m -135.88 -45.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -67.41 172.45 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.94 -37.5 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.033 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 13.7 mt-10 -63.16 -48.92 76.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.574 179.799 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.44 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -54.54 -171.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.825 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.701 ' HG ' ' HB3' ' A' ' 48' ' ' GLN . 0.0 OUTLIER -178.79 158.25 0.98 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.122 178.496 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 2.6 p30 -100.79 116.66 33.21 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.479 ' HA ' ' HG2' ' A' ' 46' ' ' ARG . 0.5 OUTLIER -133.5 162.63 31.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.02 178.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.446 ' O ' ' CG ' ' A' ' 22' ' ' GLU . 11.8 pt-20 -65.13 107.57 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 110.112 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.472 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -73.85 120.53 19.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.636 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.448 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -103.37 -152.69 23.49 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.68 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -94.87 -1.16 53.24 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.503 0.192 . . . . 0.0 111.273 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.538 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -169.57 146.6 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.881 0.848 . . . . 0.0 113.017 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.504 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.65 164.59 29.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.795 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.619 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 4.2 pm0 -114.67 113.21 24.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.498 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 38.6 t -90.31 132.64 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 111.438 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.628 HD12 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.23 -81.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.465 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.37 128.35 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.402 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -105.09 117.26 58.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 17.3 Cg_exo -66.9 62.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.55 -52.47 5.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.011 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -85.5 -44.58 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -108.77 101.04 42.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.721 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -65.91 111.19 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.711 2.274 . . . . 0.0 112.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 24.6 tt0 -152.84 -98.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -151.68 161.36 42.8 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.54 ' HD1' HG12 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -118.94 159.38 23.91 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.628 ' HD3' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -137.35 138.6 40.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.38 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.619 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -133.68 159.94 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.946 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.72 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -91.92 143.27 26.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 0.0 112.275 -178.431 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.415 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -117.21 174.74 5.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.009 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.05 18.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.479 ' HG2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.51 -7.25 59.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.719 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 3.23 87.67 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.434 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.701 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -118.02 115.65 25.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 122.181 0.192 . . . . 0.0 111.338 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.72 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -100.11 125.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.56 ' HA3' HD11 ' A' ' 19' ' ' LEU . . . -127.93 -178.9 15.56 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.555 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.528 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -73.76 135.39 43.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.848 -0.676 . . . . 0.0 111.147 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.54 HG12 ' HD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -132.83 140.86 39.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.254 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.492 ' HD2' HG21 ' A' ' 52' ' ' VAL . 42.0 Cg_endo -79.92 114.53 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.939 2.426 . . . . 0.0 111.404 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.503 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -57.95 -14.06 5.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.766 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -74.05 -8.04 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.407 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.581 ' O ' HD21 ' A' ' 8' ' ' LEU . 3.6 m-85 -117.81 15.59 14.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.455 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 0.6 OUTLIER -149.97 176.28 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 111.775 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.483 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 7.9 p -135.75 116.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 177.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 22.2 t -65.13 146.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.637 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -108.23 163.7 12.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.198 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.309 -1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.62 147.18 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.08 121.58 26.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -124.95 167.68 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.888 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.669 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -133.55 157.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.454 0.645 . . . . 0.0 111.383 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.464 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 11.4 tt0 -122.21 138.53 54.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.39 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.28 156.63 22.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.257 0.551 . . . . 0.0 111.684 -179.761 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.557 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.5 -41.24 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.752 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -94.45 161.64 28.51 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -166.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.744 2.296 . . . . 0.0 112.597 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 51.4 p90 -103.09 129.24 49.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.23 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -129.61 118.3 21.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.84 118.69 9.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.891 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.7 p -145.15 55.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.218 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.5 m -149.7 172.47 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.6 tp10 -75.13 -33.85 61.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.402 ' HG3' ' CD2' ' A' ' 51' ' ' LEU . 10.4 pt-20 -98.75 28.97 3.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.856 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.54 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.85 -168.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.204 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -178.85 148.94 0.43 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.222 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.17 116.31 32.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.134 0.492 . . . . 0.0 112.075 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.504 ' CD2' ' HB2' ' A' ' 44' ' ' ASN . 0.0 OUTLIER -133.51 162.76 31.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.349 179.021 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.478 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -76.73 97.6 4.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.407 0.622 . . . . 0.0 110.294 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -74.05 142.96 45.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.202 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.18 -144.02 8.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.72 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.95 -16.32 22.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.016 0.436 . . . . 0.0 111.263 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.43 132.84 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.095 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.506 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.3 tpt -138.57 164.64 28.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.56 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.675 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -125.14 114.21 18.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.328 . . . . 0.0 110.853 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.44 ' CG1' ' HB2' ' A' ' 40' ' ' TRP . 25.6 t -95.25 137.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.57 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.609 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -86.53 -78.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.943 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 120.68 15.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.787 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.4 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -101.79 150.2 37.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.4 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 2.9 Cg_exo -76.24 55.63 4.67 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.849 2.366 . . . . 0.0 112.268 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -88.59 -35.82 16.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.986 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -113.33 -36.62 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.8 100.95 36.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.083 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -74.5 59.14 4.72 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.851 2.367 . . . . 0.0 112.154 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.76 -88.07 0.4 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.338 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -151.26 152.84 33.79 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.617 0.246 . . . . 0.0 110.786 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.641 ' CD1' HG11 ' A' ' 52' ' ' VAL . 1.1 p90 -114.74 172.21 7.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.609 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -143.68 138.86 29.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.675 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -131.71 157.73 43.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.362 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.766 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.17 143.05 26.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.248 0.546 . . . . 0.0 111.391 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.504 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 3.9 t30 -120.87 174.69 6.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.453 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -63.12 -11.86 23.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.425 -179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.439 ' HB2' ' CG ' ' A' ' 48' ' ' GLN . 0.9 OUTLIER -83.48 0.87 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.326 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 7.57 58.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.191 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.469 ' HG3' HD22 ' A' ' 19' ' ' LEU . 3.2 pt20 -118.26 114.78 23.52 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.732 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.766 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -105.81 131.76 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.554 ' N ' HD12 ' A' ' 19' ' ' LEU . . . -140.23 -170.14 11.92 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.559 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.54 ' H ' ' HA ' ' A' ' 18' ' ' GLU . 0.5 OUTLIER -79.83 107.0 12.27 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.493 0.663 . . . . 0.0 111.466 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.641 HG11 ' CD1' ' A' ' 40' ' ' TRP . 1.9 p -92.4 146.75 33.09 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.982 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.513 ' HD2' ' CG2' ' A' ' 52' ' ' VAL . 57.2 Cg_endo -60.55 88.13 0.08 OUTLIER 'Trans proline' 0 CA--C 1.519 -0.233 0 C-N-CA 123.395 2.73 . . . . 0.0 111.283 178.06 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -52.69 -24.73 9.16 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.43 -6.66 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.553 ' O ' HD23 ' A' ' 8' ' ' LEU . 17.0 m-30 -108.67 20.6 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.526 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.442 ' HA ' HD23 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -150.07 176.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 111.78 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.464 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 5.0 p -132.85 113.56 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 21.9 t -65.67 147.26 12.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.669 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -105.66 163.91 12.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.099 -1.409 . . . . 0.0 109.174 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--N 1.309 -1.191 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.95 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.31 127.18 35.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.708 0.29 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 124.73 29.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.48 167.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.691 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.636 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.12 147.96 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.714 0.769 . . . . 0.0 111.433 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.464 ' HB2' ' CD1' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -106.24 140.39 39.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.969 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.436 ' HB ' ' HD2' ' A' ' 23' ' ' LYS . 1.0 OUTLIER -114.06 155.2 26.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.49 0.662 . . . . 0.0 112.456 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.577 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.51 -40.66 1.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.544 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.41 ' O ' ' NZ ' ' A' ' 23' ' ' LYS . 1.7 m-85 -117.68 146.61 39.14 Favored Pre-proline 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.417 ' HA ' ' HG2' ' A' ' 23' ' ' LYS . 26.4 Cg_exo -62.62 163.25 21.88 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.519 ' CE1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -117.77 153.06 34.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.548 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.056 0.455 . . . . 0.0 111.61 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -81.52 163.24 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -173.34 -42.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.1 m -94.29 172.61 8.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.3 tp10 -65.2 -37.53 87.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.801 -179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -84.72 -4.07 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.922 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.461 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -78.9 170.69 16.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.801 ' HB2' ' HA3' ' A' ' 50' ' ' GLY . 0.3 OUTLIER -159.0 156.25 29.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 112.001 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.95 101.85 4.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.582 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -132.3 165.45 24.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.04 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.28 102.24 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.582 0.706 . . . . 0.0 110.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.519 ' HB2' ' CE1' ' A' ' 11' ' ' PHE . 0.5 OUTLIER -73.45 143.64 46.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.641 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 -160.34 11.39 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.656 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -95.33 10.9 34.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.949 0.375 . . . . 0.0 110.431 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' THR . . . . . 0.404 ' CG2' ' NE2' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -155.59 133.41 11.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.388 0.614 . . . . 0.0 112.144 -179.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.5 ' O ' HG13 ' A' ' 5' ' ' VAL . 1.5 ptm -139.04 164.71 29.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.983 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 13.3 pt-20 -124.77 112.27 16.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.181 0.515 . . . . 0.0 110.696 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.463 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 31.9 t -91.85 134.7 29.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.595 ' CG1' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.79 -41.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.242 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -90.9 107.83 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.669 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . 0.41 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.7 mmmm -93.81 114.78 63.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.961 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.02 92.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.125 . . . . 0.0 111.951 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.42 -52.5 6.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -114.53 -29.21 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.244 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -101.29 101.09 15.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.941 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.0 58.67 6.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.569 2.18 . . . . 0.0 112.304 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.53 -94.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.047 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -151.66 152.03 32.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.519 ' CZ2' ' HA ' ' A' ' 54' ' ' LYS . 0.1 OUTLIER -105.27 171.27 7.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.281 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.595 ' HD2' ' CG1' ' A' ' 30' ' ' ILE . 0.0 OUTLIER -133.14 136.92 46.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 112.187 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.648 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 p -126.05 152.12 46.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.155 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HA ' ' CG1' ' A' ' 49' ' ' VAL . 0.4 OUTLIER -91.94 130.68 37.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.067 0.46 . . . . 0.0 110.343 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.57 174.61 5.8 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.353 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.29 3.14 16.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.206 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.449 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.82 -6.19 59.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.374 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.8 -27.85 14.69 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.812 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.484 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 5.1 mm-40 -117.75 138.81 51.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.648 ' HB ' ' O ' ' A' ' 42' ' ' CYS . 0.7 OUTLIER -104.9 146.88 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.081 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.801 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -133.12 -159.36 9.1 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.56 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.569 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 0.4 OUTLIER -105.14 120.24 41.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 0.0 111.089 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.486 ' H ' HG13 ' A' ' 52' ' ' VAL . 1.2 p -101.64 141.35 22.41 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.471 ' HG3' ' CD2' ' A' ' 56' ' ' TYR . 91.4 Cg_endo -70.82 105.1 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.326 2.684 . . . . 0.0 111.23 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.519 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -55.96 -21.84 23.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -76.12 -9.59 58.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.298 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.562 ' O ' HD23 ' A' ' 8' ' ' LEU . 10.8 m-30 -110.39 18.79 19.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.461 ' HA ' HD23 ' A' ' 8' ' ' LEU . 0.7 OUTLIER -150.23 176.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 112.363 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 7.1 p -136.33 118.5 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.992 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.523 HG12 ' N ' ' A' ' 60' ' ' LEU . 18.9 t -65.47 147.25 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.636 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -109.29 164.01 12.86 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.08 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.308 -1.212 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.858 -179.701 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.73 142.87 45.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.11 122.88 27.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.88 166.96 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.198 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.749 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -134.96 158.1 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.477 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.405 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 1.9 tt0 -130.98 143.84 51.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.729 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . 0.638 ' HA ' ' HB ' ' A' ' 57' ' ' VAL . 0.0 OUTLIER -116.81 167.88 10.71 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.233 0.539 . . . . 0.0 110.999 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.518 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 0.0 OUTLIER -130.93 -21.68 2.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.532 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -135.78 161.68 61.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 -179.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_exo -46.68 173.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.546 -179.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 52' ' ' VAL . 2.9 t80 -102.29 138.92 38.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.07 118.49 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.618 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -109.29 171.72 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.57 -41.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.28 172.54 12.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.782 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -83.59 -30.12 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.07 33.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.502 ' O ' HD11 ' A' ' 19' ' ' LEU . 2.6 mt-10 -117.85 -170.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.319 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.718 ' CD2' ' CZ ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -148.31 141.09 24.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -113.24 102.15 10.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.529 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.718 ' CZ ' ' CD2' ' A' ' 19' ' ' LEU . 8.9 m-30 -116.7 163.4 16.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.249 0.547 . . . . 0.0 112.083 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -156.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.228 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.567 ' HD3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -51.83 133.67 31.64 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.22 0.534 . . . . 0.0 111.517 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -110.38 92.59 0.69 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.737 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.567 ' N ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tt0 -94.63 -20.63 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.59 0.71 . . . . 0.0 109.961 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -168.13 130.88 1.51 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.105 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.536 ' O ' ' N ' ' A' ' 5' ' ' VAL . 2.7 mtt -138.85 164.54 29.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.614 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.1 mt-10 -125.7 115.26 19.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.863 0.363 . . . . 0.0 111.076 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.462 ' CG2' HG13 ' A' ' 5' ' ' VAL . 13.1 t -92.71 131.74 38.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.511 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.621 HD12 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -90.79 -67.99 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.712 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 127.78 33.07 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.0 158.94 32.28 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 111.912 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HG3' ' CZ3' ' A' ' 40' ' ' TRP . 60.1 Cg_endo -93.44 11.6 1.95 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.381 2.721 . . . . 0.0 113.09 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.81 -29.55 67.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.853 0.359 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.33 -38.87 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.738 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.06 100.94 35.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.33 53.09 4.36 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.61 2.207 . . . . 0.0 112.413 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 -83.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.578 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.417 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -151.32 152.37 33.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.575 0.226 . . . . 0.0 110.77 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.642 ' CZ2' ' HB2' ' A' ' 54' ' ' LYS . 4.5 p90 -119.63 172.12 7.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.024 0.44 . . . . 0.0 110.477 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.621 ' HD3' HD12 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -146.56 137.74 24.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.377 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 5.6 p -129.42 153.69 47.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.701 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.738 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -92.97 143.14 26.53 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.848 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . 0.541 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 32.0 t30 -121.88 174.48 6.85 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.354 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.89 -0.2 2.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.264 0.554 . . . . 0.0 109.915 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.586 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.92 -7.95 59.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.717 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.78 -5.52 52.36 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.234 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.512 ' HG2' ' HB3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -119.1 138.75 52.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.052 0.453 . . . . 0.0 112.15 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.738 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.57 126.29 72.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.231 178.038 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.555 ' HA3' HD11 ' A' ' 19' ' ' LEU . . . -119.06 -168.16 13.98 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.94 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.503 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -87.87 129.08 35.33 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' O ' ' CD1' ' A' ' 40' ' ' TRP . 4.9 p -134.12 131.38 20.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.462 ' HG2' ' O ' ' A' ' 53' ' ' PRO . 15.7 Cg_endo -84.55 92.2 0.76 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.365 2.71 . . . . 0.0 110.288 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.642 ' HB2' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -67.3 -9.51 41.61 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.304 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -46.75 -20.86 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . 0.444 ' O ' ' CD2' ' A' ' 8' ' ' LEU . 14.3 p90 -102.69 12.72 35.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.638 ' HB ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -134.27 176.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -178.757 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 8.9 p -107.58 112.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.34 146.49 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.551 0.691 . . . . 0.0 112.322 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.749 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -98.69 160.89 13.96 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 179.137 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.984 -179.68 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.04 138.96 41.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.664 0.268 . . . . 0.0 111.03 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 115.47 20.4 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.433 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.1 OUTLIER -128.43 167.22 24.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.684 ' HA ' ' H ' ' A' ' 60' ' ' LEU . 0.2 OUTLIER -132.38 160.51 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 110.974 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.477 ' HB3' ' CG1' ' A' ' 58' ' ' VAL . 3.9 tt0 -126.05 144.52 50.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.503 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.63 139.81 48.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.266 0.555 . . . . 0.0 111.317 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.85 ' CD2' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -107.96 -48.33 3.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.082 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . 0.445 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 52.5 m-85 -93.62 161.57 30.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.276 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.445 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 11.7 Cg_endo -54.56 -165.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.817 2.345 . . . . 0.0 112.119 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 45.5 p90 -108.28 128.68 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.239 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t -130.13 117.89 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.586 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.445 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 m -147.71 124.27 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.644 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.74 -4.14 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.114 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 2.6 m -91.84 168.68 11.26 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.244 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -67.5 -37.58 83.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 -179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.96 16.93 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.767 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLU . . . . . 0.445 ' HB3' ' CB ' ' A' ' 13' ' ' SER . 12.6 mt-10 -104.62 -176.62 3.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.739 ' HB2' ' HA3' ' A' ' 50' ' ' GLY . 0.4 OUTLIER -159.07 137.62 10.84 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.89 100.49 9.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.72 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PHE . . . . . 0.469 ' CD2' HD23 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -133.99 162.85 30.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.93 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -71.12 97.29 1.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.072 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 11.6 tppt? -74.71 135.43 41.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.71 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.14 -160.62 22.54 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.47 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 6' ' ' GLN . 2.6 tt0 -94.9 24.07 5.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.576 0.227 . . . . 0.0 111.211 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 1.5 p -169.79 123.12 0.74 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 111.843 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' MET . . . . . 0.522 ' O ' ' N ' ' A' ' 5' ' ' VAL . 0.8 OUTLIER -139.45 164.73 29.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.421 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.524 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 0.3 OUTLIER -121.41 120.51 35.18 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' VAL . . . . . 0.421 ' CG2' HG11 ' A' ' 5' ' ' VAL . 37.3 t -98.57 129.94 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.24 0.543 . . . . 0.0 111.674 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . 0.592 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.59 -84.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.77 147.49 53.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.36 159.27 32.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.201 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.0 -1.33 6.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.814 2.343 . . . . 0.0 113.166 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.14 -46.24 88.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -107.49 -30.18 8.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.4 ' CG ' ' HD2' ' A' ' 37' ' ' PRO . 2.3 t70 -72.55 148.36 90.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.59 179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.4 ' HD2' ' CG ' ' A' ' 36' ' ' ASP . 2.0 Cg_endo -40.41 -76.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.147 2.565 . . . . 0.0 112.713 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 3.1 tt0 -161.18 14.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 5.9 m0 -138.96 146.08 40.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.322 . . . . 0.0 111.002 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.645 ' CD1' HG11 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -111.95 178.66 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.062 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.627 ' HB3' ' CD1' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -141.73 137.03 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.143 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' CYS . . . . . 0.546 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.4 p -132.56 156.22 47.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.077 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.784 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.81 136.71 32.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.553 0.692 . . . . 0.0 111.446 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -113.07 174.97 5.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.805 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.17 0.78 12.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -83.78 -6.66 59.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.08 -18.39 40.85 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.535 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLN . . . . . 0.465 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 9.5 mm100 -118.26 138.22 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.744 0.307 . . . . 0.0 110.74 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' VAL . . . . . 0.784 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -115.77 127.13 73.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 0.0 110.49 178.908 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.739 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -112.66 -144.34 9.17 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.477 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . 0.627 ' CD1' ' HB3' ' A' ' 41' ' ' LYS . 1.0 OUTLIER -113.69 116.12 28.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.044 0.45 . . . . 0.0 110.503 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.645 HG11 ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -92.43 140.44 24.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.481 ' CD ' HG21 ' A' ' 52' ' ' VAL . 59.0 Cg_endo -62.89 92.96 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.486 2.791 . . . . 0.0 111.598 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -53.19 -22.85 7.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.866 0.365 . . . . 0.0 111.815 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -78.91 -11.93 60.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' TYR . . . . . . . . . . . . . 9.2 m-30 -110.2 15.72 22.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.989 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.85 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -142.11 166.35 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.608 . . . . 0.0 112.564 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.477 ' CG1' ' HB3' ' A' ' 6' ' ' GLN . 12.8 p -123.1 113.96 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.294 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.8 t -65.4 146.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.804 0.811 . . . . 0.0 113.112 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.684 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.9 OUTLIER -103.68 163.63 12.2 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.067 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.999 -179.745 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.702 0.287 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 125.95 30.65 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.554 ' HB ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -127.4 166.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.227 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.052 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -131.58 155.48 41.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.408 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.595 ' HG3' HG22 ' A' ' 26' ' ' THR . 3.9 tt0 -134.04 154.02 51.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.961 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.671 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.9 OUTLIER -111.44 162.05 15.48 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.284 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.71 -34.66 1.32 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.98 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.607 ' H ' HD22 ' A' ' 8' ' ' LEU . 22.6 m-85 -123.99 122.87 26.2 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.84 60.91 2.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.177 1.918 . . . . 0.0 111.161 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.656 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 9.4 m-85 -87.75 154.27 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.838 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -95.6 152.52 18.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -89.28 171.87 9.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 15' ' ' THR . 20.1 m -132.54 -55.31 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.535 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -46.17 158.4 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.807 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -31.0 68.31 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.736 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 12.0 mp0 -87.13 26.12 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.997 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.813 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.6 mt-10 -110.33 -176.76 3.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.266 0.555 . . . . 0.0 111.635 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.012 HD23 ' CE2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -138.58 137.64 37.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.391 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.457 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -113.55 100.08 8.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 111.441 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 1.012 ' CE2' HD23 ' A' ' 19' ' ' LEU . 20.5 m-30 -133.69 162.8 30.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 3.5 tp10 -81.33 95.88 7.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 0.8 OUTLIER -76.58 143.52 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.156 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.74 -39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.295 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -147.13 0.27 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.583 0.23 . . . . 0.0 111.167 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.595 HG22 ' HG3' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -108.38 146.22 33.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.589 0.709 . . . . 0.0 112.193 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.881 ' O ' HG13 ' A' ' 5' ' ' VAL . 26.8 mmt -134.24 164.97 26.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.443 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.5 mt-10 -113.71 122.78 48.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.052 HG23 HG11 ' A' ' 5' ' ' VAL . 2.8 t -92.45 127.47 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.451 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.584 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -91.28 -39.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.21 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -87.99 118.19 27.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.088 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HB3' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.5 155.52 36.27 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 1.8 Cg_endo -83.07 8.57 4.53 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.065 2.51 . . . . 0.0 113.416 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -88.43 -30.68 19.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.006 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -121.3 -36.23 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 110.649 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . 0.411 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . 2.8 m-20 -96.83 165.2 16.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.586 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 36' ' ' ASP . 1.1 Cg_endo -44.43 177.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.086 2.524 . . . . 0.0 112.838 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -4.27 15.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.202 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.02 146.06 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.701 0.286 . . . . 0.0 110.9 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.908 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -124.07 169.96 11.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.426 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.942 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.92 137.57 26.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.429 . . . . 0.0 112.14 -178.748 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 7.0 p -134.91 157.7 46.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.95 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.81 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 4.5 pttm -92.27 135.2 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 111.896 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 46' ' ' ARG . 1.9 t30 -108.78 174.58 5.81 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.167 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.9 4.46 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.532 0.682 . . . . 0.0 109.417 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.584 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.79 -8.58 59.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.8 -15.22 38.2 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.821 ' CG ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -118.22 138.25 52.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.907 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.81 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -120.08 125.7 74.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.866 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -117.51 -159.89 11.54 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.234 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.942 HD12 ' HB3' ' A' ' 41' ' ' LYS . 1.2 mp -96.13 110.46 22.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.908 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.4 p -92.47 133.16 30.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.097 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.28 106.87 2.31 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.072 2.515 . . . . 0.0 111.797 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -51.63 -23.4 4.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.984 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -67.82 -10.84 56.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.852 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' CD2' ' HB3' ' A' ' 11' ' ' PHE . 18.6 m-85 -116.67 12.99 15.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.433 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.633 ' C ' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -149.6 176.7 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.756 HG12 ' CD1' ' A' ' 8' ' ' LEU . 9.5 p -139.16 120.15 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.04 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.5 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.0 t -65.2 145.69 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.139 0.495 . . . . 0.0 111.485 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.68 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.97 100.06 3.94 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.767 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.411 ' HA ' HG23 ' A' ' 4' ' ' VAL . 90.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.898 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.779 0.323 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 121.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -121.87 167.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.005 -178.548 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.013 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -133.14 157.6 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.19 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.813 ' HG3' HG23 ' A' ' 26' ' ' THR . 1.8 tt0 -116.52 140.52 49.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.407 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.778 HG22 ' HG2' ' A' ' 27' ' ' MET . 1.9 p -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.148 0.499 . . . . 0.0 111.309 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.046 HD21 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.71 -37.74 4.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.061 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -133.12 162.28 58.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.738 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -46.1 175.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.143 2.562 . . . . 0.0 112.872 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 21' ' ' PHE . 51.7 p90 -93.42 129.23 39.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.638 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -130.04 117.78 20.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.47 126.9 46.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 15' ' ' THR . 24.3 m -132.47 -47.88 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.74 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -55.38 172.5 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.335 . . . . 0.0 110.994 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.72 -33.88 69.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.856 ' HB2' HD22 ' A' ' 51' ' ' LEU . 2.4 mm-40 -92.73 32.77 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.613 0.244 . . . . 0.0 111.419 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.636 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.7 mt-10 -121.68 166.84 13.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.957 HD11 ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -153.08 149.35 28.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.907 0.385 . . . . 0.0 110.715 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -100.65 111.56 23.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 111.389 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.957 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.53 163.2 29.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.019 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 2.0 tp10 -69.4 99.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HD2' ' HE2' ' A' ' 27' ' ' MET . 0.0 OUTLIER -73.45 128.28 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.318 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.472 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -88.92 -145.64 11.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.621 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' C ' HG23 ' A' ' 7' ' ' THR . 2.3 tt0 -95.82 -17.9 20.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.255 0.55 . . . . 0.0 110.689 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.813 HG23 ' HG3' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -142.6 144.08 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.851 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.778 ' HG2' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -138.43 164.25 29.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.261 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 1.5 pm0 -120.9 112.41 18.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.393 . . . . 0.0 110.291 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.013 HG23 HG11 ' A' ' 5' ' ' VAL . 14.3 t -91.37 137.25 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.745 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.6 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.8 -39.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.338 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -89.99 107.95 19.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.09 139.38 49.22 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -85.5 12.59 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -21.15 55.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.655 0.264 . . . . 0.0 111.079 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -115.12 -42.32 3.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.875 0.369 . . . . 0.0 110.46 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.86 100.98 36.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.98 61.61 7.47 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.575 2.184 . . . . 0.0 112.633 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -114.55 -75.46 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.38 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.418 ' CE3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 m-90 -151.77 146.19 25.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.144 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CD1' HG13 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -119.83 169.03 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.08 138.3 46.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 112.055 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.554 ' N ' HG23 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -132.28 157.73 43.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.867 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.806 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.15 143.22 26.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.277 0.561 . . . . 0.0 111.444 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.577 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 4.5 t-20 -120.93 174.52 6.57 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.462 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.11 -10.75 24.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.568 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HB2' ' CG ' ' A' ' 48' ' ' GLN . 2.8 mmp_? -83.35 -1.81 54.23 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.46 5.69 68.37 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.085 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.448 ' CG ' ' HB2' ' A' ' 46' ' ' ARG . 1.5 pt20 -118.28 115.35 24.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.096 0.474 . . . . 0.0 111.939 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.806 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -104.07 132.53 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.878 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -141.14 -178.27 17.24 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.858 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.856 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -73.47 111.52 8.68 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.279 0.561 . . . . 0.0 111.331 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.783 HG23 ' HD2' ' A' ' 53' ' ' PRO . 1.7 p -101.11 147.07 33.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.869 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 52' ' ' VAL . 53.9 Cg_endo -60.43 87.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.288 2.659 . . . . 0.0 111.519 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -53.38 -26.58 19.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.83 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -82.32 -0.18 44.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.528 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 2.5 m-85 -110.14 13.14 23.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 ' HE1' ' A' ' 27' ' ' MET . 0.8 OUTLIER -149.39 177.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.093 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 1.046 HG12 HD21 ' A' ' 8' ' ' LEU . 7.5 p -131.23 121.33 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.482 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 33.9 t -65.38 146.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.801 0.81 . . . . 0.0 113.058 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.708 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -105.4 164.06 12.15 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.331 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--N 1.308 -1.198 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.891 -179.819 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.522 -0.124 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 119.54 23.6 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.57 166.48 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.205 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.962 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -135.19 158.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.173 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.664 ' HB2' HD13 ' A' ' 60' ' ' LEU . 1.1 tt0 -134.22 139.89 46.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.95 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.74 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -111.2 165.52 11.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.184 0.516 . . . . 0.0 111.094 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.796 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.13 -31.53 3.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.639 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.533 ' CD2' HD23 ' A' ' 8' ' ' LEU . 34.4 m-85 -125.28 161.53 49.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 91.2 Cg_exo -44.11 151.72 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.661 2.24 . . . . 0.0 112.602 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 21' ' ' PHE . 9.2 t80 -95.42 130.25 42.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.954 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -129.06 144.37 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -170.94 161.87 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.808 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 14' ' ' VAL . 7.3 p -173.06 89.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.074 0.464 . . . . 0.0 111.228 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -160.94 172.6 16.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.976 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.465 ' H ' HG22 ' A' ' 15' ' ' THR . 0.7 OUTLIER -63.77 -32.83 74.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.618 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.633 ' CB ' HD22 ' A' ' 51' ' ' LEU . 3.7 mt-10 -99.12 -50.87 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.759 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 51' ' ' LEU . 10.4 mt-10 -63.99 153.52 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.155 HD21 ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -149.2 159.43 44.26 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.458 ' N ' HD22 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -101.09 153.09 19.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.475 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 1.155 ' CE1' HD21 ' A' ' 19' ' ' LEU . 46.8 m-85 -133.69 164.19 27.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.689 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.85 -156.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.43 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -51.64 126.92 18.97 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.722 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -125.16 86.26 0.36 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.086 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -95.4 -22.7 17.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 0.0 109.388 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.457 HG22 ' HG3' ' A' ' 6' ' ' GLN . 3.1 p -138.84 128.33 24.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.693 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.521 ' C ' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -138.73 164.71 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.208 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 4.6 mt-10 -125.71 115.22 19.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 0.0 111.243 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.962 HG23 HG11 ' A' ' 5' ' ' VAL . 24.9 t -94.82 127.07 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 110.645 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.665 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.31 -77.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.636 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.117 0.484 . . . . 0.0 112.022 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.74 159.32 33.66 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.508 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.502 ' HG3' ' CE3' ' A' ' 40' ' ' TRP . 6.4 Cg_exo -74.6 6.33 3.27 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.82 2.347 . . . . 0.0 113.09 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.38 -34.19 72.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.601 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -97.28 -44.77 6.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -123.27 100.83 38.66 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.372 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.92 57.18 5.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.476 2.117 . . . . 0.0 112.583 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' OE2' ' CZ2' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -121.75 -77.09 0.58 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.039 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.551 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -151.41 158.52 43.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.126 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.76 ' HE1' ' H ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -116.18 -179.23 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.665 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -151.22 138.64 19.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.834 -179.053 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 2.9 p -131.18 154.49 48.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.661 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.798 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.22 136.85 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.475 0.655 . . . . 0.0 110.864 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.599 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 4.1 t-20 -109.29 174.57 5.81 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.734 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.3 -3.69 21.92 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.295 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.54 -2.66 56.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.343 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.04 83.88 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.887 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -118.52 138.34 52.59 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.91 0.386 . . . . 0.0 111.66 -179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.798 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -132.99 126.06 52.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.647 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -133.5 -164.33 10.73 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.515 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.633 HD22 ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -84.96 129.88 34.73 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.306 0.574 . . . . 0.0 111.529 -179.104 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.635 HG22 ' HD2' ' A' ' 54' ' ' LYS . 6.0 p -134.0 140.78 37.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.442 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -91.03 60.54 1.23 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.537 2.824 . . . . 0.0 111.885 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.76 ' H ' ' HE1' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -45.24 -11.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -45.09 -20.71 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.099 -0.376 . . . . 0.0 111.495 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.735 ' O ' HD21 ' A' ' 8' ' ' LEU . 24.9 p90 -101.93 31.49 3.87 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.738 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -148.63 176.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.691 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -108.07 112.78 41.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -71.75 146.46 11.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.432 0.634 . . . . 0.0 112.07 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.767 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -100.87 161.54 13.53 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.332 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.766 0.317 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' HIS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -80.91 120.56 24.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.53 166.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.87 161.83 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.42 0.629 . . . . 0.0 111.283 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.509 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 2.8 tt0 -139.14 146.81 41.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.178 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.764 ' C ' HD13 ' A' ' 8' ' ' LEU . 5.7 p -105.7 163.05 12.99 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.922 0.392 . . . . 0.0 110.567 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.783 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -131.09 -35.81 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.368 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.518 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 10.0 m-85 -119.55 135.86 24.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.393 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.94 59.04 2.18 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.292 1.995 . . . . 0.0 110.387 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.581 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 13.1 m-85 -73.28 155.53 39.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.652 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -94.11 151.88 19.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.808 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 4.0 m -145.67 99.77 3.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 14' ' ' VAL . 16.5 m -127.65 103.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 111.554 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -158.46 172.45 18.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.548 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' H ' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -64.45 -32.78 74.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.058 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -113.44 12.23 18.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' O ' HD12 ' A' ' 19' ' ' LEU . 4.8 mt-10 -102.11 -173.79 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.675 0.274 . . . . 0.0 111.049 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.852 HD13 ' CA ' ' A' ' 50' ' ' GLY . 0.6 OUTLIER -147.02 160.53 42.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.352 0.596 . . . . 0.0 112.201 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.15 102.02 4.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.5 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.562 ' CE1' ' HE3' ' A' ' 27' ' ' MET . 4.3 p90 -129.74 164.05 24.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.701 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -52.26 133.04 34.46 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.221 0.534 . . . . 0.0 111.708 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -147.42 54.73 0.52 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.341 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.588 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 1.3 tt0 -59.72 -21.15 60.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 110.054 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -124.64 117.4 24.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.846 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.715 ' C ' HG13 ' A' ' 5' ' ' VAL . 24.4 mtp -139.14 163.41 32.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.237 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 0.7 OUTLIER -126.38 112.35 15.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.635 0.255 . . . . 0.0 110.855 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.995 HG23 HG11 ' A' ' 5' ' ' VAL . 5.8 t -85.67 113.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.277 0.56 . . . . 0.0 111.252 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.604 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.61 -38.91 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.607 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -98.35 118.08 34.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.273 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 25.5 mmtp -91.94 142.29 26.3 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 5.1 Cg_exo -79.62 7.97 4.23 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.756 2.304 . . . . 0.0 112.766 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -51.68 67.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.24 -34.55 10.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.83 165.11 56.13 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.681 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.17 -75.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.706 2.271 . . . . 0.0 112.772 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -175.41 17.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -123.37 145.8 48.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.92 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -126.09 171.11 11.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.893 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.0 137.24 27.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.196 -179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.535 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 8.3 p -132.46 151.88 51.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.805 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 7.4 mttp -91.59 140.22 29.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.392 0.615 . . . . 0.0 110.75 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -115.49 174.75 5.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.182 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.66 -1.84 17.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.254 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 5.8 ttm180 -83.56 -7.45 59.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.57 -12.76 55.14 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.774 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.589 ' HB3' HD21 ' A' ' 19' ' ' LEU . 3.0 mp0 -117.87 137.68 52.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.805 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.04 126.13 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.174 0.511 . . . . 0.0 110.123 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.852 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -110.35 -142.26 9.24 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.285 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.893 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -117.54 110.33 17.82 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.6 p -92.01 131.94 33.9 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.003 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 63.2 Cg_endo -74.53 107.19 2.4 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.3 2.667 . . . . 0.0 111.77 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.49 ' HA ' ' HZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -49.86 -25.38 3.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.129 0.49 . . . . 0.0 111.914 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.56 -11.83 58.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.603 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 15.5 m-30 -116.44 13.51 15.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.736 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.561 HG11 ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -149.4 175.75 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.617 0.722 . . . . 0.0 112.491 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.783 HG12 ' CD1' ' A' ' 8' ' ' LEU . 10.7 p -139.68 117.78 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.895 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 4' ' ' VAL . 2.2 t -65.21 145.82 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.133 0.492 . . . . 0.0 111.272 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.676 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -139.05 99.79 3.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.522 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.474 ' HA ' HG23 ' A' ' 4' ' ' VAL . 22.0 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.921 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.521 -0.16 0 CA-C-O 120.801 0.334 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 129.12 34.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.68 167.75 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.987 0.423 . . . . 0.0 111.183 -178.37 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.005 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.9 160.57 42.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.847 ' HB2' HD13 ' A' ' 60' ' ' LEU . 4.2 tt0 -124.44 140.48 52.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.757 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -111.62 154.38 24.97 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.813 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.76 -40.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.951 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.517 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -101.18 161.68 22.91 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.51 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.59 -176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.887 2.391 . . . . 0.0 112.972 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.459 ' CE2' ' N ' ' A' ' 21' ' ' PHE . 25.1 p90 -118.16 132.48 56.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.053 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -129.66 117.89 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.665 0.269 . . . . 0.0 111.517 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.645 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -92.09 140.04 30.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.702 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -144.86 -31.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 16' ' ' GLU . 20.9 m -84.15 162.88 20.09 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 111.854 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -62.69 -37.79 87.83 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.091 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -98.63 32.68 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.133 0.492 . . . . 0.0 110.253 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.673 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -101.79 176.29 5.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.829 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 18' ' ' GLU . 2.7 mp -144.24 164.54 30.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.555 0.693 . . . . 0.0 112.11 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -134.85 100.41 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.755 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HE2' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -134.81 156.88 48.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.821 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.445 ' HA ' ' CE1' ' A' ' 11' ' ' PHE . 5.9 mp0 -64.94 98.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.678 ' HD2' HG21 ' A' ' 7' ' ' THR . 0.2 OUTLIER -73.74 133.94 43.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.282 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.48 -148.73 24.61 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.737 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 6' ' ' GLN . 2.2 tt0 -94.92 -17.14 22.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 0.0 111.228 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.09 132.62 43.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.309 0.576 . . . . 0.0 112.164 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.527 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -138.87 164.2 30.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.877 178.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 pt-20 -122.75 118.66 28.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.772 0.32 . . . . 0.0 110.556 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.005 HG23 HG11 ' A' ' 5' ' ' VAL . 23.3 t -93.87 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.251 0.548 . . . . 0.0 111.762 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.576 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.19 -44.21 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.756 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -110.09 120.42 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.397 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.53 ' HE3' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -99.72 139.27 20.71 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.321 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 38.2 Cg_endo -91.32 17.59 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.022 2.481 . . . . 0.0 112.544 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.97 -37.68 38.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.09 -44.09 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -123.75 101.03 36.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.801 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.75 79.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -119.3 -83.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.6 ' CD2' HD21 ' A' ' 51' ' ' LEU . 1.3 m0 -151.63 160.89 43.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.285 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.997 ' CZ2' HG21 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -126.03 107.41 10.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.894 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -123.35 138.54 54.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.647 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -127.51 156.77 41.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.426 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.824 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 5.6 ptpp? -91.93 142.9 27.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.606 0.717 . . . . 0.0 111.655 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -122.52 175.43 6.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.953 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -0.38 4.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.082 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.77 -7.52 59.45 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.66 0.266 . . . . 0.0 110.593 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.4 -11.66 54.65 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.024 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.651 ' HB3' HD21 ' A' ' 19' ' ' LEU . 5.9 mp0 -118.1 137.79 52.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.516 0.327 . . . . 0.0 110.396 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.824 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -116.32 130.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.608 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -115.43 -159.72 12.28 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.245 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -98.5 132.49 43.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.618 0.723 . . . . 0.0 110.73 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.79 HG23 ' HD2' ' A' ' 53' ' ' PRO . 2.1 p -118.66 150.01 47.44 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.172 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.79 ' HD2' HG23 ' A' ' 52' ' ' VAL . 54.0 Cg_endo -60.79 82.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 123.355 2.704 . . . . 0.0 111.639 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HB3' ' CD2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -50.02 -26.78 4.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.82 -13.31 59.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.93 0.395 . . . . 0.0 111.157 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -101.94 30.93 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.372 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.997 HG21 ' CZ2' ' A' ' 40' ' ' TRP . 2.4 m -150.32 177.57 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.6 p -136.43 113.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.191 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.682 HG22 ' CH2' ' A' ' 40' ' ' TRP . 16.4 t -65.75 147.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.847 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -106.24 164.02 12.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.025 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.309 -1.162 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.112 -179.675 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 112.11 18.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -128.72 167.39 24.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.224 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.142 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -130.05 151.96 36.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 110.718 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.661 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.7 tt0 -115.55 144.47 43.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.25 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.844 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -115.9 153.25 31.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.844 HD13 ' C ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -131.31 -44.08 1.03 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.044 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -100.71 157.05 34.43 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.853 0.358 . . . . 0.0 111.648 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.53 162.28 15.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.772 2.315 . . . . 0.0 112.054 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.587 ' CZ ' HG21 ' A' ' 52' ' ' VAL . 3.2 m-85 -111.59 135.15 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.034 0.445 . . . . 0.0 111.616 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -129.03 118.86 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.301 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.8 m -103.53 142.7 33.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.384 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 15' ' ' THR . 27.7 m -135.88 -45.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.498 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -67.41 172.45 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' H ' HG22 ' A' ' 15' ' ' THR . 0.6 OUTLIER -74.94 -37.5 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.033 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.85 ' HB2' HD22 ' A' ' 51' ' ' LEU . 13.7 mt-10 -63.16 -48.92 76.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.574 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.47 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -54.54 -171.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.825 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.839 HD12 ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -178.79 158.25 0.98 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.122 178.496 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.465 ' N ' HD22 ' A' ' 19' ' ' LEU . 2.6 p30 -100.79 116.66 33.21 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.68 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -133.5 162.63 31.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.02 178.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 11.8 pt-20 -65.13 107.57 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 110.112 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -73.85 120.53 19.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.636 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -103.37 -152.69 23.49 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.68 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.489 ' C ' HG22 ' A' ' 26' ' ' THR . 2.5 tt0 -94.87 -1.16 53.24 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.503 0.192 . . . . 0.0 111.273 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -169.57 146.6 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.881 0.848 . . . . 0.0 113.017 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.863 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.65 164.59 29.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.795 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.645 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 4.2 pm0 -114.67 113.21 24.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.142 HG23 HG11 ' A' ' 5' ' ' VAL . 38.6 t -90.31 132.64 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 111.438 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.659 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.23 -81.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.465 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.37 128.35 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -105.09 117.26 58.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 17.3 Cg_exo -66.9 62.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.55 -52.47 5.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.011 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -85.5 -44.58 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -108.77 101.04 42.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.721 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -65.91 111.19 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.711 2.274 . . . . 0.0 112.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 24.6 tt0 -152.84 -98.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -151.68 161.36 42.8 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 1.011 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -118.94 159.38 23.91 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.701 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -137.35 138.6 40.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.38 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.645 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -133.68 159.94 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.946 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.747 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -91.92 143.27 26.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 0.0 112.275 -178.431 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -117.21 174.74 5.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.009 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.05 18.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.51 -7.25 59.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.719 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 3.23 87.67 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.434 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.729 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -118.02 115.65 25.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 122.181 0.192 . . . . 0.0 111.338 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.747 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -100.11 125.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.839 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -127.93 -178.9 15.56 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.555 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.85 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -73.76 135.39 43.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.848 -0.676 . . . . 0.0 111.147 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 1.011 HG13 ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -132.83 140.86 39.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.254 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.576 ' HD2' HG23 ' A' ' 52' ' ' VAL . 42.0 Cg_endo -79.92 114.53 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.939 2.426 . . . . 0.0 111.404 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -57.95 -14.06 5.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.766 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -8.04 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.407 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.559 ' O ' HD22 ' A' ' 8' ' ' LEU . 3.6 m-85 -117.81 15.59 14.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.549 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -149.97 176.28 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 111.775 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.9 p -135.75 116.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 177.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 22.2 t -65.13 146.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.676 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -108.23 163.7 12.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.198 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.309 -1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.82 0.343 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.08 121.58 26.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -124.95 167.68 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.888 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.974 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -133.55 157.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.454 0.645 . . . . 0.0 111.383 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.818 ' HB2' HD13 ' A' ' 60' ' ' LEU . 11.4 tt0 -122.21 138.53 54.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.39 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.774 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -112.28 156.63 22.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.257 0.551 . . . . 0.0 111.684 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.814 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.5 -41.24 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.752 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.495 ' H ' HD22 ' A' ' 8' ' ' LEU . 4.6 m-85 -94.45 161.64 28.51 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -166.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.744 2.296 . . . . 0.0 112.597 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 51.4 p90 -103.09 129.24 49.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.23 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -129.61 118.3 21.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.84 118.69 9.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.891 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 14' ' ' VAL . 7.7 p -145.15 55.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.218 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 16' ' ' GLU . 1.5 m -149.7 172.47 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 15' ' ' THR . 1.6 tp10 -75.13 -33.85 61.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HG3' HD22 ' A' ' 51' ' ' LEU . 10.4 pt-20 -98.75 28.97 3.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.856 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.85 -168.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.204 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.962 HD11 ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -178.85 148.94 0.43 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.222 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.17 116.31 32.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.134 0.492 . . . . 0.0 112.075 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.962 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.51 162.76 31.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.349 179.021 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -76.73 97.6 4.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.407 0.622 . . . . 0.0 110.294 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.657 ' HD2' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -74.05 142.96 45.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.202 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.18 -144.02 8.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.72 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.95 -16.32 22.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.016 0.436 . . . . 0.0 111.263 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.43 132.84 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.095 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.494 ' C ' HG13 ' A' ' 5' ' ' VAL . 1.3 tpt -138.57 164.64 28.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.56 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.697 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -125.14 114.21 18.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.328 . . . . 0.0 110.853 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.974 HG23 HG11 ' A' ' 5' ' ' VAL . 25.6 t -95.25 137.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.57 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.645 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -86.53 -78.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.943 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 120.68 15.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.787 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -101.79 150.2 37.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 2.9 Cg_exo -76.24 55.63 4.67 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.849 2.366 . . . . 0.0 112.268 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -88.59 -35.82 16.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.986 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -113.33 -36.62 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.8 100.95 36.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.083 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 33' ' ' PRO . 4.9 Cg_exo -74.5 59.14 4.72 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.851 2.367 . . . . 0.0 112.154 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.76 -88.07 0.4 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.338 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -151.26 152.84 33.79 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.617 0.246 . . . . 0.0 110.786 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.641 ' CD1' HG13 ' A' ' 52' ' ' VAL . 1.1 p90 -114.74 172.21 7.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.7 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -143.68 138.86 29.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.697 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -131.71 157.73 43.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.362 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.79 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.17 143.05 26.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.248 0.546 . . . . 0.0 111.391 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.526 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 3.9 t30 -120.87 174.69 6.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.453 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HB3' HH21 ' A' ' 46' ' ' ARG . . . -63.12 -11.86 23.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.425 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.584 HH21 ' HB3' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -83.48 0.87 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.326 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 7.57 58.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.191 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.573 ' CD ' HD23 ' A' ' 19' ' ' LEU . 3.2 pt20 -118.26 114.78 23.52 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.732 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.79 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -105.81 131.76 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.795 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -140.23 -170.14 11.92 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.559 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.7 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -79.83 107.0 12.27 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.493 0.663 . . . . 0.0 111.466 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.765 HG23 ' HD2' ' A' ' 53' ' ' PRO . 1.9 p -92.4 146.75 33.09 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.982 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.765 ' HD2' HG23 ' A' ' 52' ' ' VAL . 57.2 Cg_endo -60.55 88.13 0.08 OUTLIER 'Trans proline' 0 CA--C 1.519 -0.233 0 C-N-CA 123.395 2.73 . . . . 0.0 111.283 178.06 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -52.69 -24.73 9.16 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.43 -6.66 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.532 ' CG ' ' HB2' ' A' ' 53' ' ' PRO . 17.0 m-30 -108.67 20.6 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.526 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -150.07 176.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 111.78 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 6' ' ' GLN . 5.0 p -132.85 113.56 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 21.9 t -65.67 147.26 12.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -105.66 163.91 12.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.099 -1.409 . . . . 0.0 109.174 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--N 1.309 -1.191 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.95 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.708 0.29 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 124.73 29.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.48 167.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.691 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 1.114 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.12 147.96 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.714 0.769 . . . . 0.0 111.433 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.839 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -106.24 140.39 39.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.969 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.747 ' C ' HD13 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -114.06 155.2 26.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.49 0.662 . . . . 0.0 112.456 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.838 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.51 -40.66 1.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.544 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.546 ' H ' HD22 ' A' ' 8' ' ' LEU . 1.7 m-85 -117.68 146.61 39.14 Favored Pre-proline 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 9' ' ' TYR . 26.4 Cg_exo -62.62 163.25 21.88 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -117.77 153.06 34.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.548 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.056 0.455 . . . . 0.0 111.61 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -81.52 163.24 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -173.34 -42.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 16' ' ' GLU . 1.1 m -94.29 172.61 8.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' H ' HG22 ' A' ' 15' ' ' THR . 1.3 tp10 -65.2 -37.53 87.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.801 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.887 ' HB2' HD22 ' A' ' 51' ' ' LEU . 5.2 mt-10 -84.72 -4.07 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.922 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.879 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.9 170.69 16.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.879 HD12 ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -159.0 156.25 29.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 112.001 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.95 101.85 4.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.582 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -132.3 165.45 24.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.04 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.28 102.24 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.582 0.706 . . . . 0.0 110.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.633 ' CE ' HG21 ' A' ' 7' ' ' THR . 0.5 OUTLIER -73.45 143.64 46.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.641 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 -160.34 11.39 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.656 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -95.33 10.9 34.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.949 0.375 . . . . 0.0 110.431 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.59 133.41 11.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.388 0.614 . . . . 0.0 112.144 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 5' ' ' VAL . 1.5 ptm -139.04 164.71 29.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.983 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 13.3 pt-20 -124.77 112.27 16.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.181 0.515 . . . . 0.0 110.696 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 1.114 HG23 HG11 ' A' ' 5' ' ' VAL . 31.9 t -91.85 134.7 29.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.625 ' CG1' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.79 -41.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.242 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -90.9 107.83 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.669 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.7 mmmm -93.81 114.78 63.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.961 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.02 92.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.125 . . . . 0.0 111.951 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.42 -52.5 6.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -114.53 -29.21 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.244 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -101.29 101.09 15.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.941 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.0 58.67 6.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.569 2.18 . . . . 0.0 112.304 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.53 -94.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.047 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -151.66 152.03 32.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.959 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -105.27 171.27 7.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.281 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.771 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.14 136.92 46.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 112.187 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.67 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 p -126.05 152.12 46.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.155 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.691 ' HA ' HG12 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -91.94 130.68 37.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.067 0.46 . . . . 0.0 110.343 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.57 174.61 5.8 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.353 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.29 3.14 16.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.206 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.82 -6.19 59.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.374 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.8 -27.85 14.69 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.812 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.484 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 5.1 mm-40 -117.75 138.81 51.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -104.9 146.88 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.081 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.821 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -133.12 -159.36 9.1 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.56 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.887 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -105.14 120.24 41.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 0.0 111.089 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.959 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.2 p -101.64 141.35 22.41 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 52' ' ' VAL . 91.4 Cg_endo -70.82 105.1 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.326 2.684 . . . . 0.0 111.23 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -55.96 -21.84 23.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -76.12 -9.59 58.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.298 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.51 ' O ' HD22 ' A' ' 8' ' ' LEU . 10.8 m-30 -110.39 18.79 19.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.7 OUTLIER -150.23 176.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 112.363 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.1 p -136.33 118.5 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.992 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.478 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 18.9 t -65.47 147.25 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.839 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -109.29 164.01 12.86 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.08 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.308 -1.212 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.858 -179.701 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.11 122.88 27.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.88 166.96 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.198 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.947 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -134.96 158.1 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.477 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.735 ' HB2' HD13 ' A' ' 60' ' ' LEU . 2.7 tt0 -130.98 143.84 51.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.729 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.762 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -116.81 167.88 10.71 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.233 0.539 . . . . 0.0 110.999 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.901 HD21 ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -130.93 -21.68 2.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.532 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.776 ' CD2' HD23 ' A' ' 8' ' ' LEU . 22.3 m-85 -135.78 161.68 61.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 85.2 Cg_exo -46.68 173.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.546 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 52' ' ' VAL . 2.9 t80 -102.29 138.92 38.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.07 118.49 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.618 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -109.29 171.72 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.57 -41.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.28 172.54 12.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.782 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -83.59 -30.12 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.07 33.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.706 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.6 mt-10 -117.85 -170.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.319 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.923 HD23 ' CZ ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -148.31 141.09 24.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -113.24 102.15 10.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.529 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.923 ' CZ ' HD23 ' A' ' 19' ' ' LEU . 8.9 m-30 -116.7 163.4 16.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.249 0.547 . . . . 0.0 112.083 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -156.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.228 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HD3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -51.83 133.67 31.64 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.22 0.534 . . . . 0.0 111.517 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' HE3' ' A' ' 23' ' ' LYS . . . -110.38 92.59 0.69 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.737 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.574 ' N ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tt0 -94.63 -20.63 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.59 0.71 . . . . 0.0 109.961 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -168.13 130.88 1.51 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.105 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.483 ' C ' HG13 ' A' ' 5' ' ' VAL . 2.7 mtt -138.85 164.54 29.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.614 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.1 mt-10 -125.7 115.26 19.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.863 0.363 . . . . 0.0 111.076 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.947 HG23 HG11 ' A' ' 5' ' ' VAL . 13.1 t -92.71 131.74 38.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.511 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.645 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -90.79 -67.99 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.712 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 127.78 33.07 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.0 158.94 32.28 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 111.912 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HG3' ' CZ3' ' A' ' 40' ' ' TRP . 60.1 Cg_endo -93.44 11.6 1.95 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.381 2.721 . . . . 0.0 113.09 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.81 -29.55 67.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.853 0.359 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.33 -38.87 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.738 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.06 100.94 35.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.33 53.09 4.36 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.61 2.207 . . . . 0.0 112.413 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 -83.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.578 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.448 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -151.32 152.37 33.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.575 0.226 . . . . 0.0 110.77 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.725 ' HB2' HG13 ' A' ' 29' ' ' VAL . 4.5 p90 -119.63 172.12 7.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.024 0.44 . . . . 0.0 110.477 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.648 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -146.56 137.74 24.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.377 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 5.6 p -129.42 153.69 47.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.701 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.767 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -92.97 143.14 26.53 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.848 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASN . . . . . 0.559 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 32.0 t30 -121.88 174.48 6.85 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.354 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.89 -0.2 2.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.264 0.554 . . . . 0.0 109.915 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.58 ' HG2' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.92 -7.95 59.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.717 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.78 -5.52 52.36 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.234 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.775 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -119.1 138.75 52.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.052 0.453 . . . . 0.0 112.15 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.767 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.57 126.29 72.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.231 178.038 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.908 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -119.06 -168.16 13.98 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.94 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -87.87 129.08 35.33 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.663 HG11 ' HE2' ' A' ' 54' ' ' LYS . 4.9 p -134.12 131.38 20.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.44 ' O ' ' CD2' ' A' ' 56' ' ' TYR . 15.7 Cg_endo -84.55 92.2 0.76 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.365 2.71 . . . . 0.0 110.288 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HE2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -67.3 -9.51 41.61 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.304 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -46.75 -20.86 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.901 ' O ' HD21 ' A' ' 8' ' ' LEU . 14.3 p90 -102.69 12.72 35.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -134.27 176.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -178.757 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 6' ' ' GLN . 8.9 p -107.58 112.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.34 146.49 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.551 0.691 . . . . 0.0 112.322 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.804 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -98.69 160.89 13.96 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 179.137 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.984 -179.68 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.664 0.268 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 115.47 20.4 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.773 HG13 ' HG2' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -128.43 167.22 24.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.988 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.38 160.51 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 110.974 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.82 ' HB2' HD13 ' A' ' 60' ' ' LEU . 3.9 tt0 -126.05 144.52 50.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.503 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.72 HG23 ' SD ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -113.63 139.81 48.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.266 0.555 . . . . 0.0 111.317 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.862 ' CD2' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -107.96 -48.33 3.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.082 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . 0.424 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 52.5 m-85 -93.62 161.57 30.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.276 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 11.7 Cg_endo -54.56 -165.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.817 2.345 . . . . 0.0 112.119 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 45.5 p90 -108.28 128.68 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.239 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t -130.13 117.89 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.586 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 m -147.71 124.27 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.644 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.74 -4.14 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.114 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.6 m -91.84 168.68 11.26 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.244 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 15' ' ' THR . 0.2 OUTLIER -67.5 -37.58 83.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 -179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.96 16.93 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.767 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLU . . . . . 0.827 ' O ' HD12 ' A' ' 19' ' ' LEU . 12.6 mt-10 -104.62 -176.62 3.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -159.07 137.62 10.84 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.89 100.49 9.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.72 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PHE . . . . . 0.456 ' O ' ' CG ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -133.99 162.85 30.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.93 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -71.12 97.29 1.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.072 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.655 ' HG2' HG21 ' A' ' 7' ' ' THR . 11.6 tppt? -74.71 135.43 41.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.71 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.14 -160.62 22.54 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.47 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.732 ' O ' HG23 ' A' ' 26' ' ' THR . 2.6 tt0 -94.9 24.07 5.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.576 0.227 . . . . 0.0 111.211 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 25' ' ' GLU . 1.5 p -169.79 123.12 0.74 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 111.843 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' MET . . . . . 0.72 ' SD ' HG23 ' A' ' 7' ' ' THR . 0.8 OUTLIER -139.45 164.73 29.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.421 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.773 ' HG2' HG13 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -121.41 120.51 35.18 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' VAL . . . . . 0.988 HG23 HG11 ' A' ' 5' ' ' VAL . 37.3 t -98.57 129.94 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.24 0.543 . . . . 0.0 111.674 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.637 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.59 -84.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.77 147.49 53.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.36 159.27 32.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.201 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.0 -1.33 6.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.814 2.343 . . . . 0.0 113.166 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.14 -46.24 88.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -107.49 -30.18 8.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -72.55 148.36 90.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.59 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -40.41 -76.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.147 2.565 . . . . 0.0 112.713 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 3.1 tt0 -161.18 14.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 5.9 m0 -138.96 146.08 40.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.322 . . . . 0.0 111.002 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.738 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -111.95 178.66 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.062 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.912 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -141.73 137.03 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.143 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' CYS . . . . . 0.556 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.4 p -132.56 156.22 47.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.077 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.815 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.81 136.71 32.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.553 0.692 . . . . 0.0 111.446 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -113.07 174.97 5.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.805 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.17 0.78 12.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -83.78 -6.66 59.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.08 -18.39 40.85 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.535 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLN . . . . . 0.728 ' HB3' HD21 ' A' ' 19' ' ' LEU . 9.5 mm100 -118.26 138.22 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.744 0.307 . . . . 0.0 110.74 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' VAL . . . . . 0.815 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -115.77 127.13 73.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 0.0 110.49 178.908 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.764 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -112.66 -144.34 9.17 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.477 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LEU . . . . . 0.912 HD12 ' HB3' ' A' ' 41' ' ' LYS . 1.0 OUTLIER -113.69 116.12 28.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.044 0.45 . . . . 0.0 110.503 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.738 HG13 ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -92.43 140.44 24.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 52' ' ' VAL . 59.0 Cg_endo -62.89 92.96 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.486 2.791 . . . . 0.0 111.598 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -53.19 -22.85 7.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.866 0.365 . . . . 0.0 111.815 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -78.91 -11.93 60.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' TYR . . . . . 0.416 ' HB3' ' HB2' ' A' ' 9' ' ' TYR . 9.2 m-30 -110.2 15.72 22.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.989 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.862 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -142.11 166.35 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.608 . . . . 0.0 112.564 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 58' ' ' VAL . 12.8 p -123.1 113.96 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.294 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.8 t -65.4 146.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.804 0.811 . . . . 0.0 113.112 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -103.68 163.63 12.2 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.067 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.999 -179.745 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.16 121.13 43.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.702 0.287 . . . . 0.0 111.063 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 125.95 30.65 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.554 ' HB ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -127.4 166.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.227 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.052 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -131.58 155.48 41.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.408 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.595 ' HG3' HG22 ' A' ' 26' ' ' THR . 3.9 tt0 -134.04 154.02 51.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.961 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.671 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.9 OUTLIER -111.44 162.05 15.48 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.284 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.71 -34.66 1.32 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.98 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.607 ' H ' HD22 ' A' ' 8' ' ' LEU . 22.6 m-85 -123.99 122.87 26.2 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.84 60.91 2.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.177 1.918 . . . . 0.0 111.161 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.656 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 9.4 m-85 -87.75 154.27 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.838 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -95.6 152.52 18.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -89.28 171.87 9.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 15' ' ' THR . 20.1 m -132.54 -55.31 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.535 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -46.17 158.4 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.807 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -31.0 68.31 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.736 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 12.0 mp0 -87.13 26.12 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.997 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.813 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.6 mt-10 -110.33 -176.76 3.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.266 0.555 . . . . 0.0 111.635 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.012 HD23 ' CE2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -138.58 137.64 37.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.391 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -113.55 100.08 8.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 111.441 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 1.012 ' CE2' HD23 ' A' ' 19' ' ' LEU . 20.5 m-30 -133.69 162.8 30.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 3.5 tp10 -81.33 95.88 7.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 0.8 OUTLIER -76.58 143.52 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.156 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.74 -39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.295 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -147.13 0.27 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.583 0.23 . . . . 0.0 111.167 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.595 HG22 ' HG3' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -108.38 146.22 33.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.589 0.709 . . . . 0.0 112.193 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.881 ' O ' HG13 ' A' ' 5' ' ' VAL . 26.8 mmt -134.24 164.97 26.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.443 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.5 mt-10 -113.71 122.78 48.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.052 HG23 HG11 ' A' ' 5' ' ' VAL . 2.8 t -92.45 127.47 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.451 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.584 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -91.28 -39.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.21 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -87.99 118.19 27.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.088 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HB3' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.5 155.52 36.27 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 1.8 Cg_endo -83.07 8.57 4.53 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.065 2.51 . . . . 0.0 113.416 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -88.43 -30.68 19.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.006 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -121.3 -36.23 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 110.649 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . 0.411 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . 2.8 m-20 -96.83 165.2 16.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.586 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 36' ' ' ASP . 1.1 Cg_endo -44.43 177.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.086 2.524 . . . . 0.0 112.838 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -4.27 15.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.202 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.02 146.06 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.701 0.286 . . . . 0.0 110.9 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.908 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -124.07 169.96 11.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.426 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.942 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.92 137.57 26.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.429 . . . . 0.0 112.14 -178.748 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 7.0 p -134.91 157.7 46.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.95 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.81 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 4.5 pttm -92.27 135.2 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 111.896 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 46' ' ' ARG . 1.9 t30 -108.78 174.58 5.81 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.167 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.9 4.46 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.532 0.682 . . . . 0.0 109.417 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.584 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.79 -8.58 59.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.8 -15.22 38.2 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.821 ' CG ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -118.22 138.25 52.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.907 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.81 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -120.08 125.7 74.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.866 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -117.51 -159.89 11.54 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.234 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.942 HD12 ' HB3' ' A' ' 41' ' ' LYS . 1.2 mp -96.13 110.46 22.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.908 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.4 p -92.47 133.16 30.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.097 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.28 106.87 2.31 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.072 2.515 . . . . 0.0 111.797 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -51.63 -23.4 4.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.984 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -67.82 -10.84 56.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.852 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' CD2' ' HB3' ' A' ' 11' ' ' PHE . 18.6 m-85 -116.67 12.99 15.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.433 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.633 ' C ' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -149.6 176.7 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.756 HG12 ' CD1' ' A' ' 8' ' ' LEU . 9.5 p -139.16 120.15 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.04 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.5 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.0 t -65.2 145.69 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.139 0.495 . . . . 0.0 111.485 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.68 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.97 100.06 3.94 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.767 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.411 ' HA ' HG23 ' A' ' 4' ' ' VAL . 90.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.898 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.06 137.77 5.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.779 0.323 . . . . 0.0 111.166 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 121.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -121.87 167.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.005 -178.548 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.013 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -133.14 157.6 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.19 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.813 ' HG3' HG23 ' A' ' 26' ' ' THR . 1.8 tt0 -116.52 140.52 49.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.407 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.778 HG22 ' HG2' ' A' ' 27' ' ' MET . 1.9 p -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.148 0.499 . . . . 0.0 111.309 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.046 HD21 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.71 -37.74 4.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.061 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -133.12 162.28 58.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.738 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -46.1 175.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.143 2.562 . . . . 0.0 112.872 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 21' ' ' PHE . 51.7 p90 -93.42 129.23 39.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.638 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -130.04 117.78 20.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.47 126.9 46.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 15' ' ' THR . 24.3 m -132.47 -47.88 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.74 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -55.38 172.5 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.335 . . . . 0.0 110.994 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.72 -33.88 69.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.856 ' HB2' HD22 ' A' ' 51' ' ' LEU . 2.4 mm-40 -92.73 32.77 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.613 0.244 . . . . 0.0 111.419 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.636 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.7 mt-10 -121.68 166.84 13.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.957 HD11 ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -153.08 149.35 28.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.907 0.385 . . . . 0.0 110.715 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -100.65 111.56 23.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 111.389 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.957 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.53 163.2 29.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.019 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 2.0 tp10 -69.4 99.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HD2' ' HE2' ' A' ' 27' ' ' MET . 0.0 OUTLIER -73.45 128.28 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.318 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.472 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -88.92 -145.64 11.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.621 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' C ' HG23 ' A' ' 7' ' ' THR . 2.3 tt0 -95.82 -17.9 20.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.255 0.55 . . . . 0.0 110.689 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.813 HG23 ' HG3' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -142.6 144.08 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.851 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.778 ' HG2' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -138.43 164.25 29.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.261 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 1.5 pm0 -120.9 112.41 18.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.393 . . . . 0.0 110.291 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.013 HG23 HG11 ' A' ' 5' ' ' VAL . 14.3 t -91.37 137.25 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.745 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.6 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.8 -39.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.338 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -89.99 107.95 19.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.09 139.38 49.22 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -85.5 12.59 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -21.15 55.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.655 0.264 . . . . 0.0 111.079 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -115.12 -42.32 3.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.875 0.369 . . . . 0.0 110.46 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.86 100.98 36.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.98 61.61 7.47 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.575 2.184 . . . . 0.0 112.633 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -114.55 -75.46 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.38 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.418 ' CE3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 m-90 -151.77 146.19 25.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.144 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CD1' HG13 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -119.83 169.03 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.08 138.3 46.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 112.055 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.554 ' N ' HG23 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -132.28 157.73 43.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.867 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.806 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.15 143.22 26.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.277 0.561 . . . . 0.0 111.444 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.577 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 4.5 t-20 -120.93 174.52 6.57 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.462 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.11 -10.75 24.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.568 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HB2' ' CG ' ' A' ' 48' ' ' GLN . 2.8 mmp_? -83.35 -1.81 54.23 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.46 5.69 68.37 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.085 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.448 ' CG ' ' HB2' ' A' ' 46' ' ' ARG . 1.5 pt20 -118.28 115.35 24.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.096 0.474 . . . . 0.0 111.939 -179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.806 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -104.07 132.53 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.878 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -141.14 -178.27 17.24 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.858 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.856 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -73.47 111.52 8.68 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.279 0.561 . . . . 0.0 111.331 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.783 HG23 ' HD2' ' A' ' 53' ' ' PRO . 1.7 p -101.11 147.07 33.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.869 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 52' ' ' VAL . 53.9 Cg_endo -60.43 87.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.288 2.659 . . . . 0.0 111.519 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -53.38 -26.58 19.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.83 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -82.32 -0.18 44.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.528 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 2.5 m-85 -110.14 13.14 23.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 ' HE1' ' A' ' 27' ' ' MET . 0.8 OUTLIER -149.39 177.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.093 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 1.046 HG12 HD21 ' A' ' 8' ' ' LEU . 7.5 p -131.23 121.33 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.482 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 33.9 t -65.38 146.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.801 0.81 . . . . 0.0 113.058 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.708 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -105.4 164.06 12.15 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.331 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--N 1.308 -1.198 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.891 -179.819 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.35 124.25 49.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 119.54 23.6 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.57 166.48 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.205 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.962 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -135.19 158.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.173 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.664 ' HB2' HD13 ' A' ' 60' ' ' LEU . 1.1 tt0 -134.22 139.89 46.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.95 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.74 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -111.2 165.52 11.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.184 0.516 . . . . 0.0 111.094 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.796 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.13 -31.53 3.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.639 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.533 ' CD2' HD23 ' A' ' 8' ' ' LEU . 34.4 m-85 -125.28 161.53 49.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 91.2 Cg_exo -44.11 151.72 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.661 2.24 . . . . 0.0 112.602 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 21' ' ' PHE . 9.2 t80 -95.42 130.25 42.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.954 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -129.06 144.37 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -170.94 161.87 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.808 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 14' ' ' VAL . 7.3 p -173.06 89.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.074 0.464 . . . . 0.0 111.228 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -160.94 172.6 16.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.976 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.465 ' H ' HG22 ' A' ' 15' ' ' THR . 0.7 OUTLIER -63.77 -32.83 74.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.618 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.633 ' CB ' HD22 ' A' ' 51' ' ' LEU . 3.7 mt-10 -99.12 -50.87 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.759 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 51' ' ' LEU . 10.4 mt-10 -63.99 153.52 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.155 HD21 ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -149.2 159.43 44.26 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.458 ' N ' HD22 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -101.09 153.09 19.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.475 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 1.155 ' CE1' HD21 ' A' ' 19' ' ' LEU . 46.8 m-85 -133.69 164.19 27.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.689 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.85 -156.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.43 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -51.64 126.92 18.97 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.722 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -125.16 86.26 0.36 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.086 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -95.4 -22.7 17.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 0.0 109.388 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.457 HG22 ' HG3' ' A' ' 6' ' ' GLN . 3.1 p -138.84 128.33 24.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.693 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.521 ' C ' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -138.73 164.71 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.208 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 4.6 mt-10 -125.71 115.22 19.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 0.0 111.243 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.962 HG23 HG11 ' A' ' 5' ' ' VAL . 24.9 t -94.82 127.07 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 110.645 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.665 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.31 -77.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.636 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.117 0.484 . . . . 0.0 112.022 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.74 159.32 33.66 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.508 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.502 ' HG3' ' CE3' ' A' ' 40' ' ' TRP . 6.4 Cg_exo -74.6 6.33 3.27 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.82 2.347 . . . . 0.0 113.09 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.38 -34.19 72.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.601 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -97.28 -44.77 6.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -123.27 100.83 38.66 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.372 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.92 57.18 5.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.476 2.117 . . . . 0.0 112.583 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' OE2' ' CZ2' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -121.75 -77.09 0.58 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.039 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.551 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -151.41 158.52 43.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.126 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.76 ' HE1' ' H ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -116.18 -179.23 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.665 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -151.22 138.64 19.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.834 -179.053 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 2.9 p -131.18 154.49 48.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.661 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.798 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.22 136.85 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.475 0.655 . . . . 0.0 110.864 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.599 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 4.1 t-20 -109.29 174.57 5.81 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.734 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.3 -3.69 21.92 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.295 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.54 -2.66 56.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.343 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.04 83.88 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.887 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -118.52 138.34 52.59 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.91 0.386 . . . . 0.0 111.66 -179.399 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.798 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -132.99 126.06 52.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.647 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -133.5 -164.33 10.73 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.515 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.633 HD22 ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -84.96 129.88 34.73 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.306 0.574 . . . . 0.0 111.529 -179.104 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.635 HG22 ' HD2' ' A' ' 54' ' ' LYS . 6.0 p -134.0 140.78 37.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.442 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -91.03 60.54 1.23 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.537 2.824 . . . . 0.0 111.885 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.76 ' H ' ' HE1' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -45.24 -11.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -45.09 -20.71 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.099 -0.376 . . . . 0.0 111.495 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.735 ' O ' HD21 ' A' ' 8' ' ' LEU . 24.9 p90 -101.93 31.49 3.87 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.738 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -148.63 176.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.691 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -108.07 112.78 41.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -71.75 146.46 11.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.432 0.634 . . . . 0.0 112.07 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.767 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -100.87 161.54 13.53 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.332 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.65 142.31 27.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.044 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 61' ' ' SER . 0.1 OUTLIER -80.91 120.56 24.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.53 166.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.87 161.83 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.42 0.629 . . . . 0.0 111.283 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.509 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 2.8 tt0 -139.14 146.81 41.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.178 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.764 ' C ' HD13 ' A' ' 8' ' ' LEU . 5.7 p -105.7 163.05 12.99 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.922 0.392 . . . . 0.0 110.567 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.783 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -131.09 -35.81 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.368 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.518 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 10.0 m-85 -119.55 135.86 24.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.393 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.94 59.04 2.18 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.292 1.995 . . . . 0.0 110.387 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.581 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 13.1 m-85 -73.28 155.53 39.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.652 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -94.11 151.88 19.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.808 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 4.0 m -145.67 99.77 3.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 14' ' ' VAL . 16.5 m -127.65 103.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 111.554 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -158.46 172.45 18.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.548 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' H ' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -64.45 -32.78 74.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.058 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -113.44 12.23 18.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' O ' HD12 ' A' ' 19' ' ' LEU . 4.8 mt-10 -102.11 -173.79 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.675 0.274 . . . . 0.0 111.049 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.852 HD13 ' CA ' ' A' ' 50' ' ' GLY . 0.6 OUTLIER -147.02 160.53 42.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.352 0.596 . . . . 0.0 112.201 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.15 102.02 4.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.5 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.562 ' CE1' ' HE3' ' A' ' 27' ' ' MET . 4.3 p90 -129.74 164.05 24.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.701 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -52.26 133.04 34.46 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.221 0.534 . . . . 0.0 111.708 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -147.42 54.73 0.52 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.341 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.588 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 1.3 tt0 -59.72 -21.15 60.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 110.054 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -124.64 117.4 24.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.846 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.715 ' C ' HG13 ' A' ' 5' ' ' VAL . 24.4 mtp -139.14 163.41 32.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.237 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 0.7 OUTLIER -126.38 112.35 15.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.635 0.255 . . . . 0.0 110.855 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.995 HG23 HG11 ' A' ' 5' ' ' VAL . 5.8 t -85.67 113.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.277 0.56 . . . . 0.0 111.252 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.604 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.61 -38.91 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.607 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -98.35 118.08 34.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.273 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 25.5 mmtp -91.94 142.29 26.3 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 5.1 Cg_exo -79.62 7.97 4.23 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.756 2.304 . . . . 0.0 112.766 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -51.68 67.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.24 -34.55 10.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.83 165.11 56.13 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.681 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.17 -75.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.706 2.271 . . . . 0.0 112.772 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -175.41 17.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -123.37 145.8 48.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.92 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -126.09 171.11 11.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.893 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.0 137.24 27.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.196 -179.247 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.535 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 8.3 p -132.46 151.88 51.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.805 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 7.4 mttp -91.59 140.22 29.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.392 0.615 . . . . 0.0 110.75 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 16.1 t30 -115.49 174.75 5.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.182 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.66 -1.84 17.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.254 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 5.8 ttm180 -83.56 -7.45 59.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.57 -12.76 55.14 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.774 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.589 ' HB3' HD21 ' A' ' 19' ' ' LEU . 3.0 mp0 -117.87 137.68 52.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.805 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.04 126.13 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.174 0.511 . . . . 0.0 110.123 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.852 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -110.35 -142.26 9.24 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.285 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.893 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -117.54 110.33 17.82 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.6 p -92.01 131.94 33.9 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.003 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 63.2 Cg_endo -74.53 107.19 2.4 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.3 2.667 . . . . 0.0 111.77 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.49 ' HA ' ' HZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -49.86 -25.38 3.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.129 0.49 . . . . 0.0 111.914 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.56 -11.83 58.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.603 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 15.5 m-30 -116.44 13.51 15.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.736 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.561 HG11 ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -149.4 175.75 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.617 0.722 . . . . 0.0 112.491 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.783 HG12 ' CD1' ' A' ' 8' ' ' LEU . 10.7 p -139.68 117.78 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.895 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 4' ' ' VAL . 2.2 t -65.21 145.82 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.133 0.492 . . . . 0.0 111.272 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.676 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -139.05 99.79 3.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.522 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.474 ' HA ' HG23 ' A' ' 4' ' ' VAL . 22.0 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.921 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.645 -0.182 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.67 129.93 49.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 111.091 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 129.12 34.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.68 167.75 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.987 0.423 . . . . 0.0 111.183 -178.37 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.005 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.9 160.57 42.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.847 ' HB2' HD13 ' A' ' 60' ' ' LEU . 4.2 tt0 -124.44 140.48 52.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.757 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -111.62 154.38 24.97 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.813 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.76 -40.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.951 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.517 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -101.18 161.68 22.91 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.51 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.59 -176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.887 2.391 . . . . 0.0 112.972 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.459 ' CE2' ' N ' ' A' ' 21' ' ' PHE . 25.1 p90 -118.16 132.48 56.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.053 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -129.66 117.89 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.665 0.269 . . . . 0.0 111.517 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.645 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -92.09 140.04 30.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.702 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -144.86 -31.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 16' ' ' GLU . 20.9 m -84.15 162.88 20.09 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 111.854 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -62.69 -37.79 87.83 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.091 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -98.63 32.68 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.133 0.492 . . . . 0.0 110.253 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.673 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -101.79 176.29 5.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.829 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 18' ' ' GLU . 2.7 mp -144.24 164.54 30.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.555 0.693 . . . . 0.0 112.11 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -134.85 100.41 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.755 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HE2' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -134.81 156.88 48.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.821 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.445 ' HA ' ' CE1' ' A' ' 11' ' ' PHE . 5.9 mp0 -64.94 98.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.678 ' HD2' HG21 ' A' ' 7' ' ' THR . 0.2 OUTLIER -73.74 133.94 43.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.282 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.48 -148.73 24.61 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.737 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 6' ' ' GLN . 2.2 tt0 -94.92 -17.14 22.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 0.0 111.228 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.09 132.62 43.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.309 0.576 . . . . 0.0 112.164 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.527 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -138.87 164.2 30.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.877 178.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 pt-20 -122.75 118.66 28.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.772 0.32 . . . . 0.0 110.556 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.005 HG23 HG11 ' A' ' 5' ' ' VAL . 23.3 t -93.87 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.251 0.548 . . . . 0.0 111.762 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.576 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.19 -44.21 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.756 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -110.09 120.42 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.397 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.53 ' HE3' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -99.72 139.27 20.71 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.321 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 38.2 Cg_endo -91.32 17.59 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.022 2.481 . . . . 0.0 112.544 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.97 -37.68 38.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.09 -44.09 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -123.75 101.03 36.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.801 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.75 79.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -119.3 -83.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.6 ' CD2' HD21 ' A' ' 51' ' ' LEU . 1.3 m0 -151.63 160.89 43.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.285 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.997 ' CZ2' HG21 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -126.03 107.41 10.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.894 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -123.35 138.54 54.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.647 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -127.51 156.77 41.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.426 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.824 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 5.6 ptpp? -91.93 142.9 27.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.606 0.717 . . . . 0.0 111.655 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -122.52 175.43 6.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.953 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -0.38 4.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.082 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.77 -7.52 59.45 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.66 0.266 . . . . 0.0 110.593 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.4 -11.66 54.65 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.024 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.651 ' HB3' HD21 ' A' ' 19' ' ' LEU . 5.9 mp0 -118.1 137.79 52.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.516 0.327 . . . . 0.0 110.396 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.824 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -116.32 130.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.608 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -115.43 -159.72 12.28 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.245 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -98.5 132.49 43.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.618 0.723 . . . . 0.0 110.73 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.79 HG23 ' HD2' ' A' ' 53' ' ' PRO . 2.1 p -118.66 150.01 47.44 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.172 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.79 ' HD2' HG23 ' A' ' 52' ' ' VAL . 54.0 Cg_endo -60.79 82.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 123.355 2.704 . . . . 0.0 111.639 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HB3' ' CD2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -50.02 -26.78 4.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.82 -13.31 59.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.93 0.395 . . . . 0.0 111.157 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -101.94 30.93 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.372 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.997 HG21 ' CZ2' ' A' ' 40' ' ' TRP . 2.4 m -150.32 177.57 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.6 p -136.43 113.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.191 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.682 HG22 ' CH2' ' A' ' 40' ' ' TRP . 16.4 t -65.75 147.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.847 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -106.24 164.02 12.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.025 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.309 -1.162 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.112 -179.675 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.7 142.79 57.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 112.11 18.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -128.72 167.39 24.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.224 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.142 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -130.05 151.96 36.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 110.718 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.661 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.7 tt0 -115.55 144.47 43.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.25 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.844 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -115.9 153.25 31.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.844 HD13 ' C ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -131.31 -44.08 1.03 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.044 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -100.71 157.05 34.43 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.853 0.358 . . . . 0.0 111.648 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.53 162.28 15.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.772 2.315 . . . . 0.0 112.054 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.587 ' CZ ' HG21 ' A' ' 52' ' ' VAL . 3.2 m-85 -111.59 135.15 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.034 0.445 . . . . 0.0 111.616 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -129.03 118.86 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.301 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.8 m -103.53 142.7 33.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.384 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 15' ' ' THR . 27.7 m -135.88 -45.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.498 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -67.41 172.45 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' H ' HG22 ' A' ' 15' ' ' THR . 0.6 OUTLIER -74.94 -37.5 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.033 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.85 ' HB2' HD22 ' A' ' 51' ' ' LEU . 13.7 mt-10 -63.16 -48.92 76.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.574 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.47 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -54.54 -171.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.825 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.839 HD12 ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -178.79 158.25 0.98 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.122 178.496 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.465 ' N ' HD22 ' A' ' 19' ' ' LEU . 2.6 p30 -100.79 116.66 33.21 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.68 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -133.5 162.63 31.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.02 178.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 11.8 pt-20 -65.13 107.57 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 110.112 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -73.85 120.53 19.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.636 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -103.37 -152.69 23.49 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.68 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' C ' HG22 ' A' ' 26' ' ' THR . 2.5 tt0 -94.87 -1.16 53.24 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.503 0.192 . . . . 0.0 111.273 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -169.57 146.6 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.881 0.848 . . . . 0.0 113.017 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.863 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.65 164.59 29.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.795 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.645 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 4.2 pm0 -114.67 113.21 24.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.142 HG23 HG11 ' A' ' 5' ' ' VAL . 38.6 t -90.31 132.64 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 111.438 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.659 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.23 -81.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.465 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.37 128.35 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -105.09 117.26 58.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 17.3 Cg_exo -66.9 62.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.55 -52.47 5.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.011 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -85.5 -44.58 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -108.77 101.04 42.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.721 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -65.91 111.19 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.711 2.274 . . . . 0.0 112.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 24.6 tt0 -152.84 -98.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -151.68 161.36 42.8 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 1.011 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -118.94 159.38 23.91 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.701 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -137.35 138.6 40.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.38 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.645 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -133.68 159.94 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.946 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.747 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -91.92 143.27 26.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 0.0 112.275 -178.431 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.416 ' ND2' ' HB2' ' A' ' 21' ' ' PHE . 0.7 OUTLIER -117.21 174.74 5.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.009 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.05 18.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.51 -7.25 59.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.719 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 3.23 87.67 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.434 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.729 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -118.02 115.65 25.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 122.181 0.192 . . . . 0.0 111.338 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.747 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -100.11 125.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.839 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -127.93 -178.9 15.56 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.555 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.85 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -73.76 135.39 43.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.848 -0.676 . . . . 0.0 111.147 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 1.011 HG13 ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -132.83 140.86 39.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.254 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.576 ' HD2' HG23 ' A' ' 52' ' ' VAL . 42.0 Cg_endo -79.92 114.53 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.939 2.426 . . . . 0.0 111.404 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -57.95 -14.06 5.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.766 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -74.05 -8.04 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.407 -178.893 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.559 ' O ' HD22 ' A' ' 8' ' ' LEU . 3.6 m-85 -117.81 15.59 14.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.549 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -149.97 176.28 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 111.775 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.9 p -135.75 116.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 177.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 22.2 t -65.13 146.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.676 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -108.23 163.7 12.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.198 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.309 -1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.62 147.18 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.08 121.58 26.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -124.95 167.68 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.888 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.974 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -133.55 157.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.454 0.645 . . . . 0.0 111.383 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.818 ' HB2' HD13 ' A' ' 60' ' ' LEU . 11.4 tt0 -122.21 138.53 54.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.39 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.774 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -112.28 156.63 22.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.257 0.551 . . . . 0.0 111.684 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.814 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.5 -41.24 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.752 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.495 ' H ' HD22 ' A' ' 8' ' ' LEU . 4.6 m-85 -94.45 161.64 28.51 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -166.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.744 2.296 . . . . 0.0 112.597 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 51.4 p90 -103.09 129.24 49.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.23 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -129.61 118.3 21.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.84 118.69 9.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.891 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 14' ' ' VAL . 7.7 p -145.15 55.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.218 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 16' ' ' GLU . 1.5 m -149.7 172.47 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 15' ' ' THR . 1.6 tp10 -75.13 -33.85 61.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HG3' HD22 ' A' ' 51' ' ' LEU . 10.4 pt-20 -98.75 28.97 3.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.856 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.85 -168.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.204 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.962 HD11 ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -178.85 148.94 0.43 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.222 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.17 116.31 32.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.134 0.492 . . . . 0.0 112.075 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.962 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.51 162.76 31.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.349 179.021 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -76.73 97.6 4.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.407 0.622 . . . . 0.0 110.294 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.657 ' HD2' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -74.05 142.96 45.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.202 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.18 -144.02 8.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.72 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.95 -16.32 22.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.016 0.436 . . . . 0.0 111.263 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.43 132.84 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.095 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.494 ' C ' HG13 ' A' ' 5' ' ' VAL . 1.3 tpt -138.57 164.64 28.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.56 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.697 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -125.14 114.21 18.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.328 . . . . 0.0 110.853 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.974 HG23 HG11 ' A' ' 5' ' ' VAL . 25.6 t -95.25 137.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.57 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.645 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -86.53 -78.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.943 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 120.68 15.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.787 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -101.79 150.2 37.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 2.9 Cg_exo -76.24 55.63 4.67 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.849 2.366 . . . . 0.0 112.268 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -88.59 -35.82 16.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.986 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -113.33 -36.62 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.8 100.95 36.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.083 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 33' ' ' PRO . 4.9 Cg_exo -74.5 59.14 4.72 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.851 2.367 . . . . 0.0 112.154 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.76 -88.07 0.4 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.338 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -151.26 152.84 33.79 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.617 0.246 . . . . 0.0 110.786 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.641 ' CD1' HG13 ' A' ' 52' ' ' VAL . 1.1 p90 -114.74 172.21 7.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.7 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -143.68 138.86 29.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.697 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -131.71 157.73 43.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.362 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.79 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.17 143.05 26.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.248 0.546 . . . . 0.0 111.391 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.526 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 3.9 t30 -120.87 174.69 6.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.453 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HB3' HH21 ' A' ' 46' ' ' ARG . . . -63.12 -11.86 23.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.425 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.584 HH21 ' HB3' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -83.48 0.87 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.326 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 7.57 58.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.191 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.573 ' CD ' HD23 ' A' ' 19' ' ' LEU . 3.2 pt20 -118.26 114.78 23.52 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.732 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.79 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -105.81 131.76 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.795 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -140.23 -170.14 11.92 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.559 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.7 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -79.83 107.0 12.27 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.493 0.663 . . . . 0.0 111.466 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.765 HG23 ' HD2' ' A' ' 53' ' ' PRO . 1.9 p -92.4 146.75 33.09 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.982 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.765 ' HD2' HG23 ' A' ' 52' ' ' VAL . 57.2 Cg_endo -60.55 88.13 0.08 OUTLIER 'Trans proline' 0 CA--C 1.519 -0.233 0 C-N-CA 123.395 2.73 . . . . 0.0 111.283 178.06 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -52.69 -24.73 9.16 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.43 -6.66 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.532 ' CG ' ' HB2' ' A' ' 53' ' ' PRO . 17.0 m-30 -108.67 20.6 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.526 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -150.07 176.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 111.78 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 6' ' ' GLN . 5.0 p -132.85 113.56 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 21.9 t -65.67 147.26 12.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -105.66 163.91 12.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.099 -1.409 . . . . 0.0 109.174 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--N 1.309 -1.191 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.95 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.31 127.18 35.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.708 0.29 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 124.73 29.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.48 167.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.691 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 1.114 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.12 147.96 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.714 0.769 . . . . 0.0 111.433 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.839 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.6 OUTLIER -106.24 140.39 39.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.969 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.747 ' C ' HD13 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -114.06 155.2 26.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.49 0.662 . . . . 0.0 112.456 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.838 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.51 -40.66 1.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.544 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.546 ' H ' HD22 ' A' ' 8' ' ' LEU . 1.7 m-85 -117.68 146.61 39.14 Favored Pre-proline 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 9' ' ' TYR . 26.4 Cg_exo -62.62 163.25 21.88 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -117.77 153.06 34.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.548 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.056 0.455 . . . . 0.0 111.61 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -81.52 163.24 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -173.34 -42.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 16' ' ' GLU . 1.1 m -94.29 172.61 8.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' H ' HG22 ' A' ' 15' ' ' THR . 1.3 tp10 -65.2 -37.53 87.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.801 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.887 ' HB2' HD22 ' A' ' 51' ' ' LEU . 5.2 mt-10 -84.72 -4.07 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.922 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.879 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.9 170.69 16.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.879 HD12 ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -159.0 156.25 29.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 112.001 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.95 101.85 4.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.582 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -132.3 165.45 24.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.04 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.28 102.24 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.582 0.706 . . . . 0.0 110.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.633 ' CE ' HG21 ' A' ' 7' ' ' THR . 0.5 OUTLIER -73.45 143.64 46.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.641 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 -160.34 11.39 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.656 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -95.33 10.9 34.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.949 0.375 . . . . 0.0 110.431 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -155.59 133.41 11.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.388 0.614 . . . . 0.0 112.144 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 5' ' ' VAL . 1.5 ptm -139.04 164.71 29.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.983 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 13.3 pt-20 -124.77 112.27 16.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.181 0.515 . . . . 0.0 110.696 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 1.114 HG23 HG11 ' A' ' 5' ' ' VAL . 31.9 t -91.85 134.7 29.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.625 ' CG1' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.79 -41.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.242 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -90.9 107.83 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.669 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.7 mmmm -93.81 114.78 63.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.961 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.02 92.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.125 . . . . 0.0 111.951 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.42 -52.5 6.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -114.53 -29.21 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.244 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -101.29 101.09 15.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.941 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.0 58.67 6.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.569 2.18 . . . . 0.0 112.304 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.53 -94.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.047 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -151.66 152.03 32.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.959 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -105.27 171.27 7.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.281 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.771 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.14 136.92 46.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 112.187 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.67 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 p -126.05 152.12 46.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.155 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.691 ' HA ' HG12 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -91.94 130.68 37.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.067 0.46 . . . . 0.0 110.343 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.57 174.61 5.8 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.353 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.29 3.14 16.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.206 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.82 -6.19 59.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.374 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.8 -27.85 14.69 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.812 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.484 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 5.1 mm-40 -117.75 138.81 51.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -104.9 146.88 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.081 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.821 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -133.12 -159.36 9.1 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.56 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.887 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -105.14 120.24 41.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 0.0 111.089 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.959 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.2 p -101.64 141.35 22.41 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 52' ' ' VAL . 91.4 Cg_endo -70.82 105.1 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.326 2.684 . . . . 0.0 111.23 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -55.96 -21.84 23.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -76.12 -9.59 58.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.298 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.51 ' O ' HD22 ' A' ' 8' ' ' LEU . 10.8 m-30 -110.39 18.79 19.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.7 OUTLIER -150.23 176.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 112.363 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.1 p -136.33 118.5 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.992 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.478 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 18.9 t -65.47 147.25 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.839 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -109.29 164.01 12.86 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.08 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.308 -1.212 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.858 -179.701 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.73 142.87 45.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.11 122.88 27.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.88 166.96 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.198 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.947 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -134.96 158.1 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.477 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.735 ' HB2' HD13 ' A' ' 60' ' ' LEU . 2.7 tt0 -130.98 143.84 51.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.729 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.762 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -116.81 167.88 10.71 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.233 0.539 . . . . 0.0 110.999 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.901 HD21 ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -130.93 -21.68 2.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.532 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.776 ' CD2' HD23 ' A' ' 8' ' ' LEU . 22.3 m-85 -135.78 161.68 61.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 85.2 Cg_exo -46.68 173.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.546 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 52' ' ' VAL . 2.9 t80 -102.29 138.92 38.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.07 118.49 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.618 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -109.29 171.72 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.57 -41.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.28 172.54 12.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.782 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -83.59 -30.12 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.07 33.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.706 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.6 mt-10 -117.85 -170.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.319 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.923 HD23 ' CZ ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -148.31 141.09 24.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -113.24 102.15 10.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.529 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.923 ' CZ ' HD23 ' A' ' 19' ' ' LEU . 8.9 m-30 -116.7 163.4 16.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.249 0.547 . . . . 0.0 112.083 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -156.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.228 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HD3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -51.83 133.67 31.64 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.22 0.534 . . . . 0.0 111.517 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' HE3' ' A' ' 23' ' ' LYS . . . -110.38 92.59 0.69 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.737 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.574 ' N ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tt0 -94.63 -20.63 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.59 0.71 . . . . 0.0 109.961 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -168.13 130.88 1.51 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.105 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.483 ' C ' HG13 ' A' ' 5' ' ' VAL . 2.7 mtt -138.85 164.54 29.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.614 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.1 mt-10 -125.7 115.26 19.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.863 0.363 . . . . 0.0 111.076 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.947 HG23 HG11 ' A' ' 5' ' ' VAL . 13.1 t -92.71 131.74 38.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.511 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.645 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -90.79 -67.99 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.712 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 127.78 33.07 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.0 158.94 32.28 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 111.912 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HG3' ' CZ3' ' A' ' 40' ' ' TRP . 60.1 Cg_endo -93.44 11.6 1.95 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.381 2.721 . . . . 0.0 113.09 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.81 -29.55 67.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.853 0.359 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.33 -38.87 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.738 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.06 100.94 35.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.33 53.09 4.36 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.61 2.207 . . . . 0.0 112.413 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 -83.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.578 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.448 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -151.32 152.37 33.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.575 0.226 . . . . 0.0 110.77 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.725 ' HB2' HG13 ' A' ' 29' ' ' VAL . 4.5 p90 -119.63 172.12 7.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.024 0.44 . . . . 0.0 110.477 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.648 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -146.56 137.74 24.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.377 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 5.6 p -129.42 153.69 47.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.701 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.767 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -92.97 143.14 26.53 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.848 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASN . . . . . 0.559 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 32.0 t30 -121.88 174.48 6.85 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.354 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.89 -0.2 2.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.264 0.554 . . . . 0.0 109.915 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.58 ' HG2' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.92 -7.95 59.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.717 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.78 -5.52 52.36 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.234 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.775 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -119.1 138.75 52.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.052 0.453 . . . . 0.0 112.15 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.767 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.57 126.29 72.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.231 178.038 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.908 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -119.06 -168.16 13.98 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.94 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -87.87 129.08 35.33 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.663 HG11 ' HE2' ' A' ' 54' ' ' LYS . 4.9 p -134.12 131.38 20.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' O ' ' CD2' ' A' ' 56' ' ' TYR . 15.7 Cg_endo -84.55 92.2 0.76 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.365 2.71 . . . . 0.0 110.288 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HE2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -67.3 -9.51 41.61 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.304 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -46.75 -20.86 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.901 ' O ' HD21 ' A' ' 8' ' ' LEU . 14.3 p90 -102.69 12.72 35.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -134.27 176.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -178.757 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 6' ' ' GLN . 8.9 p -107.58 112.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.34 146.49 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.551 0.691 . . . . 0.0 112.322 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.804 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -98.69 160.89 13.96 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 179.137 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.984 -179.68 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.04 138.96 41.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.664 0.268 . . . . 0.0 111.03 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 115.47 20.4 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.773 HG13 ' HG2' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -128.43 167.22 24.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.988 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.38 160.51 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 110.974 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.82 ' HB2' HD13 ' A' ' 60' ' ' LEU . 3.9 tt0 -126.05 144.52 50.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.503 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.72 HG23 ' SD ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -113.63 139.81 48.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.266 0.555 . . . . 0.0 111.317 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.862 ' CD2' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -107.96 -48.33 3.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.082 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 52.5 m-85 -93.62 161.57 30.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.276 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 11.7 Cg_endo -54.56 -165.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.817 2.345 . . . . 0.0 112.119 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 45.5 p90 -108.28 128.68 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.239 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t -130.13 117.89 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.586 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 m -147.71 124.27 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.644 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.74 -4.14 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.114 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.6 m -91.84 168.68 11.26 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.244 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 15' ' ' THR . 0.2 OUTLIER -67.5 -37.58 83.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 -179.694 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.96 16.93 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.767 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLU . . . . . 0.827 ' O ' HD12 ' A' ' 19' ' ' LEU . 12.6 mt-10 -104.62 -176.62 3.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -159.07 137.62 10.84 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.89 100.49 9.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.72 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' O ' ' CG ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -133.99 162.85 30.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.93 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -71.12 97.29 1.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.072 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.655 ' HG2' HG21 ' A' ' 7' ' ' THR . 11.6 tppt? -74.71 135.43 41.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.71 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.14 -160.62 22.54 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.47 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.732 ' O ' HG23 ' A' ' 26' ' ' THR . 2.6 tt0 -94.9 24.07 5.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.576 0.227 . . . . 0.0 111.211 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 25' ' ' GLU . 1.5 p -169.79 123.12 0.74 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 111.843 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' MET . . . . . 0.72 ' SD ' HG23 ' A' ' 7' ' ' THR . 0.8 OUTLIER -139.45 164.73 29.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.421 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.773 ' HG2' HG13 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -121.41 120.51 35.18 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' VAL . . . . . 0.988 HG23 HG11 ' A' ' 5' ' ' VAL . 37.3 t -98.57 129.94 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.24 0.543 . . . . 0.0 111.674 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.637 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.59 -84.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.77 147.49 53.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.36 159.27 32.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.201 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.0 -1.33 6.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.814 2.343 . . . . 0.0 113.166 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.14 -46.24 88.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -107.49 -30.18 8.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -72.55 148.36 90.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.59 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -40.41 -76.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.147 2.565 . . . . 0.0 112.713 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 3.1 tt0 -161.18 14.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 5.9 m0 -138.96 146.08 40.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.322 . . . . 0.0 111.002 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.738 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -111.95 178.66 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.062 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.912 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -141.73 137.03 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.143 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' CYS . . . . . 0.556 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.4 p -132.56 156.22 47.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.077 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.815 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.81 136.71 32.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.553 0.692 . . . . 0.0 111.446 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -113.07 174.97 5.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.805 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.17 0.78 12.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -83.78 -6.66 59.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.08 -18.39 40.85 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.535 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLN . . . . . 0.728 ' HB3' HD21 ' A' ' 19' ' ' LEU . 9.5 mm100 -118.26 138.22 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.744 0.307 . . . . 0.0 110.74 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' VAL . . . . . 0.815 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -115.77 127.13 73.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 0.0 110.49 178.908 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.764 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -112.66 -144.34 9.17 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.477 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . 0.912 HD12 ' HB3' ' A' ' 41' ' ' LYS . 1.0 OUTLIER -113.69 116.12 28.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.044 0.45 . . . . 0.0 110.503 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.738 HG13 ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -92.43 140.44 24.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 52' ' ' VAL . 59.0 Cg_endo -62.89 92.96 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.486 2.791 . . . . 0.0 111.598 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -53.19 -22.85 7.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.866 0.365 . . . . 0.0 111.815 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -78.91 -11.93 60.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' TYR . . . . . 0.416 ' HB3' ' HB2' ' A' ' 9' ' ' TYR . 9.2 m-30 -110.2 15.72 22.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.989 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.862 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -142.11 166.35 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.608 . . . . 0.0 112.564 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 58' ' ' VAL . 12.8 p -123.1 113.96 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.294 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.8 t -65.4 146.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.804 0.811 . . . . 0.0 113.112 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -103.68 163.63 12.2 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.067 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.999 -179.745 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.521 -0.142 0 CA-C-O 120.702 0.287 . . . . 0.0 111.063 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 125.95 30.65 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.554 ' HB ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -127.4 166.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.227 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.052 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -131.58 155.48 41.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.408 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.595 ' HG3' HG22 ' A' ' 26' ' ' THR . 3.9 tt0 -134.04 154.02 51.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.961 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.671 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.9 OUTLIER -111.44 162.05 15.48 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.284 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.71 -34.66 1.32 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.98 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.607 ' H ' HD22 ' A' ' 8' ' ' LEU . 22.6 m-85 -123.99 122.87 26.2 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.84 60.91 2.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.177 1.918 . . . . 0.0 111.161 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.656 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 9.4 m-85 -87.75 154.27 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.838 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -95.6 152.52 18.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -89.28 171.87 9.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 15' ' ' THR . 20.1 m -132.54 -55.31 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.535 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -46.17 158.4 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.807 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -31.0 68.31 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.736 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 12.0 mp0 -87.13 26.12 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.997 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.813 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.6 mt-10 -110.33 -176.76 3.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.266 0.555 . . . . 0.0 111.635 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.012 HD23 ' CE2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -138.58 137.64 37.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.391 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.457 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -113.55 100.08 8.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 111.441 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 1.012 ' CE2' HD23 ' A' ' 19' ' ' LEU . 20.5 m-30 -133.69 162.8 30.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 3.5 tp10 -81.33 95.88 7.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 0.8 OUTLIER -76.58 143.52 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.156 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.74 -39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.295 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -147.13 0.27 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.583 0.23 . . . . 0.0 111.167 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.595 HG22 ' HG3' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -108.38 146.22 33.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.589 0.709 . . . . 0.0 112.193 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.881 ' O ' HG13 ' A' ' 5' ' ' VAL . 26.8 mmt -134.24 164.97 26.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.443 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.5 mt-10 -113.71 122.78 48.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.052 HG23 HG11 ' A' ' 5' ' ' VAL . 2.8 t -92.45 127.47 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.451 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.584 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -91.28 -39.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.21 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -87.99 118.19 27.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.088 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HB3' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.5 155.52 36.27 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 1.8 Cg_endo -83.07 8.57 4.53 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.065 2.51 . . . . 0.0 113.416 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -88.43 -30.68 19.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.006 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -121.3 -36.23 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 110.649 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . 0.411 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . 2.8 m-20 -96.83 165.2 16.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.586 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 36' ' ' ASP . 1.1 Cg_endo -44.43 177.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.086 2.524 . . . . 0.0 112.838 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -4.27 15.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.202 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.02 146.06 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.701 0.286 . . . . 0.0 110.9 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.908 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -124.07 169.96 11.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.426 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.942 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.92 137.57 26.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.429 . . . . 0.0 112.14 -178.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 7.0 p -134.91 157.7 46.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.95 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.81 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 4.5 pttm -92.27 135.2 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 111.896 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 46' ' ' ARG . 1.9 t30 -108.78 174.58 5.81 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.167 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.9 4.46 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.532 0.682 . . . . 0.0 109.417 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.584 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.79 -8.58 59.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.8 -15.22 38.2 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.821 ' CG ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -118.22 138.25 52.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.907 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.81 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -120.08 125.7 74.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.866 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -117.51 -159.89 11.54 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.234 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.942 HD12 ' HB3' ' A' ' 41' ' ' LYS . 1.2 mp -96.13 110.46 22.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.908 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.4 p -92.47 133.16 30.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.097 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.28 106.87 2.31 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.072 2.515 . . . . 0.0 111.797 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -51.63 -23.4 4.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.984 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -67.82 -10.84 56.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.852 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.656 ' CD2' ' HB3' ' A' ' 11' ' ' PHE . 18.6 m-85 -116.67 12.99 15.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.433 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.633 ' C ' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -149.6 176.7 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.756 HG12 ' CD1' ' A' ' 8' ' ' LEU . 9.5 p -139.16 120.15 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.04 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.5 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.0 t -65.2 145.69 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.139 0.495 . . . . 0.0 111.485 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.68 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.97 100.06 3.94 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.767 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.411 ' HA ' HG23 ' A' ' 4' ' ' VAL . 90.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.898 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.779 0.323 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 121.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -121.87 167.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.005 -178.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.013 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -133.14 157.6 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.19 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.813 ' HG3' HG23 ' A' ' 26' ' ' THR . 1.8 tt0 -116.52 140.52 49.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.407 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.778 HG22 ' HG2' ' A' ' 27' ' ' MET . 1.9 p -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.148 0.499 . . . . 0.0 111.309 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.046 HD21 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.71 -37.74 4.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.061 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -133.12 162.28 58.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.738 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -46.1 175.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.143 2.562 . . . . 0.0 112.872 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 21' ' ' PHE . 51.7 p90 -93.42 129.23 39.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.638 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -130.04 117.78 20.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.47 126.9 46.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 15' ' ' THR . 24.3 m -132.47 -47.88 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.74 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -55.38 172.5 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.335 . . . . 0.0 110.994 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.72 -33.88 69.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.856 ' HB2' HD22 ' A' ' 51' ' ' LEU . 2.4 mm-40 -92.73 32.77 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.613 0.244 . . . . 0.0 111.419 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.636 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.7 mt-10 -121.68 166.84 13.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.957 HD11 ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -153.08 149.35 28.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.907 0.385 . . . . 0.0 110.715 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -100.65 111.56 23.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 111.389 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.957 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.53 163.2 29.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.019 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 2.0 tp10 -69.4 99.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HD2' ' HE2' ' A' ' 27' ' ' MET . 0.0 OUTLIER -73.45 128.28 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.318 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.472 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -88.92 -145.64 11.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.621 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.456 ' C ' HG23 ' A' ' 7' ' ' THR . 2.3 tt0 -95.82 -17.9 20.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.255 0.55 . . . . 0.0 110.689 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.813 HG23 ' HG3' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -142.6 144.08 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.851 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.778 ' HG2' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -138.43 164.25 29.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.261 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 1.5 pm0 -120.9 112.41 18.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.393 . . . . 0.0 110.291 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.013 HG23 HG11 ' A' ' 5' ' ' VAL . 14.3 t -91.37 137.25 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.745 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.6 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.8 -39.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.338 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -89.99 107.95 19.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.09 139.38 49.22 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -85.5 12.59 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -21.15 55.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.655 0.264 . . . . 0.0 111.079 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -115.12 -42.32 3.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.875 0.369 . . . . 0.0 110.46 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.86 100.98 36.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.98 61.61 7.47 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.575 2.184 . . . . 0.0 112.633 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -114.55 -75.46 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.38 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.418 ' CE3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 m-90 -151.77 146.19 25.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.144 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CD1' HG13 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -119.83 169.03 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.08 138.3 46.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 112.055 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.554 ' N ' HG23 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -132.28 157.73 43.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.867 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.806 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.15 143.22 26.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.277 0.561 . . . . 0.0 111.444 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.577 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 4.5 t-20 -120.93 174.52 6.57 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.462 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.11 -10.75 24.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.568 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HB2' ' CG ' ' A' ' 48' ' ' GLN . 2.8 mmp_? -83.35 -1.81 54.23 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.46 5.69 68.37 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.085 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.448 ' CG ' ' HB2' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -118.28 115.35 24.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.096 0.474 . . . . 0.0 111.939 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.806 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -104.07 132.53 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -141.14 -178.27 17.24 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.858 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.856 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -73.47 111.52 8.68 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.279 0.561 . . . . 0.0 111.331 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.783 HG23 ' HD2' ' A' ' 53' ' ' PRO . 1.7 p -101.11 147.07 33.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.869 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 52' ' ' VAL . 53.9 Cg_endo -60.43 87.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.288 2.659 . . . . 0.0 111.519 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -53.38 -26.58 19.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.83 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -82.32 -0.18 44.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.528 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 2.5 m-85 -110.14 13.14 23.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 ' HE1' ' A' ' 27' ' ' MET . 0.8 OUTLIER -149.39 177.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.093 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 1.046 HG12 HD21 ' A' ' 8' ' ' LEU . 7.5 p -131.23 121.33 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.482 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 33.9 t -65.38 146.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.801 0.81 . . . . 0.0 113.058 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.708 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -105.4 164.06 12.15 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.331 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--N 1.308 -1.198 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.891 -179.819 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.522 -0.124 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 119.54 23.6 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.57 166.48 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.205 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.962 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -135.19 158.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.173 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.664 ' HB2' HD13 ' A' ' 60' ' ' LEU . 1.1 tt0 -134.22 139.89 46.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.95 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.74 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -111.2 165.52 11.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.184 0.516 . . . . 0.0 111.094 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.796 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.13 -31.53 3.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.639 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.533 ' CD2' HD23 ' A' ' 8' ' ' LEU . 34.4 m-85 -125.28 161.53 49.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 91.2 Cg_exo -44.11 151.72 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.661 2.24 . . . . 0.0 112.602 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 21' ' ' PHE . 9.2 t80 -95.42 130.25 42.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.954 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -129.06 144.37 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -170.94 161.87 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.808 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 14' ' ' VAL . 7.3 p -173.06 89.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.074 0.464 . . . . 0.0 111.228 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -160.94 172.6 16.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.976 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.465 ' H ' HG22 ' A' ' 15' ' ' THR . 0.7 OUTLIER -63.77 -32.83 74.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.618 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.633 ' CB ' HD22 ' A' ' 51' ' ' LEU . 3.7 mt-10 -99.12 -50.87 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.759 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 51' ' ' LEU . 10.4 mt-10 -63.99 153.52 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.155 HD21 ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -149.2 159.43 44.26 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.458 ' N ' HD22 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -101.09 153.09 19.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 1.155 ' CE1' HD21 ' A' ' 19' ' ' LEU . 46.8 m-85 -133.69 164.19 27.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.689 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.85 -156.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.43 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -51.64 126.92 18.97 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.722 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -125.16 86.26 0.36 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.086 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -95.4 -22.7 17.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 0.0 109.388 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.457 HG22 ' HG3' ' A' ' 6' ' ' GLN . 3.1 p -138.84 128.33 24.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.693 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.521 ' C ' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -138.73 164.71 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.208 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 4.6 mt-10 -125.71 115.22 19.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 0.0 111.243 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.962 HG23 HG11 ' A' ' 5' ' ' VAL . 24.9 t -94.82 127.07 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 110.645 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.665 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.31 -77.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.636 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.117 0.484 . . . . 0.0 112.022 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.74 159.32 33.66 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.508 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.502 ' HG3' ' CE3' ' A' ' 40' ' ' TRP . 6.4 Cg_exo -74.6 6.33 3.27 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.82 2.347 . . . . 0.0 113.09 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.38 -34.19 72.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.601 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -97.28 -44.77 6.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -123.27 100.83 38.66 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.372 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.92 57.18 5.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.476 2.117 . . . . 0.0 112.583 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.403 ' OE2' ' CZ2' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -121.75 -77.09 0.58 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.039 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.551 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -151.41 158.52 43.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.126 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.76 ' HE1' ' H ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -116.18 -179.23 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.665 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -151.22 138.64 19.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.834 -179.053 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 2.9 p -131.18 154.49 48.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.661 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.798 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.22 136.85 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.475 0.655 . . . . 0.0 110.864 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.599 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 4.1 t-20 -109.29 174.57 5.81 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.734 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.3 -3.69 21.92 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.295 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.54 -2.66 56.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.343 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.04 83.88 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.887 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -118.52 138.34 52.59 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.91 0.386 . . . . 0.0 111.66 -179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.798 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -132.99 126.06 52.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.647 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -133.5 -164.33 10.73 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.515 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.633 HD22 ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -84.96 129.88 34.73 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.306 0.574 . . . . 0.0 111.529 -179.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.635 HG22 ' HD2' ' A' ' 54' ' ' LYS . 6.0 p -134.0 140.78 37.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.442 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -91.03 60.54 1.23 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.537 2.824 . . . . 0.0 111.885 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.76 ' H ' ' HE1' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -45.24 -11.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -45.09 -20.71 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.099 -0.376 . . . . 0.0 111.495 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.735 ' O ' HD21 ' A' ' 8' ' ' LEU . 24.9 p90 -101.93 31.49 3.87 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.738 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -148.63 176.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.691 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -108.07 112.78 41.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -71.75 146.46 11.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.432 0.634 . . . . 0.0 112.07 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.767 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -100.87 161.54 13.53 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.332 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.522 -0.128 0 CA-C-O 120.766 0.317 . . . . 0.0 111.044 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -80.91 120.56 24.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.53 166.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.87 161.83 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.42 0.629 . . . . 0.0 111.283 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.509 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 2.8 tt0 -139.14 146.81 41.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.178 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.764 ' C ' HD13 ' A' ' 8' ' ' LEU . 5.7 p -105.7 163.05 12.99 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.922 0.392 . . . . 0.0 110.567 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.783 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -131.09 -35.81 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.368 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.518 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 10.0 m-85 -119.55 135.86 24.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.393 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.94 59.04 2.18 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.292 1.995 . . . . 0.0 110.387 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.581 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 13.1 m-85 -73.28 155.53 39.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.652 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -94.11 151.88 19.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.808 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 4.0 m -145.67 99.77 3.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 14' ' ' VAL . 16.5 m -127.65 103.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 111.554 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -158.46 172.45 18.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.548 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' H ' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -64.45 -32.78 74.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.058 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -113.44 12.23 18.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.637 ' O ' HD12 ' A' ' 19' ' ' LEU . 4.8 mt-10 -102.11 -173.79 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.675 0.274 . . . . 0.0 111.049 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.852 HD13 ' CA ' ' A' ' 50' ' ' GLY . 0.6 OUTLIER -147.02 160.53 42.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.352 0.596 . . . . 0.0 112.201 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.15 102.02 4.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.5 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CE1' ' HE3' ' A' ' 27' ' ' MET . 4.3 p90 -129.74 164.05 24.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.701 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -52.26 133.04 34.46 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.221 0.534 . . . . 0.0 111.708 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -147.42 54.73 0.52 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.341 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.588 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 1.3 tt0 -59.72 -21.15 60.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 110.054 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -124.64 117.4 24.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.846 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.715 ' C ' HG13 ' A' ' 5' ' ' VAL . 24.4 mtp -139.14 163.41 32.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.237 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 0.7 OUTLIER -126.38 112.35 15.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.635 0.255 . . . . 0.0 110.855 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.995 HG23 HG11 ' A' ' 5' ' ' VAL . 5.8 t -85.67 113.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.277 0.56 . . . . 0.0 111.252 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.604 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.61 -38.91 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.607 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -98.35 118.08 34.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.273 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 25.5 mmtp -91.94 142.29 26.3 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 5.1 Cg_exo -79.62 7.97 4.23 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.756 2.304 . . . . 0.0 112.766 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -51.68 67.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.24 -34.55 10.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.83 165.11 56.13 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.681 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.17 -75.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.706 2.271 . . . . 0.0 112.772 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -175.41 17.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -123.37 145.8 48.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.92 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -126.09 171.11 11.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.893 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.0 137.24 27.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.196 -179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.535 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 8.3 p -132.46 151.88 51.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.805 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 7.4 mttp -91.59 140.22 29.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.392 0.615 . . . . 0.0 110.75 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -115.49 174.75 5.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.182 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.66 -1.84 17.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.254 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 5.8 ttm180 -83.56 -7.45 59.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.57 -12.76 55.14 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.774 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.589 ' HB3' HD21 ' A' ' 19' ' ' LEU . 2.6 mp0 -117.87 137.68 52.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.805 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.04 126.13 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.174 0.511 . . . . 0.0 110.123 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.852 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -110.35 -142.26 9.24 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.285 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.893 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -117.54 110.33 17.82 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.6 p -92.01 131.94 33.9 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.003 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 63.2 Cg_endo -74.53 107.19 2.4 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.3 2.667 . . . . 0.0 111.77 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.49 ' HA ' ' HZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -49.86 -25.38 3.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.129 0.49 . . . . 0.0 111.914 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.56 -11.83 58.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.603 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 15.5 m-30 -116.44 13.51 15.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.736 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.561 HG11 ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -149.4 175.75 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.617 0.722 . . . . 0.0 112.491 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.783 HG12 ' CD1' ' A' ' 8' ' ' LEU . 10.7 p -139.68 117.78 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.895 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 4' ' ' VAL . 2.2 t -65.21 145.82 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.133 0.492 . . . . 0.0 111.272 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.676 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -139.05 99.79 3.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.522 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.474 ' HA ' HG23 ' A' ' 4' ' ' VAL . 22.0 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.921 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.521 -0.16 0 CA-C-O 120.801 0.334 . . . . 0.0 111.091 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 129.12 34.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.68 167.75 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.987 0.423 . . . . 0.0 111.183 -178.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.005 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.9 160.57 42.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.847 ' HB2' HD13 ' A' ' 60' ' ' LEU . 4.2 tt0 -124.44 140.48 52.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.757 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -111.62 154.38 24.97 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.813 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.76 -40.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.951 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.517 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -101.18 161.68 22.91 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.51 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.59 -176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.887 2.391 . . . . 0.0 112.972 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.459 ' CE2' ' N ' ' A' ' 21' ' ' PHE . 25.1 p90 -118.16 132.48 56.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.053 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -129.66 117.89 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.665 0.269 . . . . 0.0 111.517 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.645 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -92.09 140.04 30.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.702 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -144.86 -31.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 16' ' ' GLU . 20.9 m -84.15 162.88 20.09 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 111.854 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -62.69 -37.79 87.83 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.091 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -98.63 32.68 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.133 0.492 . . . . 0.0 110.253 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.673 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -101.79 176.29 5.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.829 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 18' ' ' GLU . 2.7 mp -144.24 164.54 30.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.555 0.693 . . . . 0.0 112.11 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -134.85 100.41 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.755 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HE2' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -134.81 156.88 48.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.821 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.445 ' HA ' ' CE1' ' A' ' 11' ' ' PHE . 5.9 mp0 -64.94 98.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.678 ' HD2' HG21 ' A' ' 7' ' ' THR . 0.2 OUTLIER -73.74 133.94 43.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.282 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.48 -148.73 24.61 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.737 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 6' ' ' GLN . 2.2 tt0 -94.92 -17.14 22.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 0.0 111.228 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.09 132.62 43.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.309 0.576 . . . . 0.0 112.164 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.527 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -138.87 164.2 30.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.877 178.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 pt-20 -122.75 118.66 28.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.772 0.32 . . . . 0.0 110.556 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.005 HG23 HG11 ' A' ' 5' ' ' VAL . 23.3 t -93.87 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.251 0.548 . . . . 0.0 111.762 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.576 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.19 -44.21 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.756 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -110.09 120.42 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.397 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.53 ' HE3' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -99.72 139.27 20.71 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.321 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 38.2 Cg_endo -91.32 17.59 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.022 2.481 . . . . 0.0 112.544 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.97 -37.68 38.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.09 -44.09 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -123.75 101.03 36.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.801 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.75 79.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -119.3 -83.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.6 ' CD2' HD21 ' A' ' 51' ' ' LEU . 1.3 m0 -151.63 160.89 43.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.285 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.997 ' CZ2' HG21 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -126.03 107.41 10.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.894 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -123.35 138.54 54.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.647 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -127.51 156.77 41.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.426 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.824 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 5.6 ptpp? -91.93 142.9 27.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.606 0.717 . . . . 0.0 111.655 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -122.52 175.43 6.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.953 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -0.38 4.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.082 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.77 -7.52 59.45 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.66 0.266 . . . . 0.0 110.593 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.4 -11.66 54.65 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.024 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.651 ' HB3' HD21 ' A' ' 19' ' ' LEU . 5.9 mp0 -118.1 137.79 52.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.516 0.327 . . . . 0.0 110.396 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.824 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -116.32 130.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.608 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -115.43 -159.72 12.28 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.245 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -98.5 132.49 43.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.618 0.723 . . . . 0.0 110.73 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.79 HG23 ' HD2' ' A' ' 53' ' ' PRO . 2.1 p -118.66 150.01 47.44 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.172 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.79 ' HD2' HG23 ' A' ' 52' ' ' VAL . 54.0 Cg_endo -60.79 82.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 123.355 2.704 . . . . 0.0 111.639 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HB3' ' CD2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -50.02 -26.78 4.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.82 -13.31 59.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.93 0.395 . . . . 0.0 111.157 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -101.94 30.93 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.372 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.997 HG21 ' CZ2' ' A' ' 40' ' ' TRP . 2.4 m -150.32 177.57 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.6 p -136.43 113.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.191 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.682 HG22 ' CH2' ' A' ' 40' ' ' TRP . 16.4 t -65.75 147.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.847 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -106.24 164.02 12.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.025 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.309 -1.162 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.112 -179.675 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 112.11 18.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -128.72 167.39 24.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.224 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.142 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -130.05 151.96 36.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 110.718 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.661 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.7 tt0 -115.55 144.47 43.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.25 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.844 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -115.9 153.25 31.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.844 HD13 ' C ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -131.31 -44.08 1.03 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.044 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -100.71 157.05 34.43 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.853 0.358 . . . . 0.0 111.648 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.53 162.28 15.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.772 2.315 . . . . 0.0 112.054 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.587 ' CZ ' HG21 ' A' ' 52' ' ' VAL . 3.2 m-85 -111.59 135.15 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.034 0.445 . . . . 0.0 111.616 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -129.03 118.86 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.301 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.8 m -103.53 142.7 33.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.384 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 15' ' ' THR . 27.7 m -135.88 -45.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.498 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -67.41 172.45 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.449 ' H ' HG22 ' A' ' 15' ' ' THR . 0.6 OUTLIER -74.94 -37.5 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.033 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.85 ' HB2' HD22 ' A' ' 51' ' ' LEU . 13.7 mt-10 -63.16 -48.92 76.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.574 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.47 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -54.54 -171.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.825 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.839 HD12 ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -178.79 158.25 0.98 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.122 178.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.465 ' N ' HD22 ' A' ' 19' ' ' LEU . 2.6 p30 -100.79 116.66 33.21 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.68 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -133.5 162.63 31.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.02 178.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 11.8 pt-20 -65.13 107.57 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 110.112 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -73.85 120.53 19.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.636 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -103.37 -152.69 23.49 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.68 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.489 ' C ' HG22 ' A' ' 26' ' ' THR . 2.5 tt0 -94.87 -1.16 53.24 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.503 0.192 . . . . 0.0 111.273 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -169.57 146.6 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.881 0.848 . . . . 0.0 113.017 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.863 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.65 164.59 29.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.795 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.645 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 4.2 pm0 -114.67 113.21 24.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.142 HG23 HG11 ' A' ' 5' ' ' VAL . 38.6 t -90.31 132.64 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 111.438 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.659 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.23 -81.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.465 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.37 128.35 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -105.09 117.26 58.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 17.3 Cg_exo -66.9 62.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.55 -52.47 5.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.011 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -85.5 -44.58 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -108.77 101.04 42.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.721 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -65.91 111.19 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.711 2.274 . . . . 0.0 112.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 24.6 tt0 -152.84 -98.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -151.68 161.36 42.8 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 1.011 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -118.94 159.38 23.91 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.701 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -137.35 138.6 40.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.38 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.645 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -133.68 159.94 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.946 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.747 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -91.92 143.27 26.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 0.0 112.275 -178.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.415 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -117.21 174.74 5.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.009 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.05 18.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.51 -7.25 59.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.719 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 3.23 87.67 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.434 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.729 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -118.02 115.65 25.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 122.181 0.192 . . . . 0.0 111.338 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.747 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -100.11 125.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.839 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -127.93 -178.9 15.56 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.555 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.85 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -73.76 135.39 43.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.848 -0.676 . . . . 0.0 111.147 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 1.011 HG13 ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -132.83 140.86 39.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.254 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.576 ' HD2' HG23 ' A' ' 52' ' ' VAL . 42.0 Cg_endo -79.92 114.53 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.939 2.426 . . . . 0.0 111.404 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -57.95 -14.06 5.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.766 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -74.05 -8.04 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.407 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.559 ' O ' HD22 ' A' ' 8' ' ' LEU . 3.6 m-85 -117.81 15.59 14.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.549 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -149.97 176.28 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 111.775 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.9 p -135.75 116.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 177.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 22.2 t -65.13 146.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.676 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -108.23 163.7 12.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.198 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.309 -1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.079 0 CA-C-O 120.82 0.343 . . . . 0.0 110.989 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.08 121.58 26.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -124.95 167.68 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.888 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.974 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -133.55 157.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.454 0.645 . . . . 0.0 111.383 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.818 ' HB2' HD13 ' A' ' 60' ' ' LEU . 11.4 tt0 -122.21 138.53 54.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.39 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.774 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -112.28 156.63 22.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.257 0.551 . . . . 0.0 111.684 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.814 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.5 -41.24 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.752 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.495 ' H ' HD22 ' A' ' 8' ' ' LEU . 4.6 m-85 -94.45 161.64 28.51 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -166.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.744 2.296 . . . . 0.0 112.597 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 51.4 p90 -103.09 129.24 49.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.23 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -129.61 118.3 21.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.84 118.69 9.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.891 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 14' ' ' VAL . 7.7 p -145.15 55.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.218 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 16' ' ' GLU . 1.5 m -149.7 172.47 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 15' ' ' THR . 1.6 tp10 -75.13 -33.85 61.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HG3' HD22 ' A' ' 51' ' ' LEU . 10.4 pt-20 -98.75 28.97 3.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.856 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.566 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.85 -168.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.204 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.962 HD11 ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -178.85 148.94 0.43 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.222 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.17 116.31 32.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.134 0.492 . . . . 0.0 112.075 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.962 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.51 162.76 31.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.349 179.021 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -76.73 97.6 4.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.407 0.622 . . . . 0.0 110.294 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.657 ' HD2' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -74.05 142.96 45.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.202 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.18 -144.02 8.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.72 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.95 -16.32 22.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.016 0.436 . . . . 0.0 111.263 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.43 132.84 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.095 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.494 ' C ' HG13 ' A' ' 5' ' ' VAL . 1.3 tpt -138.57 164.64 28.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.56 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.697 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -125.14 114.21 18.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.328 . . . . 0.0 110.853 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.974 HG23 HG11 ' A' ' 5' ' ' VAL . 25.6 t -95.25 137.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.57 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.645 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -86.53 -78.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.943 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 120.68 15.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.787 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -101.79 150.2 37.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 2.9 Cg_exo -76.24 55.63 4.67 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.849 2.366 . . . . 0.0 112.268 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -88.59 -35.82 16.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.986 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -113.33 -36.62 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.8 100.95 36.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.083 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 33' ' ' PRO . 4.9 Cg_exo -74.5 59.14 4.72 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.851 2.367 . . . . 0.0 112.154 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.76 -88.07 0.4 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.338 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -151.26 152.84 33.79 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.617 0.246 . . . . 0.0 110.786 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.641 ' CD1' HG13 ' A' ' 52' ' ' VAL . 1.1 p90 -114.74 172.21 7.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.7 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -143.68 138.86 29.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.697 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -131.71 157.73 43.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.362 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.79 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.17 143.05 26.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.248 0.546 . . . . 0.0 111.391 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.526 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 3.9 t30 -120.87 174.69 6.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.453 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HB3' HH21 ' A' ' 46' ' ' ARG . . . -63.12 -11.86 23.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.425 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.584 HH21 ' HB3' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -83.48 0.87 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.326 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 7.57 58.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.191 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.573 ' CD ' HD23 ' A' ' 19' ' ' LEU . 3.2 pt20 -118.26 114.78 23.52 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.732 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.79 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -105.81 131.76 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.795 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -140.23 -170.14 11.92 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.559 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.7 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -79.83 107.0 12.27 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.493 0.663 . . . . 0.0 111.466 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.765 HG23 ' HD2' ' A' ' 53' ' ' PRO . 1.9 p -92.4 146.75 33.09 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.982 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.765 ' HD2' HG23 ' A' ' 52' ' ' VAL . 57.2 Cg_endo -60.55 88.13 0.08 OUTLIER 'Trans proline' 0 CA--C 1.519 -0.233 0 C-N-CA 123.395 2.73 . . . . 0.0 111.283 178.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -52.69 -24.73 9.16 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.43 -6.66 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.532 ' CG ' ' HB2' ' A' ' 53' ' ' PRO . 17.0 m-30 -108.67 20.6 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.526 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -150.07 176.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 111.78 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 6' ' ' GLN . 5.0 p -132.85 113.56 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 21.9 t -65.67 147.26 12.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -105.66 163.91 12.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.099 -1.409 . . . . 0.0 109.174 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--N 1.309 -1.191 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.95 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.522 -0.111 0 CA-C-O 120.708 0.29 . . . . 0.0 110.933 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 124.73 29.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.48 167.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.691 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 1.114 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.12 147.96 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.714 0.769 . . . . 0.0 111.433 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.839 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -106.24 140.39 39.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.969 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.747 ' C ' HD13 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -114.06 155.2 26.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.49 0.662 . . . . 0.0 112.456 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.838 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.51 -40.66 1.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.544 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.546 ' H ' HD22 ' A' ' 8' ' ' LEU . 1.7 m-85 -117.68 146.61 39.14 Favored Pre-proline 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 9' ' ' TYR . 26.4 Cg_exo -62.62 163.25 21.88 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -117.77 153.06 34.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.548 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.056 0.455 . . . . 0.0 111.61 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -81.52 163.24 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -173.34 -42.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 16' ' ' GLU . 1.1 m -94.29 172.61 8.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.487 ' H ' HG22 ' A' ' 15' ' ' THR . 1.3 tp10 -65.2 -37.53 87.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.801 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.887 ' HB2' HD22 ' A' ' 51' ' ' LEU . 5.2 mt-10 -84.72 -4.07 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.922 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.879 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.9 170.69 16.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.879 HD12 ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -159.0 156.25 29.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 112.001 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.95 101.85 4.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.582 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -132.3 165.45 24.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.04 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.28 102.24 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.582 0.706 . . . . 0.0 110.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.633 ' CE ' HG21 ' A' ' 7' ' ' THR . 0.5 OUTLIER -73.45 143.64 46.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.641 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 -160.34 11.39 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.656 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -95.33 10.9 34.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.949 0.375 . . . . 0.0 110.431 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.404 ' CG2' ' NE2' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -155.59 133.41 11.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.388 0.614 . . . . 0.0 112.144 -179.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 5' ' ' VAL . 1.5 ptm -139.04 164.71 29.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.983 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 13.3 pt-20 -124.77 112.27 16.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.181 0.515 . . . . 0.0 110.696 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 1.114 HG23 HG11 ' A' ' 5' ' ' VAL . 31.9 t -91.85 134.7 29.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.625 ' CG1' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.79 -41.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.242 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -90.9 107.83 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.669 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.7 mmmm -93.81 114.78 63.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.961 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.02 92.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.125 . . . . 0.0 111.951 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.42 -52.5 6.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -114.53 -29.21 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.244 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -101.29 101.09 15.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.941 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.0 58.67 6.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.569 2.18 . . . . 0.0 112.304 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.53 -94.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.047 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -151.66 152.03 32.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.959 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -105.27 171.27 7.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.281 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.771 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.14 136.92 46.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 112.187 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.67 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 p -126.05 152.12 46.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.155 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.691 ' HA ' HG12 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -91.94 130.68 37.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.067 0.46 . . . . 0.0 110.343 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.57 174.61 5.8 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.353 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.29 3.14 16.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.206 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.82 -6.19 59.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.374 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.8 -27.85 14.69 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.812 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.484 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 5.1 mm-40 -117.75 138.81 51.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -104.9 146.88 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.081 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.821 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -133.12 -159.36 9.1 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.56 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.887 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -105.14 120.24 41.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 0.0 111.089 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.959 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.2 p -101.64 141.35 22.41 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 52' ' ' VAL . 91.4 Cg_endo -70.82 105.1 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.326 2.684 . . . . 0.0 111.23 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -55.96 -21.84 23.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -76.12 -9.59 58.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.298 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.51 ' O ' HD22 ' A' ' 8' ' ' LEU . 10.8 m-30 -110.39 18.79 19.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.7 OUTLIER -150.23 176.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 112.363 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.1 p -136.33 118.5 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.992 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.478 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 18.9 t -65.47 147.25 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.839 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -109.29 164.01 12.86 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.08 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.308 -1.212 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.858 -179.701 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.094 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.11 122.88 27.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.88 166.96 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.198 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.947 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -134.96 158.1 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.477 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.735 ' HB2' HD13 ' A' ' 60' ' ' LEU . 1.9 tt0 -130.98 143.84 51.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.729 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.762 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -116.81 167.88 10.71 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.233 0.539 . . . . 0.0 110.999 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.901 HD21 ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -130.93 -21.68 2.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.532 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.776 ' CD2' HD23 ' A' ' 8' ' ' LEU . 22.3 m-85 -135.78 161.68 61.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 85.2 Cg_exo -46.68 173.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.546 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 52' ' ' VAL . 2.9 t80 -102.29 138.92 38.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.07 118.49 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.618 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -109.29 171.72 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.57 -41.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.28 172.54 12.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.782 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -83.59 -30.12 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.07 33.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.706 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.6 mt-10 -117.85 -170.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.319 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.923 HD23 ' CZ ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -148.31 141.09 24.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -113.24 102.15 10.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.529 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.923 ' CZ ' HD23 ' A' ' 19' ' ' LEU . 8.9 m-30 -116.7 163.4 16.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.249 0.547 . . . . 0.0 112.083 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -156.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.228 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HD3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -51.83 133.67 31.64 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.22 0.534 . . . . 0.0 111.517 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' HE3' ' A' ' 23' ' ' LYS . . . -110.38 92.59 0.69 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.737 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.574 ' N ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tt0 -94.63 -20.63 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.59 0.71 . . . . 0.0 109.961 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -168.13 130.88 1.51 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.105 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.483 ' C ' HG13 ' A' ' 5' ' ' VAL . 2.7 mtt -138.85 164.54 29.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.614 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.1 mt-10 -125.7 115.26 19.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.863 0.363 . . . . 0.0 111.076 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.947 HG23 HG11 ' A' ' 5' ' ' VAL . 13.1 t -92.71 131.74 38.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.511 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.645 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -90.79 -67.99 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.712 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 127.78 33.07 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.0 158.94 32.28 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 111.912 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HG3' ' CZ3' ' A' ' 40' ' ' TRP . 60.1 Cg_endo -93.44 11.6 1.95 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.381 2.721 . . . . 0.0 113.09 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.81 -29.55 67.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.853 0.359 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.33 -38.87 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.738 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.06 100.94 35.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.33 53.09 4.36 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.61 2.207 . . . . 0.0 112.413 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 -83.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.578 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.448 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -151.32 152.37 33.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.575 0.226 . . . . 0.0 110.77 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.725 ' HB2' HG13 ' A' ' 29' ' ' VAL . 4.5 p90 -119.63 172.12 7.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.024 0.44 . . . . 0.0 110.477 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.648 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -146.56 137.74 24.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.377 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 5.6 p -129.42 153.69 47.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.701 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.767 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -92.97 143.14 26.53 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.848 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . 0.559 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 32.0 t30 -121.88 174.48 6.85 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.354 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.89 -0.2 2.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.264 0.554 . . . . 0.0 109.915 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.58 ' HG2' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.92 -7.95 59.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.717 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.78 -5.52 52.36 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.234 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.775 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -119.1 138.75 52.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.052 0.453 . . . . 0.0 112.15 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.767 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.57 126.29 72.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.231 178.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.908 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -119.06 -168.16 13.98 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.94 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -87.87 129.08 35.33 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.663 HG11 ' HE2' ' A' ' 54' ' ' LYS . 4.9 p -134.12 131.38 20.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.44 ' O ' ' CD2' ' A' ' 56' ' ' TYR . 15.7 Cg_endo -84.55 92.2 0.76 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.365 2.71 . . . . 0.0 110.288 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HE2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -67.3 -9.51 41.61 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -46.75 -20.86 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.901 ' O ' HD21 ' A' ' 8' ' ' LEU . 14.3 p90 -102.69 12.72 35.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -134.27 176.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -178.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 6' ' ' GLN . 8.9 p -107.58 112.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.34 146.49 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.551 0.691 . . . . 0.0 112.322 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.804 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -98.69 160.89 13.96 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 179.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.984 -179.68 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.457 -0.079 0 CA-C-O 120.664 0.268 . . . . 0.0 111.03 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 115.47 20.4 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.773 HG13 ' HG2' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -128.43 167.22 24.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.988 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.38 160.51 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 110.974 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.82 ' HB2' HD13 ' A' ' 60' ' ' LEU . 3.9 tt0 -126.05 144.52 50.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.503 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.72 HG23 ' SD ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -113.63 139.81 48.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.266 0.555 . . . . 0.0 111.317 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.862 ' CD2' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -107.96 -48.33 3.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.082 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . 0.424 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 52.5 m-85 -93.62 161.57 30.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.276 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 11.7 Cg_endo -54.56 -165.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.817 2.345 . . . . 0.0 112.119 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 45.5 p90 -108.28 128.68 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.239 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t -130.13 117.89 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.586 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 m -147.71 124.27 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.644 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.74 -4.14 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.114 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.6 m -91.84 168.68 11.26 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.244 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 15' ' ' THR . 0.2 OUTLIER -67.5 -37.58 83.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 -179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.96 16.93 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.767 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLU . . . . . 0.827 ' O ' HD12 ' A' ' 19' ' ' LEU . 12.6 mt-10 -104.62 -176.62 3.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -159.07 137.62 10.84 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.89 100.49 9.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.72 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PHE . . . . . 0.456 ' O ' ' CG ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -133.99 162.85 30.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.93 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -71.12 97.29 1.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.072 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.655 ' HG2' HG21 ' A' ' 7' ' ' THR . 11.6 tppt? -74.71 135.43 41.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.71 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.14 -160.62 22.54 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.47 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.732 ' O ' HG23 ' A' ' 26' ' ' THR . 2.6 tt0 -94.9 24.07 5.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.576 0.227 . . . . 0.0 111.211 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 25' ' ' GLU . 1.5 p -169.79 123.12 0.74 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 111.843 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' MET . . . . . 0.72 ' SD ' HG23 ' A' ' 7' ' ' THR . 0.8 OUTLIER -139.45 164.73 29.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.421 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.773 ' HG2' HG13 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -121.41 120.51 35.18 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' VAL . . . . . 0.988 HG23 HG11 ' A' ' 5' ' ' VAL . 37.3 t -98.57 129.94 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.24 0.543 . . . . 0.0 111.674 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.637 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.59 -84.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.77 147.49 53.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.36 159.27 32.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.201 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.0 -1.33 6.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.814 2.343 . . . . 0.0 113.166 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.14 -46.24 88.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -107.49 -30.18 8.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -72.55 148.36 90.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.59 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -40.41 -76.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.147 2.565 . . . . 0.0 112.713 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 3.1 tt0 -161.18 14.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 5.9 m0 -138.96 146.08 40.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.322 . . . . 0.0 111.002 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.738 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -111.95 178.66 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.062 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.912 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -141.73 137.03 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.143 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' CYS . . . . . 0.556 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.4 p -132.56 156.22 47.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.077 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.815 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.81 136.71 32.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.553 0.692 . . . . 0.0 111.446 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -113.07 174.97 5.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.805 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.17 0.78 12.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -83.78 -6.66 59.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.08 -18.39 40.85 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.535 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLN . . . . . 0.728 ' HB3' HD21 ' A' ' 19' ' ' LEU . 9.5 mm100 -118.26 138.22 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.744 0.307 . . . . 0.0 110.74 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' VAL . . . . . 0.815 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -115.77 127.13 73.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 0.0 110.49 178.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.764 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -112.66 -144.34 9.17 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.477 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LEU . . . . . 0.912 HD12 ' HB3' ' A' ' 41' ' ' LYS . 1.0 OUTLIER -113.69 116.12 28.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.044 0.45 . . . . 0.0 110.503 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.738 HG13 ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -92.43 140.44 24.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 52' ' ' VAL . 59.0 Cg_endo -62.89 92.96 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.486 2.791 . . . . 0.0 111.598 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -53.19 -22.85 7.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.866 0.365 . . . . 0.0 111.815 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -78.91 -11.93 60.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' TYR . . . . . 0.416 ' HB3' ' HB2' ' A' ' 9' ' ' TYR . 9.2 m-30 -110.2 15.72 22.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.989 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.862 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -142.11 166.35 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.608 . . . . 0.0 112.564 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 58' ' ' VAL . 12.8 p -123.1 113.96 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.294 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.8 t -65.4 146.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.804 0.811 . . . . 0.0 113.112 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -103.68 163.63 12.2 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.067 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.999 -179.745 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.238 0 N-CA-C 112.466 -0.253 . . . . 0.0 112.466 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.16 121.13 43.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.702 0.287 . . . . 0.0 111.063 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.63 125.95 30.65 Favored 'General case' 0 CA--C 1.515 -0.398 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.363 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.554 ' HB ' HD23 ' A' ' 60' ' ' LEU . 0.0 OUTLIER -127.4 166.34 24.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.227 -178.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.052 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -131.58 155.48 41.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.408 -179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.595 ' HG3' HG22 ' A' ' 26' ' ' THR . 3.9 tt0 -134.04 154.02 51.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.431 -0.804 . . . . 0.0 110.961 -178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.671 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.9 OUTLIER -111.44 162.05 15.48 Favored 'General case' 0 CA--C 1.519 -0.222 0 CA-C-O 121.458 0.647 . . . . 0.0 112.284 179.757 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.71 -34.66 1.32 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 114.929 -1.032 . . . . 0.0 110.98 -179.925 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.607 ' H ' HD22 ' A' ' 8' ' ' LEU . 22.6 m-85 -123.99 122.87 26.2 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.192 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -70.84 60.91 2.29 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.177 1.918 . . . . 0.0 111.161 178.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.656 ' HB3' ' CD2' ' A' ' 56' ' ' TYR . 9.4 m-85 -87.75 154.27 20.69 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.838 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -95.6 152.52 18.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.042 -0.981 . . . . 0.0 112.839 -178.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 m -89.28 171.87 9.46 Favored 'General case' 0 CA--C 1.529 0.157 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.063 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.535 HG23 ' N ' ' A' ' 15' ' ' THR . 20.1 m -132.54 -55.31 0.77 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.535 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -46.17 158.4 0.1 Allowed 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.898 0.38 . . . . 0.0 111.807 -178.809 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.14 -31.0 68.31 Favored 'General case' 0 C--N 1.333 -0.112 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.736 -179.329 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.416 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 12.0 mp0 -87.13 26.12 1.24 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.673 -0.24 . . . . 0.0 110.997 179.719 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.813 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.6 mt-10 -110.33 -176.76 3.07 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-O 121.266 0.555 . . . . 0.0 111.635 -179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.012 HD23 ' CE2' ' A' ' 21' ' ' PHE . 1.0 OUTLIER -138.58 137.64 37.18 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 115.236 -0.893 . . . . 0.0 110.391 179.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' O ' ' CD1' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -113.55 100.08 8.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.025 0.441 . . . . 0.0 111.441 179.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 1.012 ' CE2' HD23 ' A' ' 19' ' ' LEU . 20.5 m-30 -133.69 162.8 30.98 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 178.505 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.511 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 3.5 tp10 -81.33 95.88 7.14 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 119.724 -0.79 . . . . 0.0 109.938 -179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD2' ' OG1' ' A' ' 7' ' ' THR . 0.8 OUTLIER -76.58 143.52 40.21 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.156 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -163.74 -39.76 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.295 179.472 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -94.91 -147.13 0.27 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-O 120.583 0.23 . . . . 0.0 111.167 -179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.595 HG22 ' HG3' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -108.38 146.22 33.35 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-O 121.589 0.709 . . . . 0.0 112.193 -179.216 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.881 ' O ' HG13 ' A' ' 5' ' ' VAL . 26.8 mmt -134.24 164.97 26.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.443 178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.551 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.5 mt-10 -113.71 122.78 48.18 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 120.892 0.377 . . . . 0.0 111.226 -179.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.052 HG23 HG11 ' A' ' 5' ' ' VAL . 2.8 t -92.45 127.47 44.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.451 -179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.584 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -91.28 -39.63 11.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.21 -179.75 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 69.9 tt0 -87.99 118.19 27.37 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.088 -179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.436 ' HB3' ' HG3' ' A' ' 34' ' ' GLU . 0.0 OUTLIER -100.5 155.52 36.27 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.69 179.802 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.414 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 1.8 Cg_endo -83.07 8.57 4.53 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.065 2.51 . . . . 0.0 113.416 -179.142 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . 0.436 ' HG3' ' HB3' ' A' ' 32' ' ' LYS . 0.0 OUTLIER -88.43 -30.68 19.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.778 0.323 . . . . 0.0 111.006 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 29.8 m-20 -121.3 -36.23 3.13 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.984 0.421 . . . . 0.0 110.649 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . 0.411 ' CB ' ' HD2' ' A' ' 37' ' ' PRO . 2.8 m-20 -96.83 165.2 16.4 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.586 179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HD2' ' CB ' ' A' ' 36' ' ' ASP . 1.1 Cg_endo -44.43 177.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 123.086 2.524 . . . . 0.0 112.838 -179.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.77 -4.27 15.41 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.026 -0.534 . . . . 0.0 112.202 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -106.02 146.06 30.59 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.701 0.286 . . . . 0.0 110.9 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.908 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.3 OUTLIER -124.07 169.96 11.15 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.363 -0.381 . . . . 0.0 110.426 179.112 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.942 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.92 137.57 26.3 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.002 0.429 . . . . 0.0 112.14 -178.748 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.551 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 7.0 p -134.91 157.7 46.17 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.881 -0.6 . . . . 0.0 109.95 179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.81 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 4.5 pttm -92.27 135.2 34.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.474 0.654 . . . . 0.0 111.896 -179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.427 ' C ' ' H ' ' A' ' 46' ' ' ARG . 1.9 t30 -108.78 174.58 5.81 Favored 'General case' 0 CA--C 1.51 -0.571 0 CA-C-N 114.678 -1.146 . . . . 0.0 109.167 179.535 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.72 5.9 4.46 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.532 0.682 . . . . 0.0 109.417 178.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.584 ' HG2' ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.79 -8.58 59.2 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.811 -1.086 . . . . 0.0 111.313 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.8 -15.22 38.2 Favored Glycine 0 CA--C 1.524 0.603 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.445 -178.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.821 ' CG ' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -118.22 138.25 52.47 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 120.684 0.278 . . . . 0.0 110.907 179.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.81 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -120.08 125.7 74.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 176.906 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.866 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -117.51 -159.89 11.54 Favored Glycine 0 N--CA 1.438 -1.169 0 C-N-CA 120.38 -0.914 . . . . 0.0 111.234 179.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.942 HD12 ' HB3' ' A' ' 41' ' ' LYS . 1.2 mp -96.13 110.46 22.72 Favored 'General case' 0 C--N 1.313 -1.014 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.908 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.4 p -92.47 133.16 30.17 Favored Pre-proline 0 C--N 1.324 -0.536 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.097 -179.262 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 77.5 Cg_endo -74.28 106.87 2.31 Favored 'Trans proline' 0 C--O 1.231 0.161 0 C-N-CA 123.072 2.515 . . . . 0.0 111.797 179.175 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -51.63 -23.4 4.27 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.984 179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 56.3 t30 -67.82 -10.84 56.33 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.852 -179.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.656 ' CD2' ' HB3' ' A' ' 11' ' ' PHE . 18.6 m-85 -116.67 12.99 15.11 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.433 -179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.633 ' C ' HD11 ' A' ' 8' ' ' LEU . 0.6 OUTLIER -149.6 176.7 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.332 -0.155 0 CA-C-O 121.486 0.66 . . . . 0.0 112.559 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.756 HG12 ' CD1' ' A' ' 8' ' ' LEU . 9.5 p -139.16 120.15 15.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.04 178.16 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.5 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.0 t -65.2 145.69 13.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.139 0.495 . . . . 0.0 111.485 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.68 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.97 100.06 3.94 Favored 'General case' 0 N--CA 1.455 -0.223 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.767 -178.842 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.411 ' HA ' HG23 ' A' ' 4' ' ' VAL . 90.2 p . . . . . 0 C--O 1.249 1.068 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.898 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.18 0 N-CA-C 112.534 -0.226 . . . . 0.0 112.534 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -164.06 137.77 5.45 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.779 0.323 . . . . 0.0 111.166 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.95 121.84 26.52 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.514 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -121.87 167.87 14.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 116.574 -0.285 . . . . 0.0 111.005 -178.548 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.013 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -133.14 157.6 42.88 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.164 0.507 . . . . 0.0 111.19 -179.204 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.813 ' HG3' HG23 ' A' ' 26' ' ' THR . 1.8 tt0 -116.52 140.52 49.28 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.586 -0.734 . . . . 0.0 111.407 -178.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.778 HG22 ' HG2' ' A' ' 27' ' ' MET . 1.9 p -85.78 135.96 33.52 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 121.148 0.499 . . . . 0.0 111.309 -179.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.046 HD21 HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -114.71 -37.74 4.16 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.505 -0.77 . . . . 0.0 110.061 -179.558 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -133.12 162.28 58.6 Favored Pre-proline 0 C--N 1.332 -0.192 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.738 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -46.1 175.42 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.425 0 C-N-CA 123.143 2.562 . . . . 0.0 112.872 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.444 ' CD1' ' O ' ' A' ' 21' ' ' PHE . 51.7 p90 -93.42 129.23 39.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.638 -179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.6 t -130.04 117.78 20.54 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.207 -0.452 . . . . 0.0 111.057 179.105 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -124.47 126.9 46.64 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.725 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.494 HG23 ' N ' ' A' ' 15' ' ' THR . 24.3 m -132.47 -47.88 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.74 -179.647 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.494 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.2 OUTLIER -55.38 172.5 0.14 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.805 0.335 . . . . 0.0 110.994 -179.922 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -71.72 -33.88 69.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.397 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.856 ' HB2' HD22 ' A' ' 51' ' ' LEU . 2.4 mm-40 -92.73 32.77 1.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.613 0.244 . . . . 0.0 111.419 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.636 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 1.7 mt-10 -121.68 166.84 13.67 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.586 -0.279 . . . . 0.0 110.448 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.957 HD11 ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -153.08 149.35 28.02 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.907 0.385 . . . . 0.0 110.715 178.81 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.7 p30 -100.65 111.56 23.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.123 0.487 . . . . 0.0 111.389 -178.512 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.957 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.53 163.2 29.92 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.019 179.732 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 2.0 tp10 -69.4 99.33 1.2 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HD2' ' HE2' ' A' ' 27' ' ' MET . 0.0 OUTLIER -73.45 128.28 35.06 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.954 -0.567 . . . . 0.0 111.318 -179.237 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.472 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -88.92 -145.64 11.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.621 179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.456 ' C ' HG23 ' A' ' 7' ' ' THR . 2.3 tt0 -95.82 -17.9 20.8 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.255 0.55 . . . . 0.0 110.689 179.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.813 HG23 ' HG3' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -142.6 144.08 32.69 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.378 -0.828 . . . . 0.0 111.851 -179.321 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.778 ' HG2' HG22 ' A' ' 7' ' ' THR . 0.0 OUTLIER -138.43 164.25 29.84 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.261 178.734 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.521 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 1.5 pm0 -120.9 112.41 18.75 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.924 0.393 . . . . 0.0 110.291 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.013 HG23 HG11 ' A' ' 5' ' ' VAL . 14.3 t -91.37 137.25 22.26 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-N 115.736 -0.666 . . . . 0.0 111.745 -178.91 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.6 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.8 -39.9 9.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 115.188 -0.914 . . . . 0.0 111.338 -179.632 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 22.9 tt0 -89.99 107.95 19.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.007 -179.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 3.2 mmtp -81.09 139.38 49.22 Favored Pre-proline 0 C--N 1.327 -0.395 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.711 179.903 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 83.3 Cg_endo -85.5 12.59 3.01 Favored 'Trans proline' 0 N--CA 1.46 -0.485 0 C-N-CA 122.715 2.277 . . . . 0.0 112.929 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.82 -21.15 55.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.655 0.264 . . . . 0.0 111.079 179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.0 t-20 -115.12 -42.32 3.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.875 0.369 . . . . 0.0 110.46 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.86 100.98 36.52 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.65 179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -82.98 61.61 7.47 Favored 'Trans proline' 0 N--CA 1.462 -0.352 0 C-N-CA 122.575 2.184 . . . . 0.0 112.633 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.444 ' H ' ' HG2' ' A' ' 38' ' ' GLU . 0.9 OUTLIER -114.55 -75.46 0.59 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.38 179.993 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.418 ' CE3' ' HB2' ' A' ' 38' ' ' GLU . 2.6 m-90 -151.77 146.19 25.55 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.668 0.27 . . . . 0.0 111.144 -179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.661 ' CD1' HG13 ' A' ' 52' ' ' VAL . 1.0 OUTLIER -119.83 169.03 10.51 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.267 178.731 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.686 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.08 138.3 46.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.011 0.434 . . . . 0.0 112.055 -178.508 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.554 ' N ' HG23 ' A' ' 49' ' ' VAL . 0.8 OUTLIER -132.28 157.73 43.65 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.867 -179.889 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.806 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.15 143.22 26.66 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.277 0.561 . . . . 0.0 111.444 -179.223 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.577 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 4.5 t-20 -120.93 174.52 6.57 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.462 -179.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -64.11 -10.75 24.4 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.568 -179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' HB2' ' CG ' ' A' ' 48' ' ' GLN . 2.8 mmp_? -83.35 -1.81 54.23 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 178.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 73.46 5.69 68.37 Favored Glycine 0 C--N 1.334 0.469 0 C-N-CA 120.891 -0.671 . . . . 0.0 112.085 -179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.448 ' CG ' ' HB2' ' A' ' 46' ' ' ARG . 0.9 OUTLIER -118.28 115.35 24.54 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-O 121.096 0.474 . . . . 0.0 111.939 -179.591 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.806 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -104.07 132.53 50.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 177.878 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.715 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -141.14 -178.27 17.24 Favored Glycine 0 N--CA 1.437 -1.255 0 C-N-CA 120.261 -0.971 . . . . 0.0 111.858 -179.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.856 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.5 OUTLIER -73.47 111.52 8.68 Favored 'General case' 0 C--N 1.312 -1.033 0 CA-C-O 121.279 0.561 . . . . 0.0 111.331 -179.47 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.783 HG23 ' HD2' ' A' ' 53' ' ' PRO . 1.7 p -101.11 147.07 33.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.869 -179.61 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.783 ' HD2' HG23 ' A' ' 52' ' ' VAL . 53.9 Cg_endo -60.43 87.36 0.08 OUTLIER 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 123.288 2.659 . . . . 0.0 111.519 178.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.494 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.7 OUTLIER -53.38 -26.58 19.94 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.83 -179.433 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -82.32 -0.18 44.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.887 179.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.528 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 2.5 m-85 -110.14 13.14 23.26 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.747 HG11 ' HE1' ' A' ' 27' ' ' MET . 0.8 OUTLIER -149.39 177.04 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.549 -0.75 . . . . 0.0 111.093 -178.607 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 1.046 HG12 HD21 ' A' ' 8' ' ' LEU . 7.5 p -131.23 121.33 48.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 177.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.482 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 33.9 t -65.38 146.8 12.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-O 121.801 0.81 . . . . 0.0 113.058 -177.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.708 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.4 OUTLIER -105.4 164.06 12.15 Favored 'General case' 0 N--CA 1.437 -1.098 0 CA-C-N 114.218 -1.356 . . . . 0.0 109.331 179.34 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 23.9 t . . . . . 0 C--N 1.308 -1.198 0 CA-C-O 118.232 -0.889 . . . . 0.0 110.891 -179.819 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.244 0 N-CA-C 112.44 -0.264 . . . . 0.0 112.44 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -105.35 124.25 49.23 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.783 0.325 . . . . 0.0 110.917 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.93 119.54 23.6 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 178.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.445 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.57 166.48 25.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.205 -178.83 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.962 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -135.19 158.83 41.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.583 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.173 179.263 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.664 ' HB2' HD13 ' A' ' 60' ' ' LEU . 1.1 tt0 -134.22 139.89 46.1 Favored 'General case' 0 C--N 1.318 -0.786 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.95 -177.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.74 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -111.2 165.52 11.85 Favored 'General case' 0 CA--C 1.519 -0.221 0 CA-C-O 121.184 0.516 . . . . 0.0 111.094 179.531 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.796 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -122.13 -31.53 3.85 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.451 -0.795 . . . . 0.0 110.639 -179.354 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.533 ' CD2' HD23 ' A' ' 8' ' ' LEU . 34.4 m-85 -125.28 161.53 49.38 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.591 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.437 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 91.2 Cg_exo -44.11 151.72 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.661 2.24 . . . . 0.0 112.602 -179.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CD2' ' A' ' 21' ' ' PHE . 9.2 t80 -95.42 130.25 42.29 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.037 -0.528 . . . . 0.0 110.954 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.0 m -129.06 144.37 51.17 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.884 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -170.94 161.87 7.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.808 179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.654 ' O ' HG13 ' A' ' 14' ' ' VAL . 7.3 p -173.06 89.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-O 121.074 0.464 . . . . 0.0 111.228 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.465 HG22 ' H ' ' A' ' 16' ' ' GLU . 0.9 OUTLIER -160.94 172.6 16.65 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.976 -179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.465 ' H ' HG22 ' A' ' 15' ' ' THR . 0.7 OUTLIER -63.77 -32.83 74.46 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.618 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.633 ' CB ' HD22 ' A' ' 51' ' ' LEU . 3.7 mt-10 -99.12 -50.87 4.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.759 179.867 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.513 ' HG2' ' HB2' ' A' ' 51' ' ' LEU . 10.4 mt-10 -63.99 153.52 36.95 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.311 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.155 HD21 ' CE1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -149.2 159.43 44.26 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 110.569 -0.159 . . . . 0.0 110.569 178.964 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.458 ' N ' HD22 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -101.09 153.09 19.86 Favored 'General case' 0 N--CA 1.465 0.311 0 N-CA-C 113.23 0.826 . . . . 0.0 113.23 -177.475 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 1.155 ' CE1' HD21 ' A' ' 19' ' ' LEU . 46.8 m-85 -133.69 164.19 27.76 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.689 179.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -63.85 -156.03 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 108.482 -0.932 . . . . 0.0 108.482 177.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.43 ' C ' ' CD ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -51.64 126.92 18.97 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 120.437 -0.505 . . . . 0.0 109.722 -179.955 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.418 ' O ' ' OG1' ' A' ' 7' ' ' THR . . . -125.16 86.26 0.36 Allowed Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.673 -0.775 . . . . 0.0 113.086 -179.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -95.4 -22.7 17.55 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 121.586 0.708 . . . . 0.0 109.388 178.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.457 HG22 ' HG3' ' A' ' 6' ' ' GLN . 3.1 p -138.84 128.33 24.5 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 114.586 -1.188 . . . . 0.0 110.693 179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.521 ' C ' HG13 ' A' ' 5' ' ' VAL . 0.1 OUTLIER -138.73 164.71 28.86 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.802 -0.636 . . . . 0.0 110.208 179.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.593 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 4.6 mt-10 -125.71 115.22 19.75 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.751 0.31 . . . . 0.0 111.243 179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.962 HG23 HG11 ' A' ' 5' ' ' VAL . 24.9 t -94.82 127.07 47.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 121.228 0.537 . . . . 0.0 110.645 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.665 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.31 -77.11 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.522 -0.763 . . . . 0.0 112.636 -178.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -85.07 136.03 33.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.117 0.484 . . . . 0.0 112.022 -178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -94.74 159.32 33.66 Favored Pre-proline 0 N--CA 1.452 -0.368 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.508 179.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.502 ' HG3' ' CE3' ' A' ' 40' ' ' TRP . 6.4 Cg_exo -74.6 6.33 3.27 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.82 2.347 . . . . 0.0 113.09 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -59.38 -34.19 72.11 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.909 0.385 . . . . 0.0 110.601 179.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.2 p30 -97.28 -44.77 6.76 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.399 179.614 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -123.27 100.83 38.66 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.372 179.494 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.92 57.18 5.64 Favored 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.476 2.117 . . . . 0.0 112.583 -179.79 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.403 ' OE2' ' CZ2' ' A' ' 39' ' ' TRP . 0.0 OUTLIER -121.75 -77.09 0.58 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.039 -179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.551 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -151.41 158.52 43.81 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.126 179.997 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.76 ' HE1' ' H ' ' A' ' 54' ' ' LYS . 0.5 OUTLIER -116.18 -179.23 3.61 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 177.716 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.665 ' HD3' HD11 ' A' ' 30' ' ' ILE . 0.0 OUTLIER -151.22 138.64 19.47 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.705 0.288 . . . . 0.0 110.834 -179.053 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.593 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 2.9 p -131.18 154.49 48.32 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.661 -179.174 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.798 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.22 136.85 32.85 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 121.475 0.655 . . . . 0.0 110.864 -179.686 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.599 ' CB ' ' CD1' ' A' ' 21' ' ' PHE . 4.1 t-20 -109.29 174.57 5.81 Favored 'General case' 0 CA--C 1.509 -0.625 0 CA-C-N 114.917 -1.038 . . . . 0.0 109.734 -179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -71.3 -3.69 21.92 Favored 'General case' 0 C--N 1.319 -0.722 0 C-N-CA 120.452 -0.499 . . . . 0.0 110.295 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.438 ' HD2' ' N ' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.54 -2.66 56.51 Favored 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.343 179.244 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 76.58 6.04 83.88 Favored Glycine 0 C--N 1.336 0.536 0 C-N-CA 120.883 -0.675 . . . . 0.0 111.887 -178.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.56 ' O ' ' CE1' ' A' ' 21' ' ' PHE . 0.3 OUTLIER -118.52 138.34 52.59 Favored 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.91 0.386 . . . . 0.0 111.66 -179.399 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.798 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -132.99 126.06 52.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 176.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.647 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -133.5 -164.33 10.73 Favored Glycine 0 N--CA 1.434 -1.477 0 C-N-CA 120.453 -0.88 . . . . 0.0 111.515 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.633 HD22 ' CB ' ' A' ' 17' ' ' GLU . 0.0 OUTLIER -84.96 129.88 34.73 Favored 'General case' 0 C--N 1.311 -1.083 0 CA-C-O 121.306 0.574 . . . . 0.0 111.529 -179.104 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.635 HG22 ' HD2' ' A' ' 54' ' ' LYS . 6.0 p -134.0 140.78 37.33 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.442 -178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.557 ' HD2' HG23 ' A' ' 52' ' ' VAL . 0.5 OUTLIER -91.03 60.54 1.23 Allowed 'Trans proline' 0 CA--C 1.532 0.397 0 C-N-CA 123.537 2.824 . . . . 0.0 111.885 179.408 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.76 ' H ' ' HE1' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -45.24 -11.48 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . 0.452 ' N ' ' O ' ' A' ' 53' ' ' PRO . 0.1 OUTLIER -45.09 -20.71 0.05 OUTLIER 'General case' 0 CA--C 1.534 0.358 0 O-C-N 122.099 -0.376 . . . . 0.0 111.495 179.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.735 ' O ' HD21 ' A' ' 8' ' ' LEU . 24.9 p90 -101.93 31.49 3.87 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-O 121.069 0.461 . . . . 0.0 110.088 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.738 HG21 ' HG3' ' A' ' 54' ' ' LYS . 0.9 OUTLIER -148.63 176.34 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.691 -178.727 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.561 ' O ' HG13 ' A' ' 58' ' ' VAL . 9.8 p -108.07 112.78 41.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 177.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 24.4 t -71.75 146.46 11.47 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.432 0.634 . . . . 0.0 112.07 -178.613 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.767 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.2 OUTLIER -100.87 161.54 13.53 Favored 'General case' 0 N--CA 1.43 -1.472 0 CA-C-N 114.981 -1.009 . . . . 0.0 109.332 179.212 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.306 -1.311 0 CA-C-O 118.296 -0.859 . . . . 0.0 110.87 -179.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.205 0 N-CA-C 112.533 -0.227 . . . . 0.0 112.533 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -89.65 142.31 27.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.766 0.317 . . . . 0.0 111.044 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.403 ' HA ' ' CB ' ' A' ' 61' ' ' SER . 0.0 OUTLIER -80.91 120.56 24.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 178.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.527 ' HB ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.53 166.7 25.25 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.183 -178.713 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.995 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -128.87 161.83 37.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-O 121.42 0.629 . . . . 0.0 111.283 -179.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.509 ' N ' ' CG2' ' A' ' 5' ' ' VAL . 2.8 tt0 -139.14 146.81 41.08 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.178 -179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.764 ' C ' HD13 ' A' ' 8' ' ' LEU . 5.7 p -105.7 163.05 12.99 Favored 'General case' 0 CA--C 1.52 -0.195 0 CA-C-O 120.922 0.392 . . . . 0.0 110.567 178.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.783 ' CD1' HG12 ' A' ' 58' ' ' VAL . 0.0 OUTLIER -131.09 -35.81 1.36 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.368 -179.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.518 ' HB3' ' CD2' ' A' ' 11' ' ' PHE . 10.0 m-85 -119.55 135.86 24.35 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.444 -0.343 . . . . 0.0 111.393 -179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 57.0 Cg_endo -70.94 59.04 2.18 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 122.292 1.995 . . . . 0.0 110.387 178.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.581 ' CD2' ' CD1' ' A' ' 56' ' ' TYR . 13.1 m-85 -73.28 155.53 39.4 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.945 -1.025 . . . . 0.0 112.652 -178.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.9 m -94.11 151.88 19.17 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 114.61 -1.177 . . . . 0.0 111.808 -178.259 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.511 ' HB2' ' O ' ' A' ' 19' ' ' LEU . 4.0 m -145.67 99.77 3.33 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.597 179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 14' ' ' VAL . 16.5 m -127.65 103.7 10.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-O 120.949 0.404 . . . . 0.0 111.554 -179.722 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.46 HG22 ' H ' ' A' ' 16' ' ' GLU . 0.8 OUTLIER -158.46 172.45 18.29 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.548 179.842 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' H ' HG22 ' A' ' 15' ' ' THR . 0.0 OUTLIER -64.45 -32.78 74.55 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.058 -179.835 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -113.44 12.23 18.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.449 -0.341 . . . . 0.0 111.273 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.637 ' O ' HD12 ' A' ' 19' ' ' LEU . 4.8 mt-10 -102.11 -173.79 2.42 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.675 0.274 . . . . 0.0 111.049 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.852 HD13 ' CA ' ' A' ' 50' ' ' GLY . 0.6 OUTLIER -147.02 160.53 42.27 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-O 121.352 0.596 . . . . 0.0 112.201 179.717 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -137.15 102.02 4.71 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.5 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.518 ' CE1' ' HE3' ' A' ' 27' ' ' MET . 4.3 p90 -129.74 164.05 24.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.202 -178.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -63.61 -157.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.701 -178.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.553 ' HD3' ' H ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -52.26 133.04 34.46 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 121.221 0.534 . . . . 0.0 111.708 -178.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.435 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -147.42 54.73 0.52 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.32 -0.854 . . . . 0.0 112.341 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.588 ' HA ' ' OG1' ' A' ' 7' ' ' THR . 1.3 tt0 -59.72 -21.15 60.26 Favored 'General case' 0 CA--C 1.514 -0.439 0 CA-C-O 121.119 0.485 . . . . 0.0 110.054 179.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 71.7 p -124.64 117.4 24.18 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.846 178.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.715 ' C ' HG13 ' A' ' 5' ' ' VAL . 24.4 mtp -139.14 163.41 32.49 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.19 -0.914 . . . . 0.0 110.237 179.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.5 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 0.7 OUTLIER -126.38 112.35 15.55 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.635 0.255 . . . . 0.0 110.855 179.313 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.995 HG23 HG11 ' A' ' 5' ' ' VAL . 5.8 t -85.67 113.22 23.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.277 0.56 . . . . 0.0 111.252 -179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.604 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -79.61 -38.91 19.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.607 -179.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 19.2 tp10 -98.35 118.08 34.21 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.273 -179.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 25.5 mmtp -91.94 142.29 26.3 Favored Pre-proline 0 N--CA 1.452 -0.363 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.761 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 5.1 Cg_exo -79.62 7.97 4.23 Favored 'Trans proline' 0 C--N 1.348 0.507 0 C-N-CA 122.756 2.304 . . . . 0.0 112.766 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.34 -51.68 67.84 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.812 0.339 . . . . 0.0 110.843 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -99.24 -34.55 10.3 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.542 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -73.83 165.11 56.13 Favored Pre-proline 0 C--N 1.331 -0.236 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.681 179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_exo -42.17 -75.4 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.706 2.271 . . . . 0.0 112.772 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -175.41 17.89 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 112.77 0.656 . . . . 0.0 112.77 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 3.5 m0 -123.37 145.8 48.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.717 0.294 . . . . 0.0 110.735 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.92 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -126.09 171.11 11.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.938 0.399 . . . . 0.0 111.225 179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.893 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -144.0 137.24 27.57 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.196 -179.247 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.535 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 8.3 p -132.46 151.88 51.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.712 -179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.805 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 7.4 mttp -91.59 140.22 29.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.392 0.615 . . . . 0.0 110.75 -179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -115.49 174.75 5.84 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 115.149 -0.932 . . . . 0.0 110.182 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -72.66 -1.84 17.81 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.254 178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.528 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 5.8 ttm180 -83.56 -7.45 59.52 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.442 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 84.57 -12.76 55.14 Favored Glycine 0 C--N 1.335 0.489 0 C-N-CA 120.951 -0.642 . . . . 0.0 113.774 178.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.589 ' HB3' HD21 ' A' ' 19' ' ' LEU . 2.6 mp0 -117.87 137.68 52.63 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.837 0.351 . . . . 0.0 111.125 -179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.805 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.04 126.13 73.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.174 0.511 . . . . 0.0 110.123 178.498 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.852 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -110.35 -142.26 9.24 Favored Glycine 0 N--CA 1.438 -1.216 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.285 179.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.893 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -117.54 110.33 17.82 Favored 'General case' 0 C--N 1.317 -0.836 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 179.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.92 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.6 p -92.01 131.94 33.9 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.003 -178.582 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.603 ' HG2' ' HB2' ' A' ' 56' ' ' TYR . 63.2 Cg_endo -74.53 107.19 2.4 Favored 'Trans proline' 0 C--N 1.342 0.219 0 C-N-CA 123.3 2.667 . . . . 0.0 111.77 178.809 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.49 ' HA ' ' HZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -49.86 -25.38 3.1 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 121.129 0.49 . . . . 0.0 111.914 179.686 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 21.0 t-20 -67.56 -11.83 58.98 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.748 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.603 ' HB2' ' HG2' ' A' ' 53' ' ' PRO . 15.5 m-30 -116.44 13.51 15.45 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.543 -0.753 . . . . 0.0 110.736 -179.786 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.561 HG11 ' CG2' ' A' ' 52' ' ' VAL . 0.6 OUTLIER -149.4 175.75 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 121.617 0.722 . . . . 0.0 112.491 -179.126 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.783 HG12 ' CD1' ' A' ' 8' ' ' LEU . 10.7 p -139.68 117.78 11.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 114.634 -1.167 . . . . 0.0 108.895 178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.526 HG12 ' O ' ' A' ' 4' ' ' VAL . 2.2 t -65.21 145.82 13.68 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.133 0.492 . . . . 0.0 111.272 -178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.676 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.0 OUTLIER -139.05 99.79 3.86 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.573 -0.739 . . . . 0.0 110.522 -178.836 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.474 ' HA ' HG23 ' A' ' 4' ' ' VAL . 22.0 p . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.22 -0.895 . . . . 0.0 110.921 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.126 0 N-CA-C 112.645 -0.182 . . . . 0.0 112.645 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -102.67 129.93 49.42 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.801 0.334 . . . . 0.0 111.091 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.71 129.12 34.34 Favored 'General case' 0 CA--C 1.515 -0.391 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 178.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.419 ' O ' ' O ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.68 167.75 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 120.987 0.423 . . . . 0.0 111.183 -178.37 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.005 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.9 160.57 42.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.881 -179.346 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.847 ' HB2' HD13 ' A' ' 60' ' ' LEU . 4.2 tt0 -124.44 140.48 52.91 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.907 -178.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.757 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.4 OUTLIER -111.62 154.38 24.97 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.276 0.56 . . . . 0.0 111.576 -179.91 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.813 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.76 -40.02 1.09 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.951 179.318 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.517 ' H ' HD22 ' A' ' 8' ' ' LEU . 0.1 OUTLIER -101.18 161.68 22.91 Favored Pre-proline 0 CA--C 1.529 0.169 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.51 -179.391 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_exo -54.59 -176.27 0.04 OUTLIER 'Trans proline' 0 C--N 1.347 0.463 0 C-N-CA 122.887 2.391 . . . . 0.0 112.972 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.459 ' CE2' ' N ' ' A' ' 21' ' ' PHE . 25.1 p90 -118.16 132.48 56.33 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.053 -179.68 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 47.2 t -129.66 117.89 21.07 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.665 0.269 . . . . 0.0 111.517 179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.645 ' HA ' ' HG2' ' A' ' 18' ' ' GLU . 0.2 OUTLIER -92.09 140.04 30.03 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.451 -0.341 . . . . 0.0 110.702 179.2 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.4 m -144.86 -31.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.427 HG22 ' N ' ' A' ' 16' ' ' GLU . 20.9 m -84.15 162.88 20.09 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 120.959 0.409 . . . . 0.0 111.854 -179.004 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.427 ' N ' HG22 ' A' ' 15' ' ' THR . 0.4 OUTLIER -62.69 -37.79 87.83 Favored 'General case' 0 N--CA 1.462 0.131 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.091 -179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -98.63 32.68 2.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.133 0.492 . . . . 0.0 110.253 179.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.673 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -101.79 176.29 5.27 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.829 -179.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.673 HD12 ' O ' ' A' ' 18' ' ' GLU . 2.7 mp -144.24 164.54 30.44 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.555 0.693 . . . . 0.0 112.11 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 9.3 p-10 -134.85 100.41 4.59 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 114.747 -1.115 . . . . 0.0 109.755 178.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.533 ' HE2' HD22 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -134.81 156.88 48.12 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.821 179.789 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.445 ' HA ' ' CE1' ' A' ' 11' ' ' PHE . 5.9 mp0 -64.94 98.32 0.28 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.16 0.505 . . . . 0.0 110.355 179.482 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.678 ' HD2' HG21 ' A' ' 7' ' ' THR . 0.2 OUTLIER -73.74 133.94 43.4 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.282 -179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -96.48 -148.73 24.61 Favored Glycine 0 N--CA 1.448 -0.532 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.737 179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.417 ' O ' ' CG ' ' A' ' 6' ' ' GLN . 2.2 tt0 -94.92 -17.14 22.27 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.874 0.368 . . . . 0.0 111.228 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -132.09 132.62 43.47 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.309 0.576 . . . . 0.0 112.164 -179.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.527 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.8 OUTLIER -138.87 164.2 30.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.307 -0.861 . . . . 0.0 109.877 178.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.594 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 6.3 pt-20 -122.75 118.66 28.56 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 120.772 0.32 . . . . 0.0 110.556 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.005 HG23 HG11 ' A' ' 5' ' ' VAL . 23.3 t -93.87 137.81 21.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.251 0.548 . . . . 0.0 111.762 -179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.576 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -96.19 -44.21 12.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.756 179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -110.09 120.42 42.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.397 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.53 ' HE3' HG12 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -99.72 139.27 20.71 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.321 -179.207 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 38.2 Cg_endo -91.32 17.59 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.022 2.481 . . . . 0.0 112.544 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -78.97 -37.68 38.86 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.84 0.352 . . . . 0.0 110.741 179.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.8 p30 -97.09 -44.09 7.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.641 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -123.75 101.03 36.85 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.801 179.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_exo -61.75 79.36 0.09 OUTLIER 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.598 2.199 . . . . 0.0 112.236 -179.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -119.3 -83.71 0.65 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.908 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.6 ' CD2' HD21 ' A' ' 51' ' ' LEU . 1.3 m0 -151.63 160.89 43.46 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.869 0.366 . . . . 0.0 111.285 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.997 ' CZ2' HG21 ' A' ' 57' ' ' VAL . 0.0 OUTLIER -126.03 107.41 10.41 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.894 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -123.35 138.54 54.58 Favored 'General case' 0 CA--C 1.517 -0.293 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.647 -177.445 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.594 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.0 OUTLIER -127.51 156.77 41.64 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.426 -179.124 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.824 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 5.6 ptpp? -91.93 142.9 27.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.606 0.717 . . . . 0.0 111.655 -179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -122.52 175.43 6.47 Favored 'General case' 0 N--CA 1.451 -0.424 0 CA-C-N 114.704 -1.135 . . . . 0.0 109.953 -179.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.44 -0.38 4.9 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 116.072 -0.513 . . . . 0.0 112.082 -179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -83.77 -7.52 59.45 Favored 'General case' 0 CA--C 1.528 0.116 0 CA-C-O 120.66 0.266 . . . . 0.0 110.593 179.217 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 83.4 -11.66 54.65 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.024 -178.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.651 ' HB3' HD21 ' A' ' 19' ' ' LEU . 5.9 mp0 -118.1 137.79 52.69 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 122.516 0.327 . . . . 0.0 110.396 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.824 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -116.32 130.76 70.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.014 0.435 . . . . 0.0 110.534 179.126 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.608 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -115.43 -159.72 12.28 Favored Glycine 0 N--CA 1.443 -0.881 0 C-N-CA 120.662 -0.78 . . . . 0.0 112.245 179.568 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.894 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -98.5 132.49 43.89 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.618 0.723 . . . . 0.0 110.73 -179.943 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.79 HG23 ' HD2' ' A' ' 53' ' ' PRO . 2.1 p -118.66 150.01 47.44 Favored Pre-proline 0 C--N 1.319 -0.75 0 CA-C-N 114.84 -1.073 . . . . 0.0 112.172 -177.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.79 ' HD2' HG23 ' A' ' 52' ' ' VAL . 54.0 Cg_endo -60.79 82.14 0.08 OUTLIER 'Trans proline' 0 N--CA 1.472 0.23 0 C-N-CA 123.355 2.704 . . . . 0.0 111.639 177.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.472 ' HB3' ' CD2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -50.02 -26.78 4.65 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.327 0.491 . . . . 0.0 112.327 -179.355 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -80.82 -13.31 59.07 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.93 0.395 . . . . 0.0 111.157 -179.617 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.591 ' CD1' ' HB2' ' A' ' 53' ' ' PRO . 0.5 OUTLIER -101.94 30.93 4.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.372 -179.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.997 HG21 ' CZ2' ' A' ' 40' ' ' TRP . 2.4 m -150.32 177.57 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 N-CA-C 112.74 0.644 . . . . 0.0 112.74 -178.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.776 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.6 p -136.43 113.83 13.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 115.153 -0.93 . . . . 0.0 109.191 177.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.682 HG22 ' CH2' ' A' ' 40' ' ' TRP . 16.4 t -65.75 147.25 12.71 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 N-CA-C 114.091 1.145 . . . . 0.0 114.091 -177.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.847 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -106.24 164.02 12.35 Favored 'General case' 0 N--CA 1.438 -1.056 0 CA-C-N 114.225 -1.352 . . . . 0.0 109.025 178.285 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 1.2 m . . . . . 0 C--N 1.309 -1.162 0 CA-C-O 118.221 -0.895 . . . . 0.0 111.112 -179.675 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.222 0 N-CA-C 112.54 -0.224 . . . . 0.0 112.54 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.7 142.79 57.29 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.692 0.282 . . . . 0.0 110.942 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.94 112.11 18.03 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 108.944 -0.762 . . . . 0.0 108.944 178.558 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.455 HG13 ' HB3' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -128.72 167.39 24.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.224 -178.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.142 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -130.05 151.96 36.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 CA-C-O 121.221 0.534 . . . . 0.0 110.718 179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.661 ' HB3' HG13 ' A' ' 58' ' ' VAL . 3.7 tt0 -115.55 144.47 43.82 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.25 -178.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.844 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.8 OUTLIER -115.9 153.25 31.89 Favored 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 121.202 0.525 . . . . 0.0 111.641 -179.833 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.844 HD13 ' C ' ' A' ' 7' ' ' THR . 0.0 OUTLIER -131.31 -44.08 1.03 Allowed 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.044 179.737 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 44.2 m-85 -100.71 157.05 34.43 Favored Pre-proline 0 C--N 1.332 -0.168 0 CA-C-O 120.853 0.358 . . . . 0.0 111.648 -179.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -59.53 162.28 15.43 Favored 'Trans proline' 0 C--N 1.348 0.518 0 C-N-CA 122.772 2.315 . . . . 0.0 112.054 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.587 ' CZ ' HG21 ' A' ' 52' ' ' VAL . 3.2 m-85 -111.59 135.15 52.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.034 0.445 . . . . 0.0 111.616 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.6 m -129.03 118.86 23.25 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.301 179.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 10.8 m -103.53 142.7 33.83 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.928 0.394 . . . . 0.0 111.384 -179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 15' ' ' THR . 27.7 m -135.88 -45.16 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.235 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.498 ' N ' HG23 ' A' ' 14' ' ' VAL . 0.5 OUTLIER -67.41 172.45 4.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.984 -179.786 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.449 ' H ' HG22 ' A' ' 15' ' ' THR . 0.6 OUTLIER -74.94 -37.5 61.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.033 -179.986 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.85 ' HB2' HD22 ' A' ' 51' ' ' LEU . 13.7 mt-10 -63.16 -48.92 76.38 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.574 179.799 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.47 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.4 OUTLIER -54.54 -171.67 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.825 179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.839 HD12 ' HA3' ' A' ' 50' ' ' GLY . 0.0 OUTLIER -178.79 158.25 0.98 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.122 178.496 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.465 ' N ' HD22 ' A' ' 19' ' ' LEU . 2.6 p30 -100.79 116.66 33.21 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -178.136 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.68 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.5 OUTLIER -133.5 162.63 31.37 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.02 178.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.446 ' CG ' ' O ' ' A' ' 22' ' ' GLU . 11.8 pt-20 -65.13 107.57 1.59 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.183 0.516 . . . . 0.0 110.112 179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.485 ' HE3' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -73.85 120.53 19.56 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.002 -0.545 . . . . 0.0 111.636 -179.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' N ' ' HD3' ' A' ' 23' ' ' LYS . . . -103.37 -152.69 23.49 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.757 -0.735 . . . . 0.0 111.68 178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.489 ' C ' HG22 ' A' ' 26' ' ' THR . 2.5 tt0 -94.87 -1.16 53.24 Favored 'General case' 0 N--CA 1.441 -0.882 0 CA-C-O 120.503 0.192 . . . . 0.0 111.273 179.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.547 ' HA ' ' HA ' ' A' ' 6' ' ' GLN . 0.6 OUTLIER -169.57 146.6 3.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.881 0.848 . . . . 0.0 113.017 -179.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.863 ' O ' HG13 ' A' ' 5' ' ' VAL . 0.0 OUTLIER -138.65 164.59 29.11 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.204 -1.362 . . . . 0.0 108.795 178.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.645 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 4.2 pm0 -114.67 113.21 24.03 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 110.074 -0.343 . . . . 0.0 110.074 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.142 HG23 HG11 ' A' ' 5' ' ' VAL . 38.6 t -90.31 132.64 34.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.307 0.575 . . . . 0.0 111.438 -178.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.659 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.23 -81.99 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.465 -179.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -74.37 128.35 35.33 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.931 0.396 . . . . 0.0 111.152 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.426 ' HA ' ' HD3' ' A' ' 33' ' ' PRO . 0.0 OUTLIER -105.09 117.26 58.98 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.656 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 32' ' ' LYS . 17.3 Cg_exo -66.9 62.36 0.6 Allowed 'Trans proline' 0 C--N 1.347 0.461 0 C-N-CA 122.684 2.256 . . . . 0.0 112.433 -179.562 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -88.55 -52.47 5.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.011 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 10.6 t30 -85.5 -44.58 12.58 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.795 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -108.77 101.04 42.19 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.721 179.841 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_exo -65.91 111.19 1.88 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.711 2.274 . . . . 0.0 112.405 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.488 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 24.6 tt0 -152.84 -98.69 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.764 179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.488 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 0.8 OUTLIER -151.68 161.36 42.8 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 110.369 -0.234 . . . . 0.0 110.369 179.874 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 1.011 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.2 OUTLIER -118.94 159.38 23.91 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.978 178.688 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.701 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -137.35 138.6 40.12 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.38 -178.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.645 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -133.68 159.94 39.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.946 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.747 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.1 OUTLIER -91.92 143.27 26.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 121.689 0.757 . . . . 0.0 112.275 -178.431 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.415 ' CG ' ' CG ' ' A' ' 21' ' ' PHE . 0.2 OUTLIER -117.21 174.74 5.95 Favored 'General case' 0 CA--C 1.513 -0.467 0 CA-C-N 114.46 -1.246 . . . . 0.0 110.009 179.983 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -68.83 -5.05 18.62 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.888 179.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -83.51 -7.25 59.57 Favored 'General case' 0 N--CA 1.454 -0.228 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.719 179.352 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 78.9 3.23 87.67 Favored Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.498 -0.858 . . . . 0.0 111.434 -178.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.729 ' HB3' ' HG ' ' A' ' 19' ' ' LEU . 0.6 OUTLIER -118.02 115.65 25.31 Favored 'General case' 0 CA--C 1.512 -0.487 0 C-N-CA 122.181 0.192 . . . . 0.0 111.338 179.855 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.747 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -100.11 125.53 53.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 176.356 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.839 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -127.93 -178.9 15.56 Favored Glycine 0 N--CA 1.432 -1.603 0 C-N-CA 119.95 -1.119 . . . . 0.0 112.555 -179.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.85 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.1 OUTLIER -73.76 135.39 43.57 Favored 'General case' 0 C--N 1.31 -1.141 0 CA-C-N 114.848 -0.676 . . . . 0.0 111.147 -179.224 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 1.011 HG13 ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -132.83 140.86 39.02 Favored Pre-proline 0 C--N 1.324 -0.51 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.254 -179.334 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.576 ' HD2' HG23 ' A' ' 52' ' ' VAL . 42.0 Cg_endo -79.92 114.53 3.17 Favored 'Trans proline' 0 N--CA 1.462 -0.325 0 C-N-CA 122.939 2.426 . . . . 0.0 111.404 178.65 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.491 ' HB3' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -57.95 -14.06 5.65 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.766 179.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -74.05 -8.04 54.67 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.873 -0.603 . . . . 0.0 111.407 -178.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.559 ' O ' HD22 ' A' ' 8' ' ' LEU . 3.6 m-85 -117.81 15.59 14.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.618 -179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.549 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.6 OUTLIER -149.97 176.28 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.268 0.556 . . . . 0.0 111.775 -179.345 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.661 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.9 p -135.75 116.11 18.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 115.304 -0.862 . . . . 0.0 108.852 177.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 22.2 t -65.13 146.44 13.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 113.148 0.796 . . . . 0.0 113.148 -177.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.676 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.1 OUTLIER -108.23 163.7 12.95 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-N 114.258 -1.337 . . . . 0.0 109.198 179.303 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.309 -1.181 0 CA-C-O 118.23 -0.89 . . . . 0.0 110.868 -179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.217 0 N-CA-C 112.501 -0.24 . . . . 0.0 112.501 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -132.62 147.18 52.34 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.82 0.343 . . . . 0.0 110.989 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -81.08 121.58 26.26 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.439 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -124.95 167.68 18.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.888 -178.824 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.974 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -133.55 157.7 42.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.454 0.645 . . . . 0.0 111.383 -179.544 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.818 ' HB2' HD13 ' A' ' 60' ' ' LEU . 11.4 tt0 -122.21 138.53 54.45 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.296 -0.866 . . . . 0.0 110.39 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.774 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.5 OUTLIER -112.28 156.63 22.08 Favored 'General case' 0 CA--C 1.517 -0.294 0 CA-C-O 121.257 0.551 . . . . 0.0 111.684 -179.761 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.814 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.5 -41.24 1.08 Allowed 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.752 179.572 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.495 ' H ' HD22 ' A' ' 8' ' ' LEU . 4.6 m-85 -94.45 161.64 28.51 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.095 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -54.45 -166.12 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.435 0 C-N-CA 122.744 2.296 . . . . 0.0 112.597 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.455 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 51.4 p90 -103.09 129.24 49.86 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.23 -179.709 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -129.61 118.3 21.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.987 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -143.84 118.69 9.92 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.39 -0.368 . . . . 0.0 110.891 179.779 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.586 HG22 ' O ' ' A' ' 14' ' ' VAL . 7.7 p -145.15 55.21 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.218 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.497 HG22 ' H ' ' A' ' 16' ' ' GLU . 1.5 m -149.7 172.47 15.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.837 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.497 ' H ' HG22 ' A' ' 15' ' ' THR . 1.6 tp10 -75.13 -33.85 61.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.299 -0.409 . . . . 0.0 110.62 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.598 ' HG3' HD22 ' A' ' 51' ' ' LEU . 10.4 pt-20 -98.75 28.97 3.96 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.856 179.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.566 ' HA ' ' H ' ' A' ' 51' ' ' LEU . 0.1 OUTLIER -124.85 -168.64 1.85 Allowed 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.204 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.962 HD11 ' CE2' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -178.85 148.94 0.43 Allowed 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.222 178.283 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -101.17 116.31 32.53 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 121.134 0.492 . . . . 0.0 112.075 -178.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.962 ' CE2' HD11 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -133.51 162.76 31.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.349 179.021 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.452 ' O ' ' HG3' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -76.73 97.6 4.52 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.407 0.622 . . . . 0.0 110.294 179.73 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.657 ' HD2' HG21 ' A' ' 7' ' ' THR . 0.1 OUTLIER -74.05 142.96 45.66 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.202 -179.919 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.18 -144.02 8.87 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.837 -0.696 . . . . 0.0 111.72 179.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -94.95 -16.32 22.89 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.016 0.436 . . . . 0.0 111.263 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -136.43 132.84 35.98 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.095 -179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.494 ' C ' HG13 ' A' ' 5' ' ' VAL . 1.3 tpt -138.57 164.64 28.93 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.209 -0.905 . . . . 0.0 109.56 178.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.697 ' O ' ' HB3' ' A' ' 42' ' ' CYS . 0.0 OUTLIER -125.14 114.21 18.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.79 0.328 . . . . 0.0 110.853 179.952 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.974 HG23 HG11 ' A' ' 5' ' ' VAL . 25.6 t -95.25 137.57 23.15 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.57 -179.342 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.645 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -86.53 -78.37 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.943 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.2 120.68 15.41 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.876 0.369 . . . . 0.0 110.787 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' HE3' ' O ' ' A' ' 29' ' ' VAL . 0.0 OUTLIER -101.79 150.2 37.15 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.833 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.406 ' HB3' ' HA ' ' A' ' 37' ' ' PRO . 2.9 Cg_exo -76.24 55.63 4.67 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.849 2.366 . . . . 0.0 112.268 -179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -88.59 -35.82 16.67 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.986 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -113.33 -36.62 4.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.985 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -123.8 100.95 36.77 Favored Pre-proline 0 C--N 1.331 -0.238 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.083 -179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.406 ' HA ' ' HB3' ' A' ' 33' ' ' PRO . 4.9 Cg_exo -74.5 59.14 4.72 Favored 'Trans proline' 0 C--N 1.346 0.427 0 C-N-CA 122.851 2.367 . . . . 0.0 112.154 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -102.76 -88.07 0.4 Allowed 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.338 -179.695 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 1.7 m-90 -151.26 152.84 33.79 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-O 120.617 0.246 . . . . 0.0 110.786 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.641 ' CD1' HG13 ' A' ' 52' ' ' VAL . 1.1 p90 -114.74 172.21 7.18 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.883 0.373 . . . . 0.0 110.985 179.38 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.7 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -143.68 138.86 29.22 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.903 -178.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.697 ' HB3' ' O ' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -131.71 157.73 43.02 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.362 -179.061 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.79 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 0.0 OUTLIER -92.17 143.05 26.82 Favored 'General case' 0 CA--C 1.518 -0.271 0 CA-C-O 121.248 0.546 . . . . 0.0 111.391 -179.281 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.526 ' HB2' ' CD2' ' A' ' 21' ' ' PHE . 3.9 t30 -120.87 174.69 6.46 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.453 -179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.584 ' HB3' HH21 ' A' ' 46' ' ' ARG . . . -63.12 -11.86 23.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.425 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.584 HH21 ' HB3' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -83.48 0.87 44.46 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.326 178.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 69.46 7.57 58.07 Favored Glycine 0 N--CA 1.45 -0.431 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.191 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.573 ' CD ' HD23 ' A' ' 19' ' ' LEU . 3.2 pt20 -118.26 114.78 23.52 Favored 'General case' 0 CA--C 1.514 -0.419 0 CA-C-O 121.025 0.44 . . . . 0.0 111.732 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.79 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -105.81 131.76 54.51 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.618 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 177.681 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.795 ' HA3' HD12 ' A' ' 19' ' ' LEU . . . -140.23 -170.14 11.92 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 120.324 -0.941 . . . . 0.0 111.559 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.7 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.5 OUTLIER -79.83 107.0 12.27 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.493 0.663 . . . . 0.0 111.466 -179.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.765 HG23 ' HD2' ' A' ' 53' ' ' PRO . 1.9 p -92.4 146.75 33.09 Favored Pre-proline 0 C--N 1.324 -0.523 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.982 -179.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.765 ' HD2' HG23 ' A' ' 52' ' ' VAL . 57.2 Cg_endo -60.55 88.13 0.08 OUTLIER 'Trans proline' 0 CA--C 1.519 -0.233 0 C-N-CA 123.395 2.73 . . . . 0.0 111.283 178.06 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.545 ' HA ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -52.69 -24.73 9.16 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -179.29 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -82.43 -6.66 59.43 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.935 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.532 ' CG ' ' HB2' ' A' ' 53' ' ' PRO . 17.0 m-30 -108.67 20.6 18.33 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.526 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.498 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.8 OUTLIER -150.07 176.78 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.22 0.533 . . . . 0.0 111.78 -179.138 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.771 HG13 ' HB3' ' A' ' 6' ' ' GLN . 5.0 p -132.85 113.56 20.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.395 -0.82 . . . . 0.0 108.824 177.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.48 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 21.9 t -65.67 147.26 12.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 -177.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.818 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -105.66 163.91 12.32 Favored 'General case' 0 N--CA 1.439 -0.989 0 CA-C-N 114.099 -1.409 . . . . 0.0 109.174 178.92 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 60.9 p . . . . . 0 C--N 1.309 -1.191 0 CA-C-O 118.283 -0.865 . . . . 0.0 110.95 -179.865 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.29 0 N-CA-C 112.477 -0.249 . . . . 0.0 112.477 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -88.31 127.18 35.47 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.708 0.29 . . . . 0.0 110.933 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.68 124.73 29.26 Favored 'General case' 0 CA--C 1.515 -0.382 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 178.405 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.458 ' O ' ' N ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.48 167.52 23.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.691 -178.569 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 1.114 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.12 147.96 32.18 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.714 0.769 . . . . 0.0 111.433 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.839 ' HB2' HD13 ' A' ' 60' ' ' LEU . 0.1 OUTLIER -106.24 140.39 39.25 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.921 -1.036 . . . . 0.0 109.969 -179.203 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.747 ' C ' HD13 ' A' ' 8' ' ' LEU . 1.0 OUTLIER -114.06 155.2 26.39 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.49 0.662 . . . . 0.0 112.456 -179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.838 ' N ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -131.51 -40.66 1.1 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 114.847 -1.069 . . . . 0.0 110.544 179.624 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.546 ' H ' HD22 ' A' ' 8' ' ' LEU . 1.7 m-85 -117.68 146.61 39.14 Favored Pre-proline 0 N--CA 1.462 0.14 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.751 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.426 ' HD3' ' HA ' ' A' ' 9' ' ' TYR . 26.4 Cg_exo -62.62 163.25 21.88 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.623 2.215 . . . . 0.0 112.926 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.54 ' CE1' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -117.77 153.06 34.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.76 -0.655 . . . . 0.0 110.548 179.205 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -125.67 136.66 53.46 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.056 0.455 . . . . 0.0 111.61 -179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.424 ' OG ' ' N ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -81.52 163.24 22.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.774 179.695 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.4 p -173.34 -42.69 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.812 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.487 HG22 ' H ' ' A' ' 16' ' ' GLU . 1.1 m -94.29 172.61 8.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.121 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.487 ' H ' HG22 ' A' ' 15' ' ' THR . 1.3 tp10 -65.2 -37.53 87.62 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.801 -179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.887 ' HB2' HD22 ' A' ' 51' ' ' LEU . 5.2 mt-10 -84.72 -4.07 58.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.361 -0.381 . . . . 0.0 110.922 179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.879 ' O ' HD12 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -78.9 170.69 16.28 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.772 179.995 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.879 HD12 ' O ' ' A' ' 18' ' ' GLU . 0.3 OUTLIER -159.0 156.25 29.02 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.252 0.548 . . . . 0.0 112.001 179.463 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -135.95 101.85 4.86 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.353 -0.839 . . . . 0.0 109.582 178.492 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.515 ' CE1' ' CZ ' ' A' ' 11' ' ' PHE . 0.0 OUTLIER -132.3 165.45 24.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.05 -0.977 . . . . 0.0 110.04 -179.741 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -62.28 102.24 0.29 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.582 0.706 . . . . 0.0 110.422 -178.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.633 ' CE ' HG21 ' A' ' 7' ' ' THR . 0.5 OUTLIER -73.45 143.64 46.59 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 114.685 -1.143 . . . . 0.0 112.641 -178.711 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.78 -160.34 11.39 Favored Glycine 0 N--CA 1.446 -0.638 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.656 177.664 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.2 mt-10 -95.33 10.9 34.53 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.949 0.375 . . . . 0.0 110.431 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.404 ' CG2' ' NE2' ' A' ' 6' ' ' GLN . 0.2 OUTLIER -155.59 133.41 11.28 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.388 0.614 . . . . 0.0 112.144 -179.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.613 ' HG2' HG13 ' A' ' 5' ' ' VAL . 1.5 ptm -139.04 164.71 29.05 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.983 178.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.536 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 13.3 pt-20 -124.77 112.27 16.51 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.181 0.515 . . . . 0.0 110.696 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 1.114 HG23 HG11 ' A' ' 5' ' ' VAL . 31.9 t -91.85 134.7 29.31 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.061 -179.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.625 ' CG1' ' HD2' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -103.79 -41.72 7.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 115.278 -0.874 . . . . 0.0 111.242 -179.427 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -90.9 107.83 19.45 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.669 179.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . 0.406 ' N ' ' HD2' ' A' ' 32' ' ' LYS . 6.7 mmmm -93.81 114.78 63.97 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.961 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.02 92.7 0.08 OUTLIER 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.125 . . . . 0.0 111.951 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 -84.42 -52.5 6.13 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.298 -179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -114.53 -29.21 6.91 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.244 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 66.1 m-20 -101.29 101.09 15.34 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.941 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -78.0 58.67 6.64 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 122.569 2.18 . . . . 0.0 112.304 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -98.53 -94.36 0.24 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.047 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . . . . . . . . . 13.7 m-90 -151.66 152.03 32.27 Favored 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 120.779 0.323 . . . . 0.0 111.129 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.959 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -105.27 171.27 7.41 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.281 179.121 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.771 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -133.14 136.92 46.06 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-O 121.147 0.499 . . . . 0.0 112.187 -179.117 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.67 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.6 p -126.05 152.12 46.22 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.155 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.691 ' HA ' HG12 ' A' ' 49' ' ' VAL . 0.4 OUTLIER -91.94 130.68 37.64 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.067 0.46 . . . . 0.0 110.343 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -108.57 174.61 5.8 Favored 'General case' 0 CA--C 1.512 -0.489 0 CA-C-N 115.652 -0.703 . . . . 0.0 110.353 -179.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -78.29 3.14 16.24 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.996 -0.547 . . . . 0.0 111.206 179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.461 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.0 OUTLIER -83.82 -6.19 59.37 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.374 179.452 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 95.8 -27.85 14.69 Favored Glycine 0 C--N 1.336 0.583 0 C-N-CA 121.031 -0.604 . . . . 0.0 113.812 178.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.484 ' O ' ' CD2' ' A' ' 19' ' ' LEU . 5.1 mm-40 -117.75 138.81 51.78 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.691 HG12 ' HA ' ' A' ' 43' ' ' LYS . 0.7 OUTLIER -104.9 146.88 11.54 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.081 178.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.821 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -133.12 -159.36 9.1 Favored Glycine 0 N--CA 1.442 -0.939 0 C-N-CA 120.487 -0.863 . . . . 0.0 111.56 177.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.887 HD22 ' HB2' ' A' ' 17' ' ' GLU . 0.4 OUTLIER -105.14 120.24 41.03 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-O 121.1 0.476 . . . . 0.0 111.089 -179.777 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.959 HG13 ' CD1' ' A' ' 40' ' ' TRP . 1.2 p -101.64 141.35 22.41 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.468 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.69 ' HD2' HG23 ' A' ' 52' ' ' VAL . 91.4 Cg_endo -70.82 105.1 1.59 Allowed 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 123.326 2.684 . . . . 0.0 111.23 178.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.51 ' HB3' ' CE2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -55.96 -21.84 23.14 Favored 'General case' 0 C--N 1.319 -0.733 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -179.281 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -76.12 -9.59 58.74 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.298 -179.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.51 ' O ' HD22 ' A' ' 8' ' ' LEU . 10.8 m-30 -110.39 18.79 19.48 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.643 -179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.506 HG23 ' N ' ' A' ' 58' ' ' VAL . 0.7 OUTLIER -150.23 176.81 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.266 0.555 . . . . 0.0 112.363 -178.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.827 HG13 ' HB3' ' A' ' 6' ' ' GLN . 7.1 p -136.33 118.5 20.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.207 -0.906 . . . . 0.0 108.992 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.478 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 18.9 t -65.47 147.25 12.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 114.04 1.126 . . . . 0.0 114.04 -177.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.839 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.8 OUTLIER -109.29 164.01 12.86 Favored 'General case' 0 N--CA 1.441 -0.891 0 CA-C-N 113.889 -1.505 . . . . 0.0 109.08 178.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 57.6 p . . . . . 0 C--N 1.308 -1.212 0 CA-C-O 118.293 -0.861 . . . . 0.0 110.858 -179.701 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.146 0 N-CA-C 112.582 -0.207 . . . . 0.0 112.582 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -113.73 142.87 45.52 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.81 0.338 . . . . 0.0 110.902 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.11 122.88 27.9 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.869 179.213 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.431 ' O ' ' CB ' ' A' ' 60' ' ' LEU . 0.0 OUTLIER -128.88 166.96 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.198 -178.975 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.947 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -134.96 158.1 41.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 115.954 -0.567 . . . . 0.0 110.477 179.096 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.735 ' HB2' HD13 ' A' ' 60' ' ' LEU . 1.9 tt0 -130.98 143.84 51.03 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.729 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.762 ' C ' HD13 ' A' ' 8' ' ' LEU . 0.0 OUTLIER -116.81 167.88 10.71 Favored 'General case' 0 CA--C 1.519 -0.218 0 CA-C-O 121.233 0.539 . . . . 0.0 110.999 179.621 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.901 HD21 ' O ' ' A' ' 56' ' ' TYR . 0.0 OUTLIER -130.93 -21.68 2.67 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.419 -0.81 . . . . 0.0 111.532 -179.189 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.776 ' CD2' HD23 ' A' ' 8' ' ' LEU . 22.3 m-85 -135.78 161.68 61.4 Favored Pre-proline 0 C--N 1.332 -0.162 0 CA-C-O 120.629 0.252 . . . . 0.0 110.859 -179.702 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.422 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 85.2 Cg_exo -46.68 173.38 0.02 OUTLIER 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.608 2.205 . . . . 0.0 112.546 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.462 ' CE2' ' CG2' ' A' ' 52' ' ' VAL . 2.9 t80 -102.29 138.92 38.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.266 -179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.07 118.49 27.84 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.618 179.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.5 m -109.29 171.72 7.27 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.969 0.414 . . . . 0.0 111.252 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 1.2 p -167.57 -41.36 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.942 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -76.28 172.54 12.71 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.319 -0.401 . . . . 0.0 110.782 179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -83.59 -30.12 27.23 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.802 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.415 ' O ' ' HB2' ' A' ' 51' ' ' LEU . 0.0 OUTLIER -96.07 33.19 1.76 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.136 -179.91 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.706 ' O ' HD12 ' A' ' 19' ' ' LEU . 2.6 mt-10 -117.85 -170.64 1.91 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.319 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.923 HD23 ' CZ ' ' A' ' 21' ' ' PHE . 0.4 OUTLIER -148.31 141.09 24.63 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -179.903 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.4 p30 -113.24 102.15 10.08 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.529 178.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.923 ' CZ ' HD23 ' A' ' 19' ' ' LEU . 8.9 m-30 -116.7 163.4 16.18 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.249 0.547 . . . . 0.0 112.083 -178.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -64.06 -156.68 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.308 -0.86 . . . . 0.0 111.228 -179.833 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.574 ' HD3' ' N ' ' A' ' 25' ' ' GLU . 0.0 OUTLIER -51.83 133.67 31.64 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 121.22 0.534 . . . . 0.0 111.517 -179.021 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.406 ' N ' ' HE3' ' A' ' 23' ' ' LYS . . . -110.38 92.59 0.69 Allowed Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.737 179.29 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.574 ' N ' ' HD3' ' A' ' 23' ' ' LYS . 2.5 tt0 -94.63 -20.63 19.42 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.59 0.71 . . . . 0.0 109.961 179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.452 HG23 ' O ' ' A' ' 25' ' ' GLU . 0.1 OUTLIER -168.13 130.88 1.51 Allowed 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 114.696 -1.138 . . . . 0.0 111.105 179.813 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.483 ' C ' HG13 ' A' ' 5' ' ' VAL . 2.7 mtt -138.85 164.54 29.38 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.829 179.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.614 ' O ' ' CB ' ' A' ' 42' ' ' CYS . 2.1 mt-10 -125.7 115.26 19.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.863 0.363 . . . . 0.0 111.076 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.947 HG23 HG11 ' A' ' 5' ' ' VAL . 13.1 t -92.71 131.74 38.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.511 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.645 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -90.79 -67.99 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.712 179.811 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.74 127.78 33.07 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.96 -0.385 . . . . 0.0 109.96 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.0 158.94 32.28 Favored Pre-proline 0 C--N 1.328 -0.362 0 CA-C-O 121.087 0.47 . . . . 0.0 111.912 -178.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.493 ' HG3' ' CZ3' ' A' ' 40' ' ' TRP . 60.1 Cg_endo -93.44 11.6 1.95 Allowed 'Trans proline' 0 N--CA 1.454 -0.839 0 C-N-CA 123.381 2.721 . . . . 0.0 113.09 -179.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -68.81 -29.55 67.93 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.853 0.359 . . . . 0.0 110.655 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -117.33 -38.87 3.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.738 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.06 100.94 35.92 Favored Pre-proline 0 C--N 1.33 -0.245 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.07 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.3 Cg_endo -82.33 53.09 4.36 Favored 'Trans proline' 0 C--N 1.346 0.406 0 C-N-CA 122.61 2.207 . . . . 0.0 112.413 179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -103.33 -83.79 0.48 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.578 -179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.448 ' HB2' ' HG ' ' A' ' 51' ' ' LEU . 0.3 OUTLIER -151.32 152.37 33.08 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.575 0.226 . . . . 0.0 110.77 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.725 ' HB2' HG13 ' A' ' 29' ' ' VAL . 4.5 p90 -119.63 172.12 7.89 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-O 121.024 0.44 . . . . 0.0 110.477 178.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.648 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -146.56 137.74 24.31 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.377 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.614 ' CB ' ' O ' ' A' ' 28' ' ' GLU . 5.6 p -129.42 153.69 47.67 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.597 -0.274 . . . . 0.0 110.701 -178.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.767 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -92.97 143.14 26.53 Favored 'General case' 0 CA--C 1.518 -0.285 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.848 -179.825 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . 0.559 ' HB3' ' CE2' ' A' ' 21' ' ' PHE . 32.0 t30 -121.88 174.48 6.85 Favored 'General case' 0 CA--C 1.51 -0.593 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.354 -179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -65.89 -0.2 2.15 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.264 0.554 . . . . 0.0 109.915 178.394 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.58 ' HG2' ' CD1' ' A' ' 21' ' ' PHE . 0.0 OUTLIER -82.92 -7.95 59.62 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.273 -0.876 . . . . 0.0 109.717 179.115 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 77.78 -5.52 52.36 Favored Glycine 0 C--N 1.337 0.629 0 C-N-CA 121.125 -0.559 . . . . 0.0 112.234 -178.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.775 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -119.1 138.75 52.68 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 121.052 0.453 . . . . 0.0 112.15 -179.618 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.767 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.1 OUTLIER -123.57 126.29 72.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.231 178.038 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.908 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -119.06 -168.16 13.98 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.94 179.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.648 HD12 ' HB3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -87.87 129.08 35.33 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.276 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.663 HG11 ' HE2' ' A' ' 54' ' ' LYS . 4.9 p -134.12 131.38 20.74 Favored Pre-proline 0 C--N 1.324 -0.507 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -177.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' O ' ' CD2' ' A' ' 56' ' ' TYR . 15.7 Cg_endo -84.55 92.2 0.76 Allowed 'Trans proline' 0 CA--C 1.529 0.268 0 C-N-CA 123.365 2.71 . . . . 0.0 110.288 177.257 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.663 ' HE2' HG11 ' A' ' 52' ' ' VAL . 0.0 OUTLIER -67.3 -9.51 41.61 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.369 0.507 . . . . 0.0 112.369 -178.304 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -46.75 -20.86 0.15 Allowed 'General case' 0 CA--C 1.536 0.416 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 179.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.901 ' O ' HD21 ' A' ' 8' ' ' LEU . 14.3 p90 -102.69 12.72 35.92 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.713 0.292 . . . . 0.0 111.174 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.664 ' HB ' ' HA ' ' A' ' 7' ' ' THR . 0.9 OUTLIER -134.27 176.57 8.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.934 -178.757 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.656 HG13 ' HB3' ' A' ' 6' ' ' GLN . 8.9 p -107.58 112.54 40.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 177.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.34 146.49 10.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.551 0.691 . . . . 0.0 112.322 -178.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.804 ' H ' ' HA ' ' A' ' 5' ' ' VAL . 0.4 OUTLIER -98.69 160.89 13.96 Favored 'General case' 0 N--CA 1.432 -1.329 0 CA-C-N 114.824 -1.08 . . . . 0.0 109.186 179.137 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 4.8 t . . . . . 0 C--N 1.306 -1.287 0 CA-C-O 118.214 -0.898 . . . . 0.0 110.984 -179.68 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.167 0 N-CA-C 112.481 -0.248 . . . . 0.0 112.481 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.04 138.96 41.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.664 0.268 . . . . 0.0 111.03 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.9 115.47 20.4 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.773 HG13 ' HG2' ' A' ' 28' ' ' GLU . 0.1 OUTLIER -128.43 167.22 24.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.178 -178.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.988 HG11 HG23 ' A' ' 29' ' ' VAL . 0.2 OUTLIER -132.38 160.51 42.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.385 0.612 . . . . 0.0 110.974 179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.82 ' HB2' HD13 ' A' ' 60' ' ' LEU . 3.9 tt0 -126.05 144.52 50.69 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.503 -178.99 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.72 HG23 ' SD ' ' A' ' 27' ' ' MET . 0.0 OUTLIER -113.63 139.81 48.72 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.266 0.555 . . . . 0.0 111.317 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.862 ' CD2' ' HA ' ' A' ' 57' ' ' VAL . 0.2 OUTLIER -107.96 -48.33 3.41 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.327 -0.852 . . . . 0.0 111.082 -179.379 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . 0.424 ' HB3' ' HD2' ' A' ' 10' ' ' PRO . 52.5 m-85 -93.62 161.57 30.03 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.857 -0.611 . . . . 0.0 111.276 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.424 ' HD2' ' HB3' ' A' ' 9' ' ' TYR . 11.7 Cg_endo -54.56 -165.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.817 2.345 . . . . 0.0 112.119 179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . 0.456 ' CG ' ' O ' ' A' ' 21' ' ' PHE . 45.5 p90 -108.28 128.68 54.95 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.847 0.356 . . . . 0.0 111.239 -179.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.5 t -130.13 117.89 20.62 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.586 179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.459 ' CB ' ' HB3' ' A' ' 18' ' ' GLU . 1.2 m -147.71 124.27 11.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.841 0.353 . . . . 0.0 111.644 179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 34.8 m -137.74 -4.14 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-N 116.083 -0.508 . . . . 0.0 112.114 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.444 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.6 m -91.84 168.68 11.26 Favored 'General case' 0 N--CA 1.463 0.197 0 CA-C-O 120.804 0.335 . . . . 0.0 111.244 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.444 ' H ' HG22 ' A' ' 15' ' ' THR . 0.2 OUTLIER -67.5 -37.58 83.03 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.359 -179.694 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -91.96 16.93 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.767 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLU . . . . . 0.827 ' O ' HD12 ' A' ' 19' ' ' LEU . 12.6 mt-10 -104.62 -176.62 3.13 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.958 -179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.827 HD12 ' O ' ' A' ' 18' ' ' GLU . 0.4 OUTLIER -159.07 137.62 10.84 Favored 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -179.943 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.5 p-10 -108.89 100.49 9.69 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.72 178.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PHE . . . . . 0.456 ' O ' ' CG ' ' A' ' 11' ' ' PHE . 0.1 OUTLIER -133.99 162.85 30.93 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.693 -0.685 . . . . 0.0 109.93 179.852 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 25.2 mp0 -71.12 97.29 1.47 Allowed 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.297 -0.561 . . . . 0.0 110.072 179.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.655 ' HG2' HG21 ' A' ' 7' ' ' THR . 11.6 tppt? -74.71 135.43 41.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.71 -179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.14 -160.62 22.54 Favored Glycine 0 N--CA 1.446 -0.663 0 C-N-CA 120.808 -0.711 . . . . 0.0 111.47 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.732 ' O ' HG23 ' A' ' 26' ' ' THR . 2.6 tt0 -94.9 24.07 5.06 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.576 0.227 . . . . 0.0 111.211 179.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' THR . . . . . 0.732 HG23 ' O ' ' A' ' 25' ' ' GLU . 1.5 p -169.79 123.12 0.74 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.369 0.604 . . . . 0.0 111.843 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' MET . . . . . 0.72 ' SD ' HG23 ' A' ' 7' ' ' THR . 0.8 OUTLIER -139.45 164.73 29.1 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.421 178.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.773 ' HG2' HG13 ' A' ' 4' ' ' VAL . 0.3 OUTLIER -121.41 120.51 35.18 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.64 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' VAL . . . . . 0.988 HG23 HG11 ' A' ' 5' ' ' VAL . 37.3 t -98.57 129.94 48.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.24 0.543 . . . . 0.0 111.674 -179.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.637 HD11 ' HD3' ' A' ' 41' ' ' LYS . 0.0 OUTLIER -81.59 -84.46 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.213 179.987 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -66.77 147.49 53.18 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.877 0.37 . . . . 0.0 110.8 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.36 159.27 32.75 Favored Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.201 -179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.0 -1.33 6.8 Favored 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.814 2.343 . . . . 0.0 113.166 -179.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLU . . . . . . . . . . . . . 17.3 pt-20 -59.14 -46.24 88.85 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 110.531 179.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 13.8 p30 -107.49 -30.18 8.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.414 179.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -72.55 148.36 90.29 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.59 179.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -40.41 -76.26 0.03 OUTLIER 'Trans proline' 0 C--N 1.347 0.467 0 C-N-CA 123.147 2.565 . . . . 0.0 112.713 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.416 ' O ' ' CD1' ' A' ' 39' ' ' TRP . 3.1 tt0 -161.18 14.43 0.1 Allowed 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' TRP . . . . . 0.416 ' CD1' ' O ' ' A' ' 38' ' ' GLU . 5.9 m0 -138.96 146.08 40.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.775 0.322 . . . . 0.0 111.002 179.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.738 ' CD1' HG13 ' A' ' 52' ' ' VAL . 0.1 OUTLIER -111.95 178.66 4.24 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.062 179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.912 ' HB3' HD12 ' A' ' 51' ' ' LEU . 0.0 OUTLIER -141.73 137.03 31.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.143 -179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' CYS . . . . . 0.556 ' O ' ' HB ' ' A' ' 49' ' ' VAL . 2.4 p -132.56 156.22 47.24 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.077 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.815 ' HA ' ' HB ' ' A' ' 49' ' ' VAL . 1.0 OUTLIER -91.81 136.71 32.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.553 0.692 . . . . 0.0 111.446 -179.204 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -113.07 174.97 5.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 114.65 -1.159 . . . . 0.0 109.805 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . . . . . . . . . . . -74.17 0.78 12.94 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.869 179.215 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ARG . . . . . 0.448 ' O ' ' HG3' ' A' ' 46' ' ' ARG . 0.1 OUTLIER -83.78 -6.66 59.48 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.671 179.701 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 88.08 -18.39 40.85 Favored Glycine 0 C--N 1.338 0.657 0 C-N-CA 120.915 -0.659 . . . . 0.0 113.535 178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLN . . . . . 0.728 ' HB3' HD21 ' A' ' 19' ' ' LEU . 9.5 mm100 -118.26 138.22 52.51 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 120.744 0.307 . . . . 0.0 110.74 -179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' VAL . . . . . 0.815 ' HB ' ' HA ' ' A' ' 43' ' ' LYS . 0.2 OUTLIER -115.77 127.13 73.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.01 0.433 . . . . 0.0 110.49 178.908 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.764 ' HA3' ' HB2' ' A' ' 19' ' ' LEU . . . -112.66 -144.34 9.17 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.541 -0.838 . . . . 0.0 111.477 179.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . 0.912 HD12 ' HB3' ' A' ' 41' ' ' LYS . 1.0 OUTLIER -113.69 116.12 28.93 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-O 121.044 0.45 . . . . 0.0 110.503 179.515 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.738 HG13 ' CD1' ' A' ' 40' ' ' TRP . 0.2 OUTLIER -92.43 140.44 24.15 Favored Pre-proline 0 C--N 1.324 -0.507 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.876 -179.477 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 52' ' ' VAL . 59.0 Cg_endo -62.89 92.96 0.14 Allowed 'Trans proline' 0 C--N 1.343 0.257 0 C-N-CA 123.486 2.791 . . . . 0.0 111.598 178.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' CB ' ' CZ2' ' A' ' 40' ' ' TRP . 0.0 OUTLIER -53.19 -22.85 7.21 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 120.866 0.365 . . . . 0.0 111.815 -179.523 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -78.91 -11.93 60.01 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.202 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' TYR . . . . . 0.416 ' HB3' ' HB2' ' A' ' 9' ' ' TYR . 9.2 m-30 -110.2 15.72 22.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.989 -179.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.862 ' HA ' ' CD2' ' A' ' 8' ' ' LEU . 0.9 OUTLIER -142.11 166.35 16.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-O 121.376 0.608 . . . . 0.0 112.564 -179.098 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.544 ' O ' HG13 ' A' ' 58' ' ' VAL . 12.8 p -123.1 113.96 40.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.294 178.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' CG2' ' CH2' ' A' ' 40' ' ' TRP . 17.8 t -65.4 146.91 12.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.804 0.811 . . . . 0.0 113.112 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.82 HD13 ' HB2' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -103.68 163.63 12.2 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.067 178.734 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.8 p . . . . . 0 C--N 1.307 -1.256 0 CA-C-O 118.299 -0.858 . . . . 0.0 110.999 -179.745 . . . . . . . . 0 0 . 1 stop_ save_